Patent Grant
11988965
An Application Data Sheet is filed concurrently with this specification as part of the present application. Each application that the present application claims benefit of or priority to as identified in the concurrently filed Application Data Sheet is incorporated by reference herein in their entireties and for all purposes.
This disclosure relates generally to the field of semiconductor processing, and in particular to extreme ultraviolet (EUV) photoresist (PR) lithography techniques and materials.
As semiconductor fabrication continues to advance, feature sizes continue to shrink, and new processing methods are needed. One area where advances are being made is in the context of patterning, for example using photoresist materials that are sensitive to lithographic radiation.
The background description provided herein is for the purposes of generally presenting the context of the disclosure. Work of the presently named inventors, to the extent it is described in this background section, as well as aspects of the description that may not otherwise qualify as prior art at the time of filing, are neither expressly nor impliedly admitted as prior art against the present disclosure.
Various embodiments herein relate to methods, materials, apparatus, and systems for depositing an underlayer on a substrate.
In a first aspect, the present disclosure encompasses a pattering structure including: a radiation-sensitive imaging layer disposed over a substrate; and an underlayer disposed between the substrate and the imaging layer. In some embodiments, the underlayer is configured to: increase adhesion between the substrate and the imaging layer and/or reduce a radiation dose for effective photoresist exposure of the imaging layer.
In some embodiments, the substrate further includes a hardmask disposed thereon.
In some embodiments, the imaging layer includes an Extreme Ultraviolet (EUV)-sensitive inorganic photoresist layer. In particular embodiments, the imaging layer is a chemical vapor deposited (CVD) film, an atomic layer deposition (ALD) film, or a spin-on film. In other embodiments, the imaging layer includes a tin oxide film or a tin oxide hydroxide film.
In some embodiments, the substrate is or includes a hardmask, amorphous carbon film, amorphous hydrogenated carbon film, silicon oxide film, silicon nitride film, silicon oxynitride film, silicon carbide film, silicon boronitride film, amorphous silicon film, polysilicon film, or a combination thereof. In particular embodiments, the amorphous carbon film is doped with boron (B) or tungsten (W).
In some embodiments, the underlayer has a thickness of no more than 25 nm. In other embodiments, the underlayer has a thickness of about 2 to 20 nm.
In particular embodiments, the underlayer includes a hydronated carbon doped with oxygen (O), silicon (Si), nitrogen (N), tungsten (W), boron (B), iodine (I), chlorine (Cl), or a combination of two or more of any of these. In particular embodiments, the underlayer includes about 0-30 atomic % oxygen (O) and/or about 20-50 atomic % hydrogen (H) and/or 30-70 atomic % carbon (C). In other embodiments, the underlayer includes the hydronated carbon doped with iodine configured to improve generation of secondary electrons upon exposure to radiation. In yet other embodiments, a surface of the underlayer includes hydroxyl groups (e.g., —OH), carboxyl groups (e.g., —CO2H), peroxy groups (e.g., —OOH), sp2 carbons, sp carbons, and/or unsaturated carbon-containing bonds (e.g., C═C and/or C≡C bonds).
In some embodiments, the underlayer includes a density of about 0.7 to 2.9 g/cm3. In other embodiments, the underlayer further provides increased etch selectivity. In yet other embodiments, the underlayer further provides decreased line edge and line width roughness and/or decreased dose to size.
In particular embodiments, the underlayer further includes beta hydrogen atoms configured to be released upon exposure to radiation and/or oxygen atoms configured to form oxygen bonds to an atom in the imaging layer.
In a second aspect, the present disclosure encompasses a pattering structure including: a substrate including a partially fabricated semiconductor device film stack; a radiation-sensitive imaging layer disposed over the substrate; and an underlayer disposed between the substrate and the imaging layer. In particular embodiments, the underlayer includes a vapor deposited film of hydronated carbon doped with O, Si, N, W, B, I, Cl, or a combination of two or more of any of these, wherein the film has a thickness of no more than about 25 nm or a thickness of about 2 to 20 nm. In yet other embodiments, the substrate further includes an amorphous carbon hardmask disposed on the substrate and/or disposed on the partially fabricated semiconductor device film stack. In some embodiments, the amorphous carbon hardmask is doped.
In a third aspect, the present disclosure encompasses a method of making a pattering structure, including: providing a substrate; depositing an underlayer (e.g., any described herein) on the substrate; and forming a radiation-sensitive imaging layer on the underlayer. In some embodiments, the underlayer is configured to: increase adhesion between the substrate and the photoresist and/or reduce radiation dose for effective photoresist exposure.
In some embodiments, the substrate is a partially fabricated semiconductor device film stack. In other embodiments, the substrate further comprises a hardmask, amorphous carbon film, amorphous hydrogenated carbon film, silicon oxide film, silicon nitride film, silicon oxynitride film, silicon carbide film, silicon boronitride film, amorphous silicon film, polysilicon film, or a combination thereof, disposed thereon the substrate and/or the partially fabricated semiconductor device film stack; the imaging layer includes a tin oxide-based photoresist or a tin oxide hydroxide-based photoresist; and the underlayer includes a vapor deposited film of hydronated carbon doped with O, Si, N, W, B, I, Cl, or a combination of two or more of any of these, wherein the film has a thickness of no more than 25 nm.
In some embodiments, the underlayer is vapor deposited on the substrate using a hydrocarbon precursor, thereby providing a carbon-containing film. In particular embodiments, the hydrocarbon precursor includes an alkane, an alkene, an alkyne, or other hydrocarbon precursors described herein. In other embodiments, the underlayer is vapor deposited using the hydrocarbon precursor in the presence or absence of an oxocarbon precursor (e.g., any described herein including carbon and oxygen atoms).
In yet other embodiments, the underlayer is vapor deposited using the hydrocarbon precursor in the presence of a nitrogen-containing precursor, a tungsten-containing precursor, a boron-containing precursor, and/or an iodine-containing precursor, thereby providing a doped film. In some embodiments, the doped film includes iodine; a combination of iodine and silicon; or a combination of iodine, silicon, and nitrogen.
In some embodiments, the underlayer is vapor deposited on the substrate using an oxocarbon precursor that co-reacts with hydrogen (H2) or a hydrocarbon. In other embodiments, the oxocarbon precursor co-reacts with H2 or a hydrocarbon and optionally further co-reacts with a Si source dopant. In particular embodiments, the underlayer is vapor deposited on the substrate by using a Si-containing precursor that co-reacts with an oxidizer (e.g., an oxocarbon or an O-containing precursor). In further embodiments, the Si-containing precursor further co-reacts with a C source dopant (e.g., a hydrocarbon precursor).
In some embodiments, said depositing further includes applying a bias at a bias power of 0 W to about 1000 W (e.g., from 0-500 W, 0-400 W, or 0-300 W) and using a duty cycle of about 1% to 100% or about 5% to 100%. In particular embodiments, said applying the bias provides the underlayer having an increased density, as compared to an underlayer formed without applying the bias.
In some embodiments, the underlayer is vapor deposited on the substrate by plasma enhanced chemical vapor deposition (PECVD) as a termination operation of a vapor deposition on the substrate. In other embodiments, the underlayer is vapor deposited on the substrate by PECVD or ALD.
In further embodiments, the method includes (e.g., after said depositing) modifying the underlayer to provide a roughened surface. In some embodiments, said modifying can include sputtering by way of non-reactive ion bombardment of a surface of the underlayer, thereby providing the roughened surface. Non-limiting non-reactive ions can include argon (Ar), helium (He), krypton (Kr), or other non-reactive species. In other embodiments, modifying can include exposing a surface of the underlayer or the roughened surface to an oxygen-containing plasma to provide an oxygen-containing surface. Non-limiting oxygen-containing plasma can include carbon dioxide (CO2), oxygen (O2), or water (as H2O or as mixtures of H2 and O2).
In a fourth aspect, the present disclosure encompasses a method of depositing an underlayer, the method including: providing a substrate in a process chamber; and depositing by a PECVD process a hydronated carbon film on a surface of the substrate, wherein the hydronated carbon film is a low density film. In some embodiments, the substrate is or includes a hardmask.
In some embodiments, the PECVD process includes introducing a carbon-containing precursor selected from methane (CH4), acetylene (C2H2), ethylene (C2H4), propylene (C3H6), propyne (C3H4), allene (C3H4), cyclopropene (C3H4), butane (C4H10), cyclohexane (C6H12), benzene (C6H6), and toluene (C7H8). In other embodiments, the PECVD process further includes introducing nitrogen-containing precursor, a tungsten-containing precursor, a boron-containing precursor, and/or an iodine-containing precursor, thereby providing a doped film.
In some embodiments, the PECVD process includes a transformer coupled plasma (TCP) or an inductively coupled plasma (ICP). In particular embodiments, a TCP power is about 100-1000 W with no bias. In other embodiments, the PECVD process further includes a pressure of about 10-1000 mTorr and/or a temperature of about 0-100° C. In yet other embodiments, the PECVD process further includes an applied pulsed bias including a power of about 10-1000 W or an applied continuous wave bias including a power of about 10-500 W. In further embodiments, the applied pulsed bias includes a duty cycle of about 1-99% and a pulsing frequency of about 10-2000 Hz.
In further embodiments, the method includes (e.g., after said depositing) modifying the hydronated carbon film to provide a roughened surface. In some embodiments, said modifying can include sputtering by way of non-reactive ion bombardment of a surface of the film, thereby providing the roughened surface. Non-limiting non-reactive ions can include argon (Ar), helium (He), krypton (Kr), or other non-reactive species. In other embodiments, modifying can include exposing a surface of the film or the roughened surface to an oxygen-containing plasma to provide an oxygen-containing surface. Non-limiting oxygen-containing plasma can include carbon dioxide (CO2), oxygen (O2), or water (as H2O or as mixtures of H2 and O2).
In a fifth aspect, the present disclosure features an apparatus for processing a substrate, the apparatus including: a process chamber including a substrate support; a process gas source connected with the process chamber and associated flow-control hardware; substrate handling hardware connected with the process chamber; and a controller having a processor and a memory, wherein the processer and the memory are communicatively connected with one another. In particular embodiments, the processor is at least operatively connected with the flow-control and substrate handling hardware.
In particular embodiments, the substrate support can be a chuck or a pedestal. In other embodiments, the apparatus includes one or more gas inlets into the process chambers, in which the gas inlet(s) are fluidically connected to the process gas source and the associated flow-control hardware; and one or more gas outlets for removing materials from the process chamber and associated flow-control hardware.
In some embodiments, the memory stores computer-executable instructions for conducting the operations recited in any methods described herein. In one embodiment, the computer-executable instructions include machine-readable instructions for causing providing a substrate or a hardmask disposed on a substrate; causing deposition of an underlayer (e.g., any described herein) on the substrate and/or the hardmask; and causing formation of a radiation-sensitive imaging layer (e.g., any described herein) on the underlayer.
In another embodiment, the computer-executable instructions include machine-readable instructions for causing deposition by a PECVD process a hydronated carbon film (e.g., any described herein) on a surface of the substrate or the hardmask. In further embodiments, the computer-executable instructions include machine-readable instructions for causing formation of a radiation-sensitive imaging layer (e.g., any described herein) on the hydronated carbon film.
In particular embodiments, said causing deposition of the underlayer includes introducing or delivering one or more precursors (e.g., a hydrocarbon precursor, an oxocarbon precursor, a C-containing precursor, an O-containing precursor, an Si-containing precursor, an N-containing precursor, a W-containing precursor, a B-containing precursor, an I-containing precursor, or a Cl-containing precursor) and/or one or more process gases (e.g., any described herein).
In other embodiments, said causing deposition of the underlayer includes a plasma (e.g., transformer coupled plasma (TCP), inductively coupled plasma (ICP), or capacitively coupled plasma (CCP)). In particular embodiments, the plasma is TCP or ICP with a power of about 100-1000 W, a pressure of about 10-1000 mTorr, and/or a temperature of about 0-100° C. In yet other embodiments, the plasma further comprises an applied pulsed bias (e.g., a power of about 10-1000 W) or an applied continuous wave bias (e.g., a power of about 10-500 W).
In some embodiments, said causing formation of the imaging layer includes causing deposition of an element having a high patterning radiation-absorption cross-section. In particular embodiments, the element has a high EUV absorption cross-section (e.g., equal to or greater than 1×107 cm2/mol).
In other embodiments, causing formation of the imaging layer includes introducing or delivering one or more precursors (e.g., a structure having formula (I), (II), (IIa), (III), (IV), (V), (VI), (VII), or (VIII)). In some embodiments, causing formation of the imaging layer can further include providing the one or more precursors in the presence of the counter-reactant. Non-limiting counter-reactants include an oxygen-containing counter-reactant, including oxygen (O2), ozone (O3), water, a peroxide, hydrogen peroxide, oxygen plasma, water plasma, an alcohol, a dihydroxy alcohol, a polyhydroxy alcohol, a fluorinated dihydroxy alcohol, a fluorinated polyhydroxy alcohol, a fluorinated glycol, formic acid, and other sources of hydroxyl moieties, as well as combinations thereof.
In any embodiment herein, the substrate is or includes a partially fabricated semiconductor device film stack.
In any embodiment herein, the substrate is a hardmask. In other embodiments, the substrate includes a hardmask. In yet other embodiments, the substrate includes a hardmask disposed on a work piece (e.g., disposed on a wafer, a semiconductor wafer, a stack, a partially fabricated integrated circuit, a partially fabricated semiconductor device film stack, a film, a surface, etc.). In non-limiting instances, the hardmask includes an amorphous carbon hardmask, which can be optionally doped.
In any embodiment herein, the imaging layer includes an EUV-sensitive inorganic photoresist layer. In particular embodiments, the imaging layer includes a tin oxide film, a tin oxide hydroxide film, a tin oxide-based photoresist, or a tin oxide hydroxide-based photoresist. In other embodiments, the imaging layer includes an EUV-sensitive film, a DUV-sensitive film, a UV-sensitive film, a photoresist film, a photopatternable film.
In any embodiment herein, the substrate is or includes a hardmask, amorphous carbon film, amorphous hydrogenated carbon film, silicon oxide film, silicon nitride film, silicon oxynitride film, silicon carbide film, silicon boronitride film, amorphous silicon film, polysilicon film, or a combination thereof. In some embodiments, the hardmask is an amorphous carbon film, amorphous hydrogenated carbon film, silicon oxide film, silicon nitride film, silicon oxynitride film, silicon carbide film, silicon boronitride film, amorphous silicon film, polysilicon film, or a combination thereof.
In any embodiment herein, the underlayer includes a hydronated carbon doped with oxygen (O), silicon (Si), nitrogen (N), tungsten (W), boron (B), iodine (I), chlorine (Cl), or a combination of two or more of any of these.
In any embodiment herein, the underlayer or a surface of the underlayer includes hydroxyl groups (e.g., —OH), carboxyl groups (e.g., —CO2H), peroxy groups (e.g., —OOH), sp2 carbons, sp carbons, and/or unsaturated carbon-containing bonds (e.g., C═C and/or C≡C bonds).
In any embodiment herein, the underlayer includes a doped film. In particular embodiments, the doped film includes I; a combination of I and Si; or a combination of I, Si, and N. In some embodiments, the doped film includes Cl; a combination of Cl and Si; or a combination of Cl, Si, and N. In other embodiments, the doped films includes N; a combination of N and Si; or a combination of N, Si, and O. In yet other embodiments, the doped film includes B or W.
In any embodiment herein, the underlayer includes about 0-30 atomic % O (e.g., 1-30%, 2-30%, or 4-30%), about 20-50 atomic % H (e.g., 20-45%, 30-50%, or 30-45%), and/or 30-70 atomic % C (e.g., 30-60%, 30-65%, or 30-68%).
In any embodiment herein, the underlayer includes a density less than about 1.5 g/cm3 or a density of about 0.7-1.4 g/cm3. In yet other embodiments, the doped film has a density of about 0.7-1.4 g/cm3.
In any embodiment herein, the underlayer further provides increased etch selectivity. In yet other embodiments, the underlayer further provides decreased line edge and line width roughness and/or decreased dose to size. In particular embodiments, the underlayer further includes beta hydrogen atoms configured to be released upon exposure to radiation and/or oxygen atoms configured to form oxygen bonds to an atom in the imaging layer.
In any embodiment herein, depositing includes providing or depositing the precursor(s) in vapor form. In other embodiments, depositing includes providing one or more counter-reactant(s) in vapor form. In particular embodiments, depositing includes CVD, ALD, or plasma-enhanced forms thereof (e.g., PECVD).
In any embodiment herein, depositing can include delivering or introducing one or more precursors described herein. Non-limiting precursors include a hydrocarbon precursor, an oxocarbon precursor, and/or a dopant precursor (e.g., an O-containing precursor, an Si-containing precursor, an N-containing precursor, a W-containing precursor, a B-containing precursor, an I-containing precursor, or a Cl-containing precursor). Said depositing can also include delivering or introducing one or more process gases, such as an inert gas, carbon monoxide (CO), carbon dioxide (CO2), helium (He), argon (Ar), krypton (Kr), neon (Ne), nitrogen (N2), hydrogen (H2), or combinations thereof.
In any embodiment herein, depositing can include providing a plasma. Providing can include a PECVD process. Non-limiting plasma processes can include TCP, ICP, or CCP. Other non-limiting process conditions include a pressure of >1 milliTorr (mTorr) (e.g., from about 5-1000 mTorr), a power level of <4000 Watts (W) (e.g., from about 10-3000 W), and/or a temperature of <200° C. (e.g., from about 0-100° C.). Plasma can be generated with a power between about 10-3000 W with a radio frequency (RF) source operating at 0.3-600 MHz. Bias can be applied using an applied pulsed bias (e.g., a power of about 10-1000 W) or an applied continuous wave bias (e.g., a power of about 10-500 W), as described herein.
Other features and advantages of the invention will be apparent from the following description and the claims.
Reference is made herein in detail to specific embodiments of the disclosure. Examples of the specific embodiments are illustrated in the accompanying drawings. While the disclosure will be described in conjunction with these specific embodiments, it will be understood that it is not intended to limit the disclosure to such specific embodiments. On the contrary, it is intended to cover alternatives, modifications, and equivalents as may be included within the spirit and scope of the disclosure. In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present disclosure. The present disclosure may be practiced without some or all of these specific details. In other instances, well known process operations have not been described in detail so as to not unnecessarily obscure the present disclosure.
Extreme ultraviolet (EUV) lithography—typically at a wavelength of 13.5 nm—is considered as the next enabling technology for lithographic patterning. However, a number of technological stumbling blocks have delayed the widespread introduction and implementation of this technique. EUV photoresist (PR) is one of the roadblocks.
Traditional chemically amplified resist (CAR) provides a cost-effective approach. But organic polymer CARs generate line edge roughness (LER) and line width roughness (LWR), and have sensitivity and resolution limitations due to random fluctuation of the use of polymer. Recent research and development efforts have focused on new EUV inorganic photoresist platform development. Such systems offer several advantages compared to a polymer-based CAR system. These inorganic photoresists are generally based on metal oxides, including metal hydroxide oxides. The small metal oxide molecule size enhances ultimate resolution of the patterning step, and metal oxide photoresists generally show higher etch resistance than CAR, which can reduce PR thickness to reduce structure aspect ratio.
However, there are various challenges associated with inorganic PR, as well. Spin-On-Carbon (SOC) hardmask materials are often used in hardmask film stacks to which EUV PRs are applied for patterning. But SOCs have a soft carbon (C)-rich film with poor etch resistance and poor LWR. Common hardmask materials such as silicon oxide (e.g., silicon dioxide, SiO2), silicon nitride, and ashable hardmasks (AHMs) can be used directly under PR for better etch selectivity and good LER and LWR. But delamination between EUV PR and hardmask material, particularly after wet development of the EUV-exposed PR, is a persistent problem. And only about twenty percent of the EUV photons are absorbed by a typical PR, meaning that a large amount of primary and secondary electrons will often be created in a PR underlayer. Dose to Size (DtS) data have shown that there is higher dose required for EUV inorganic PR disposed directly on a common hardmask material than for EUV inorganic PR on SOC for resolving the same line critical dimension.
As described herein, a thin underlayer film disposed directly under the EUV inorganic PR enables a film stack EUV inorganic PR having improved performance. With this underlayer, the resulting multilayer (e.g., bilayer) hardmask scheme has comparable or better DtS performance, as compared to EUV inorganic PR directly on a SOC stack. And the underlayer can also serve as an adhesion layer between the EUV inorganic PR and the hardmask, regardless of hardmask film composition, which enables improved etch selectivity and LER/LWR performance. Surfaces other than a hardmask can be employed below the underlayer, in which the underlayer can serve as an adhesion layer between the EUV PR and any useful substrate (e.g., a hardmask, a wafer, a partially fabricated semiconductor device film stack, etc.).
As further described below, suitable underlayer thin films can be deposited by chemical vapor deposition (CVD), plasma enhanced chemical vapor deposition (PECVD), atomic layer deposition (ALD), plasma enhanced atomic layer deposition (PEALD), or other vapor deposition methods (e.g. by sputter deposition, physical vapor deposition (PVD) including PVD co-sputtering). The underlayer deposition process can be implemented in either an etch tool (e.g., Kiyo® or Flex®, available from Lam Research Corporation, Fremont, CA) or a deposition tool (e.g., Lam Striker®). In some implementations, it can be integrated as a termination step in a hardmask deposition process. Different film compositions of the underlayer can be chosen depending on the film stack.
It should also be understood that while the present disclosure relates to lithographic patterning techniques and materials exemplified by EUV lithography, it is also applicable to other next generation lithographic techniques. In addition to EUV, which includes the standard 13.5 nm EUV wavelength currently in use and development, the radiation sources most relevant to such lithography are DUV (deep-UV), which generally refers to use of 248 nm or 193 nm excimer laser sources; X-ray, which formally includes EUV at the lower energy range of the X-ray range; as well as e-beam, which can cover a wide energy range. Such methods include those where a substrate, having exposed hydroxyl groups, is contacted with a hydrocarbyl-substituted tin capping agent to form a hydrocarbyl-terminated tin oxide (SnOx) film as the imaging/PR layer on the surface of the substrate. The specific methods may depend on the particular materials and applications used in the semiconductor substrate and ultimate semiconducting device. Thus, the methods described in this application are merely exemplary of the methods and materials that may be used in present technology.
Yet other substrates can be employed. For instance, the substrate can be or include an amorphous hydrogenated carbon, silicon oxide, silicon nitride, silicon oxynitride, silicon carbide, silicon boronitride, amorphous silicon, polysilicon, or a combination of any described herein, in any form (e.g., a bulk film, a thin film, another film, a stack, etc.).
At 103, a photoresist underlayer is deposited on the substrate. The underlayer is configured to increase adhesion between the substrate and a subsequently formed EUV-sensitive inorganic photoresist, and to reduce EUV dose for effective EUV exposure of the photoresist. The underlayer may be or include a vapor deposited film of hydronated carbon doped with O, silicon (Si), nitrogen (N), tungsten (W), boron (B), iodine (I), chlorine (Cl), or a combination of any of these (e.g., a combination of Si and O). In one embodiment, the film is deposited by introducing or delivering a hydrocarbon precursor (e.g., to provide carbon atoms) and a dopant precursor (e.g., to provide the doping, non-carbon atoms). In another embodiment, the film is deposited by introducing or delivering a heteroatom-containing precursor, such as an iodine-containing precursors, that provides a doped film after deposition. In particular, a hydronated carbon film doped with iodine can improve generation of secondary electrons upon exposure to EUV radiation. Further non-limiting precursors and dopants to provide such underlayers are described herein.
The film can have a thickness of no more than about 25 nm. For example, the photoresist underlayer may a thickness of about 2 to 20 nm, e.g., 2, 3, 4, 5, 6, 7, 8, 9, 10, 15 or 20 nm, and may optionally include about 0-30 atomic % O and/or about 20-50 atomic % hydrogen (H) and/or 30-70 atomic % C. Other underlayer properties are described herein.
In some implementations, the underlayer may be vapor deposited on the substrate by PECVD or ALD using a hydrocarbon precursor, which can be with or without carbon monoxide (CO) and/or carbon dioxide (CO2). In particular embodiments, vapor deposition includes introducing or delivering a hydrocarbon precursor without CO and without CO2.
In some implementations, the underlayer may be vapor deposited on the substrate by PECVD or ALD using an oxocarbon precursor that co-reacts with hydrogen (H2) or a hydrocarbon. In variations on this implementation, the oxocarbon precursor may further co-react with a Si source dopant during the deposition. In particular embodiments, oxocarbon precursors can include CO or CO2. Without wishing to be limited by mechanism, the use of oxocarbon precursors can include hydroxyl (—OH) groups or other oxygen-containing groups to the underlayer, which can provide a hydrophilic surface or a surface with increased hydrophilicity (as compared to an underlayer lacking such —OH or oxygen-containing groups). In non-limiting examples, a hydrophilic surface can improve adhesion between the underlayer and the PR layer.
In other implementations, the underlayer may be vapor deposited on the substrate by PECVD or ALD using a Si-containing precursor that co-reacts with an oxidizer (e.g., an oxocarbon, an O-containing precursor, CO, or CO2). In variations on this implementation, the Si-containing precursor further co-reacts with a C source dopant (e.g., a hydrocarbon precursor, as described herein). Non-limiting Si-containing precursors are described herein, such as silanes, halosilanes, aminosilanes, alkoxysilanes, organosilanes, etc.
In some implementations, the underlayer may be vapor deposited on the substrate by PECVD as a termination operation of a vapor deposition on the substrate, for example by adjusting the precursor flows entering the PECVD process chamber to achieve the desired composition of the photoresist underlayer.
In other implementations, underlayer may be vapor deposited on the substrate by PECVD to provide a hydronated carbon film. In some embodiments, the film is a low density film (e.g., from 0.7-2.9 g/cm3). In other embodiments, the undoped film (or a film prior to doping) has a density less than about 1.5 g/cm3 or a density of about 0.7-1.4 g/cm3. In yet other embodiments, the doped film has a density of about 0.7-1.4 g/cm3.
The PECVD process can include any useful precursor or combinations of precursors. In one embodiment, the precursor is a hydrocarbon precursor (e.g., any described herein). Optionally, a doped, hydronated carbon film is formed by using a heteroatom-containing precursor (e.g., a nitrogen-containing precursor, a tungsten-containing precursor, a boron-containing precursor, and/or an iodine-containing precursor) during the PECVD process.
Deposition of the underlayer can include use of plasma (e.g., as in a PECVD process), including transformer coupled plasma (TCP), inductively coupled plasma (ICP), or capacitively coupled plasma (CCP). In particular embodiments, deposition can use low TCP power (e.g., about 100-1000 W) with minimum bias (e.g., no bias) to provide a low density film. Of course, higher power plasmas can be employed, as described herein. In certain embodiments, generation of plasma (e.g., TCP or ICP) can be controlled by power, which is in a continuous wave (CW) mode.
Deposition (e.g., with TCP or ICP power in CW mode) can include an applied bias (regardless of frequency) that is pulsed (e.g., in the range of about 1 Hz to about 10 kHz, such as 10-2000 Hz) with a duty cycle between about 1% and 99%. Additional pulsing frequencies and duty cycles are described herein. In some embodiments, the applied pulsed bias can be provided to control ion energy. Non-limiting applied pulsed bias power can be from about 10-1000 W, as well as other ranges described herein.
In yet other embodiments, deposition can include an applied CW bias. CW bias may also be used to control ion energy. In some embodiments, the applied CW bias power can be from 10-1000 W (e.g., 10-500 W, 10-400 W, as well as other ranges described herein).
Yet other conditions (e.g., useful for a low density film) includes use of certain pressure conditions (e.g., such as 5-1000 millitorr (mTorr), including 10-1000 mTorr, 10-500 mTorr, or 10-400 mTorr) and certain temperature conditions (e.g., such as about 0-100° C., including 0-50° C. and 10-40° C.).
Pulsed or continuous bias can be employed to fine tune properties of the film. In one embodiment, pulsed bias can provide a higher density film, as compared to a low density film prepared with 0 W of bias power. Such higher density films can, in some instances, provide increased etch resistance, as compared to the low density film. In other instances, such higher density films can provide reduced undercut, as compared to a low density film prepared with 0 W of bias power. Additional plasma conditions and processes are also described herein.
Turning again to
In test structures in accordance with described embodiments, DtS performance of EUV PR on an amorphous carbon AHM with an underlayer, as described herein, is as good as or even better than EUV PR on SOC, in some cases decreasing required dose by 10% or more. Furthermore, post-development peeling of the EUV PR from the hardmask bilayer (amorphous carbon AHM with a photoresist underlayer) is not observed.
The underlayer 206 can further provide increased etch selectivity and/or decreased line edge and line width roughness (LER/LWR) in the structure. In test structures in accordance with described embodiments, LER/LWR were as about good to as much as 25% or more improved relative to EUV PR on AHM or SOC.
Referring again to
The use of an underlayer within the stack can provide improved properties. In one instance, interactions between the underlayer and the imaging layer provides a reduction in DtS. As seen in
In addition, the composition of the underlayer and the imaging layer can be designed to promote favorable reactions, which in turn can improve DtS. For instance, as seen in
Thus, in one instance, as seen in
Implementation 1: Dry Deposition of the Underlayer
The underlayer can be deposited in any useful manner. In one instance, deposition includes vapor deposition of a hydrocarbon precursor or a carbon-containing precursor (e.g., any described herein). Deposition can include use of a process gas (e.g., as a plasma or as an inert gas) during deposition, in which non-limiting process gases include carbon monoxide (CO), helium (He), argon (Ar), krypton (Kr), neon (Ne), nitrogen (N2), and/or hydrogen (H2).
Deposition conditions include control of precursor flow rate(s), gas flow rate(s), process pressure, temperature (e.g., electrostatic chuck (ESC) temperature), plasma (e.g., TCP) power, bias power, and duty cycle (DC) within the processing chamber. The flow rate of precursor(s) may be between about 1-100 standard cubic centimeter per minute (sccm). The flow rate of gas(es) may be between about 1-1600 sccm. The chamber pressure may be between about 5-1000 mTorr (e.g., 5-800 mTorr, 10-500 mTorr, 10-400 mTorr, 30-500 mTorr, 10-1000 mTorr, or 30-1000 mTorr). The ESC temperature may be between about 0-100° C. (e.g., 0-50° C. or 10-40° C.). The power used to generate the plasma may be between about 10-3000 W per station (e.g., 100-1000 W, 200-1000 W, 200-800 W, or 200-500 W). The RF frequency used to generate the plasma can be between about 0.3-600 MHz (e.g., 13.56 MHz, 60 MHz, 27 MHz, 2 MHz, 400 kHz, or combinations thereof). The RF bias power may be between about 0-1000 W using a pulsed plasma or a continuous wave (CW) plasma. The processing chamber can be an ICP chamber or a CCP chamber. In some embodiments of the ICP chamber, the frequency of both the top ICP generator and the bias generator is 13.5 MHz. Depending on the underlayer, in some embodiments, the pressure can be about 10-400 mTorr, and the TCP power can be about 200-500 W.
Table 1 provides examples of processing regimes for non-limiting underlayers. For Embodiment 1, the hydrocarbon precursor is methane (CH4) with another gas being He. For Embodiment 2, the hydrocarbon precursor is CH4, and process gases include CO, H2, and He.
Implementation 2: Pulsing Bias Process for Use in Deposition of the Underlayer
Further processes were developed to improve etch resistance of the underlayer. In particular, bias power was used to modify the density of the underlayer. For instance, deposition of the underlayer can include a bias (regardless of frequency) that is pulsed (e.g., in the range of about 1 Hz to about 10 kHz) with a DC of between about 1% and 99%. Such bias can be provided at any useful power, such as from about 10-500 W.
It will be understood that plasma pulsing may involve repetitions of periods, each of which may last a duration T. The duration T includes the duration for pulse ON time (the duration for which the plasma is in an ON state) and the duration for plasma OFF time (the duration from which the plasma is in an OFF state) during a given period. The pulse frequency will be understood as 1/T. For example, for a plasma pulsing period T=100 μs, frequency is 1/T=1/100 μs, or 10 kHz. The duty cycle or duty ratio is the fraction or percentage in a period T during which the plasma is in the ON state such that duty cycle or duty ratio is pulse ON time divided by T. For example, for a plasma pulsing period T=100 μs, if a pulse ON time is 70 μs (such that the duration for which the plasma is in an ON state in a period is 70 μs) and a pulse OFF time is 30 μs (such that the duration for which the plasma is in an OFF state in a period is 30 μs), the duty cycle is 70%.
Yet other deposition conditions can include control of precursor flow rate(s), gas flow rate(s), process pressure, temperature (e.g., ESC temperature), plasma power, bias power, pulse frequency, DC, and TCCT parameter within the processing chamber. The flow rate of precursor(s) may be between about 1-100 sccm. The flow rate of process gas(es) may be between about 1-1600 sccm. The chamber pressure may be between about 5-1000 mTorr (e.g., 5-800 mTorr, 10-500 mTorr, 10-400 mTorr, 30-500 mTorr, 10-1000 mTorr, or 30-1000 mTorr). The ESC temperature may be between about 0-100° C. (e.g., 0-50° C. or 10-40° C.). The power used to generate the plasma may be between about 10-3000 W (e.g., 100-1000 W, 200-1000 W, 200-800 W, or 200-500 W). The RF frequency used to generate the plasma may be between about 0.3-600 MHz (e.g., 13.56 MHz, 60 MHz, 27 MHz, 2 MHz, 400 kHz, or combinations thereof). The RF bias power may be between about 10-1000 W using a pulsed plasma with a DC between 1-100%, in which 100% indicated CW (e.g., 1-99%). The RF bias power can be pulsed below 5000 Hz, such as a frequency from about 10-2000 Hz. The TCCT parameter can be from 0.1 to 1.5. In some non-limiting process, plasma exposure can include a high frequency (HF) RF component (e.g., generally between about 2-60 MHz) and a low frequency (LF) RF component (e.g., generally from about 100 kHz-2 MHz). The processing chamber can be an ICP chamber or a CCP chamber.
Table 3 provides examples of processing regimes for non-limiting underlayers formed with a pulsing bias process (Embodiment 3). Various underlayer films were formed using Embodiment 3, in which bias power was either 70 W or 140 W and in which DC was varied from 10-50%. Density for such non-limiting films are provided in
The pulsing process may improve other characteristics of the film, in addition to increasing density, decreasing etch rate, and/or increasing etch resistance. As seen in
Implementation 3: Deposition of Doped Underlayers
The underlayer can include one or more dopants (e.g., non-carbon dopants when a hydrocarbon precursor is employed). The dopant can be provided by using a hydrocarbon precursor (e.g., to provide carbon atoms) and a separate dopant precursor (e.g., to provide the doping, non-carbon atoms). In another embodiment, the dopant is provided by employing a single dopant precursor including carbon atom(s) and heteroatom(s). Non-limiting non-carbon heteroatoms include oxygen (O), silicon (Si), nitrogen (N), tungsten (W), boron (B), iodine (I), chlorine (Cl), or a combination of any of these. Other dopants and heteroatom-containing dopant precursors are described herein.
Use of dopants can, in some instances, improve etch resistance. Any of the process regimes herein can be modified to incorporate dopants into the underlayer. For instance, deposition can include use of a dopant precursor (e.g., any described herein), and process regimes described herein for a precursor generally (e.g., flow rate, pressure, temperature, plasma power, bias power, pulse frequency, duty cycle, TCCT, etc.) can be used for the dopant precursor.
For instance, the flow rate of precursor(s) (e.g., hydrocarbon precursor and/or dopant precursor) may be between about 1-100 sccm. The flow rate of process gas(es) may be between about 1-1600 sccm. The chamber pressure may be between about 5-1000 mTorr (e.g., 5-800 mTorr, 10-500 mTorr, 10-400 mTorr, 30-500 mTorr, 10-1000 mTorr, or 30-1000 mTorr). The ESC temperature may be between about 0-100° C. (e.g., 0-50° C. or 10-40° C.). The power used to generate the plasma may be between about 10-3000 W (e.g., 100-1000 W, 200-1000 W, 200-800 W, or 200-500 W). The RF frequency used to generate the plasma may be between about 0.3-600 MHz (e.g., 13.56 MHz, 60 MHz, 27 MHz, 2 MHz, 400 kHz, or combinations thereof). The RF bias power may be between about 0-1000 W using a pulsed plasma with a DC between about 1-99% or a CW plasma (DC of 100%). The RF bias power can be pulsed below 5000 Hz, such as a frequency from about 10-2000 Hz. The TCCT parameter can be from 0.1 to 1.5. The processing chamber can be an ICP chamber or a CCP chamber.
In one instance, the dopant is or includes nitrogen (N) to provide N-doped underlayers. Non-limiting N-containing precursors can include any described herein, such as nitrogen (N2), ammonia (NH3), hydrazine (N2H4), amines, and aminosilanes. In one instance, an N-doped underlayer is formed by co-flowing of a hydrocarbon precursor and an N-containing precursor.
Table 4 provides examples of processing regimes for non-limiting N-doped underlayers. For Embodiment 4, the hydrocarbon precursor is CH4, and the N-containing precursor is N2. For Embodiment 5, the hydrocarbon precursor is CH4, and the N-containing precursor is NH3.
In particular embodiments, the N-doped underlayer can be characterized by the presence of N—H bonds (e.g., with a peak at about 3500 to 3100 cm−1 and/or about 1635 cm−1 in a Fourier transform infrared spectroscopy (FTIR) spectrum) and/or C≡N bonds (e.g., with peak(s) at about 2260 to 2222 cm−1, about 2244 cm−1, and/or about 2183 cm−1 in an FTIR spectrum).
The etch rates of doped underlayers can be improved, in some instances.
In another instance, the dopant is or includes tungsten (W) to provide W-doped underlayers. Non-limiting W-containing precursors can include any described herein, such as tungsten halides (e.g., WF6, WCl6, or WCl5), tungsten carbonyl (e.g., W(CO)6), or others. In one instance, a W-doped underlayer is formed by co-flowing of a hydrocarbon precursor and a W-containing precursor.
In particular embodiments, the W-doped underlayer can be characterized by the presence of W—OH . . . H2O bonds (e.g., with a peak at about 3500 to 3400 cm−1 in a FTIR spectrum), W═O bonds (e.g., with a peak at about 981 cm−1 in a FTIR spectrum), and/or W—O—W bonds (e.g., with peak(s) at about 837 cm−1, 800 cm−1, and/or 702 cm−1 in an FTIR spectrum).
Table 5 provides examples of processing regimes for non-limiting W-doped underlayers. For each embodiment, the hydrocarbon precursor is CH4. For Embodiment 6, the W-containing precursor is WF6 at a lower flow rate of 1 sccm. For Embodiment 7, the W-containing precursor is WF6 at a higher flow rate of 2 sccm. For Embodiment 8, the W-containing precursor is WF6 at a lower flow rate of 1 sccm but at a higher pressure of 50 mTorr.
Density of doped underlayers can be increased. Table 6 provides the refractive index (RI at 633 nm), deposition rate (Dep. Rate), and density of the underlayers. As can be further seen for Embodiment 7, co-flow of the hydrocarbon precursor with the W-containing dopant precursor increased density and RI, as compared to the baseline that was deposited without the dopant precursor.
In yet another instance, the dopant is or includes boron (B) to provide B-doped underlayers. Non-limiting B-containing precursors can include any described herein, such as boron halides (e.g., BCl3), boranes (e.g., B2H6), borates (e.g., B(OH)3), and organoboron compounds (e.g., B(CH3)3). In one instance, a B-doped underlayer is formed by co-flowing of a hydrocarbon precursor and a B-containing precursor.
In particular embodiments, the B-doped underlayer can be characterized by the presence of B . . . OH bonds (e.g., with a peak at about 3200 cm−1 in a FTIR spectrum), B—O bonds (e.g., with a peak at about 1340 cm−1 in a FTIR spectrum), and/or B—O—H bonds (e.g., with a peak at about 1194 cm−1 in an FTIR spectrum).
Table 7 provides examples of processing regimes for non-limiting B-doped underlayers. For Embodiment 9, the hydrocarbon precursor is CH4, and the B-containing precursor is BCl3. For Embodiment 10, the deposition conditions are the same as Embodiment 9, but the film is further treated with H2. In Table 7, H2 treatment conditions included pressure=5 mTorr; TCP=300 W; bias power=100 W; flow rate of H2=200 sccm; processing time=1 second.
In particular embodiments, both the deposition rate and the density of doped underlayers can be increased. Table 8 provides RI at 633 nm, deposition rate (Dep. Rate), and density of the underlayers. As can be seen for Embodiment 9, co-flow of the hydrocarbon precursor with the B-containing dopant precursor increased deposition rate and increased density, as compared to the baseline that was deposited without the dopant precursor.
As described herein, dopant precursors can be employed during deposition to provide a doped underlayer. In particular embodiments, the doped underlayer can have enhanced characteristics, such as improved etch resistance, etch rate, refractive index, deposition rate, and/or density.
Implementation 4: Deposition of Various Hydrocarbon Precursors
The underlayer can be deposited with any useful precursor. For instance, the precursor can include a hydrocarbon precursor having only carbon and hydrogen atoms. In another instance, the precursor can be a heteroatom-containing, hydrocarbon precursor having carbon atoms, hydrogen atoms, and non-carbon heteroatoms. In yet another instance, the precursor can be a dopant precursor (e.g., as described herein).
Of the hydrocarbon precursors, various compounds can be employed. For instance, the hydrocarbon precursor can include aliphatic and aromatic compounds (e.g., alkanes, alkenes, alkynes, benzene, etc.), including substituted forms thereof. By using different hydrocarbon precursors, the type and amount of certain chemical bonds within the underlayer can be modified. For instance, using unsaturated hydrocarbon precursors can provide an underlayer having increased unsaturated bond content (e.g., increased C═C and/or C≡C bond content), increased sp2 carbon content, increased sp carbon content, decreased saturated bond content (e.g., decreased C—C bond content), decreased sp3 carbon content, and/or decreased C—H bond content (e.g., as compared to a film formed with an increased amount saturated hydrocarbon precursors or a decreased amount of unsaturated hydrocarbon precursors). The selection of the hydrocarbon precursor can depend on various factors. In one non-limiting instance, a hydrocarbon precursor includes a saturated precursor (e.g., having increased C—H bond content, as compared to C—C, C═C, or C≡C content), which can provide sufficient H atoms. Without wishing to be limited by mechanism, selection of such a precursor can provide releasable H atoms that interact with atoms in the imaging layer, thus, resulting in improved DtS, as compared to use of an unsaturated precursor. Yet, in other non-limiting instances, a hydrocarbon precursor includes an unsaturated precursor (e.g., having increased C—C, C═C, or C≡C content, as compared to C—H bond content). Without wishing to be limited by mechanism, selection of such a precursor can provide enhanced etch resistance, as compared to use of a saturated precursor.
In particular embodiments, the underlayer can be characterized by the presence of C═CH bonds (e.g., with a peak at about 3310 cm−1 in a FTIR spectrum) and/or C═C bonds (e.g., with peak(s) at about 1650 to 1600 cm−1 or 1000 to 660 cm−1 in a FTIR spectrum).
Table 9 provides examples of processing regimes for non-limiting hydrocarbon precursors. For Embodiment 1, the hydrocarbon precursor is CH4. For Embodiment 11, the hydrocarbon precursor is acetylene (C2H2). For Embodiment 12, the hydrocarbon precursor is propyne (C3H4). Different plasma types can be employed (e.g., ICP or CCP). In one instance, ICP is employed to allow for separate control of ion energy and ion density. Process conditions can be optimized to achieve a similar film whether using ICP or CCP. For instance, CCP generally employs a higher self-bias voltage than ICP, thus resulting in a plasma characterized by a higher ion energy. This higher energy can be reduced, e.g., by using a higher process pressure, thus achieving comparable processing environment to provide similar film properties as obtained using ICP. Accordingly, processes herein can include use of ICP or CCP with modifications in one or more processing conditions (e.g., pressure, temperature, flow rate of precursor(s) or inert gases, process time, etc.) to achieve targeted film compositions and film properties.
In particular embodiments, use of unsaturated hydrocarbon precursors improves etch resistance.
Implementation 5: Use of High EUV Absorbing Atoms
The underlayer can also include one or more atoms having a high patterning radiation absorption cross-section (e.g., an EUV absorption cross-section that is equal to or greater than 1×107 cm2/mol). Such atoms include, e.g., iodine (I). Iodine can be provided in any useful source. For instance, the precursor employed during deposition can be a dopant precursor that is a hydrocarbon having one or more iodine atoms. Non-limiting precursors an aliphatic or an aromatic compound (e.g., an alkane, alkene, or alkyne, including cyclic forms thereof, as well as benzene) having one or more I atoms. Yet other examples of precursors include iodoacetylene (C2HI), diiodoacetylene (C2I2), vinyl iodide (C2H3I), iodomethane (CH3I), diiodomethane (CH2I2), 1,1-diiodoethene (C2H2I2), (E)-1,2-diiodoethylene (trans-C2H2I2), (Z)-1,2-diiodoethylene (cis-C2H2I2), allyl iodide (C3H5I), 1-iodo-1-propyne (C3H3I), iodocyclopropane (C3H5I), and 1,1-diiodocyclopropane (C3H4I2).
Any of the deposition conditions herein can be combined to provide a beneficial underlayer. For instance, a pulsing bias process can be used with any precursor (e.g., a hydrocarbon precursor, a dopant precursor, or a combination thereof) described herein. In another instance, a dopant precursor can be combined with any hydrocarbon precursor described herein. Furthermore, the process can include the use of one, two, three, or more different precursors (e.g., two or more hydrocarbon precursors; and/or two or more dopant precursors). In yet another instance, a dopant precursor can be generated by modifying any hydrocarbon precursor herein (e.g., saturated or unsaturated hydrocarbon precursors) with one or more non-carbon heteroatoms.
Combinations of precursors can be selected to provide desired film properties. For instance, a particular hydrocarbon precursor (e.g., an unsaturated hydrocarbon precursor) can be selected to improve etch resistance. Then, certain heteroatoms can be selected to provide a film with increased density or refractive index (e.g., heteroatoms such as O, Si, N, W, B, or I). In one instance, the underlayer can include I, C, H, and O atoms; I, C, H, and Si atoms; I, H, N, O, and Si atoms; or I, C, H, N, O, and Si atoms.
Finally, yet other non-carbon heteroatoms can be selected to provide a film with enhanced EUV absorption (e.g., heteroatoms, such as I or another heteroatom having an EUV absorption cross-section that is equal to or greater than 1×107 cm2/mol). The thickness of the underlayer can be controlled (e.g., more than about 5 nm).
Precursors (e.g., for Underlayers)
The underlayers herein can employ any useful precursor or combination of precursors. Such precursors can include hydrocarbon precursors including only carbon (C) and hydrogen (H) atoms, in which the precursor can be saturated (having only single bonds) or unsaturated (having one or more double or triple bonds), as well as linear or cyclic. Yet other precursors can include one or more non-carbon heteroatoms, and such precursors are referred herein as dopant precursors. Such dopant precursors can optionally include carbon atoms in combination with non-carbon atoms. In some embodiments, any hydrocarbon precursor herein can be modified with one or more heteroatoms to provide a dopant precursor. The generic term “precursor” can refer to a hydrocarbon precursor and/or a dopant precursor. Such precursors can, in some instances, be a gas, thereby allowing for vapor deposition within a process chamber.
Hydrocarbon precursors generally include carbon-containing precursors. In some instances, the hydrocarbon precursor includes only C and H atoms. The hydrocarbon precursor may be, for example, one defined by the formula CxHy, wherein x is an integer from 1 to 10 and y is an integer from 2 to 24. Examples of such precursors include methane (CH4), acetylene (C2H2), ethane (C2H6), ethylene (C2H4), propane (C3H8), propylene (C3H6), propyne (C3H4), allene (C3H4), cyclopropene (C3H4), butane (C4H10), butylene (C4H8), butadiene (C4H6), cyclohexane (C6H12), benzene (C6H6), and toluene (C7H8).
The hydrocarbon precursor can be an aliphatic compound (e.g., a C1-10 alkane, C2-10 alkene, C2-10 alkyne, including linear or cyclic forms thereof) or an aromatic compound (e.g., benzene, as well as polycyclic forms thereof). The hydrocarbon precursor can include saturated bonds (single bonds, e.g., C—C bonds or C—H bonds) and/or unsaturated bonds (double or triple bonds, e.g., C═C, C≡C, or C≡N bonds).
Useful precursors for underlayers can also include one or more heteroatoms. Such heteroatoms can be any useful non-carbon atoms, such as oxygen (O), silicon (Si), nitrogen (N), tungsten (W), boron (B), iodine (I), chlorine (Cl), and combinations thereof. Thus, non-limiting heteroatom-containing precursors (also referred to herein as dopant precursors) can include an O-containing precursor, an Si-containing precursor, an N-containing precursor, a W-containing precursor, a B-containing precursor, an I-containing precursor, or a Cl-containing precursor. Such dopant precursors can be inorganic (lacking carbon atoms) or organic (including carbon atoms), as described herein.
O-containing precursors can include an oxocarbon precursor comprising O and C atoms. In particular embodiments, the oxocarbon precursor reacts with hydrogen (H2) or a hydrocarbon and optionally further co-reacts with an Si source or an Si-containing precursor. Yet other O-containing precursors can include carbon monoxide (CO), carbon dioxide (CO2), water (H2O), oxygen (O2), ozone (O3), hydrogen peroxide (H2O2), alcohol (e.g., t-amyl alcohol, ethanol, propanol, etc.), polyol (e.g., a diol, such as ethylene glycol), ketone, aldehyde, ether, ester, carboxylic acid, alkoxysilane, oxolane, or furan.
Si-containing precursors can include silanes, halosilanes, aminosilanes, alkoxysilanes, organosilanes, etc. In particular embodiments, the Si-containing precursor co-reacts with an oxidizer (e.g., any described herein, such as an O-containing precursor or an oxocarbon precursor, including CO and CO2). Non-limiting Si-containing precursors include polysilanes (H3Si—(SiH2)n—SiH3), where n≥0. Examples of silanes are silane (SiH4), disilane (Si2H6), and organosilanes such as methylsilane, ethylsilane, isopropylsilane, t-butylsilane, dimethylsilane, diethylsilane, di-t-butylsilane, allylsilane, sec-butylsilane, thexylsilane, isoamylsilane, t-butyldisilane, di-t-butyldisilane, and the like.
A halosilane includes at least one halogen group and may or may not include H and/or C atoms. Examples of halosilanes are iodosilanes, bromosilanes, chlorosilanes, and fluorosilanes. Specific chlorosilanes are tetrachlorosilane, trichlorosilane, dichlorosilane, monochlorosilane, chloroallylsilane, chloromethylsilane, dichloromethylsilane, chlorodimethylsilane, chloroethylsilane, t-butylchlorosilane, di-t-butylchlorosilane, chloroisopropylsilane, chloro-sec-butylsilane, t-butyldimethylchlorosilane, hexyldimethylchlorosilane, and the like. Specific iodosilanes are tetraiodosilane, triiodosilane, diiodosilane, monoiodosilane, trimethylsilyl iodide, and the like.
An aminosilane includes at least one N atom bonded to a Si atom, but may also contain H, O, halogen, and/or C atoms. Examples of aminosilanes are mono-, di-, tri- and tetra-aminosilane (H3Si(NH2), H2Si(NH2)2, HSi(NH2)3 and Si(NH2)4, respectively), as well as substituted mono-, di-, tri- and tetra-aminosilanes, for example, t-butylaminosilane, methylaminosilane, t-butylsilanamine, bi(t-butylamino)silane (SiH2(NHC(CH3)3)2 (BTBAS), t-butyl silylcarbamate, SiH(CH3)—(N(CH3)2)2, SiHCl—(N(CH3)2)2, (Si(CH3)2NH)3 and the like. A further example of an aminosilane is trisilylamine (N(SiH3)).
An alkoxysilane includes at least one O atom bonded to a Si atom, but may also contain H, N, halogen, and/or C atoms. Examples of alkoxysilanes are mono-, di-, tri- and tetra-alkoxysilanes (H3Si(OR), H2Si(OR)2, HSi(OR)3 and Si(OR)4, respectively, in which each R can be, independently, optionally substituted alkyl or aryl), as well as substituted mono-, di-, tri- and tetra-alkoxysilanes, for example, trimethoxymethylsilane (CH3Si(OCH3)3), (3-aminopropyl) trimethoxysilane (NH2(CH2)3Si(OCH3)3), (3-aminopropyl)triethoxysilane (NH2(CH2)3Si(OCH2CH3)3), triethoxyvinylsilane (CH2═CHSi(OCH2CH3)3), triethoxyethylsilane (CH3CH2Si(OCH2CH3)3), trimethoxyphenylsilane (PhSi(OCH3)3), isobutyltriethoxysilane (i-BuSi(OCH2CH3)3), diacetoxydimethylsilane ((CH3)2Si(OCOCH3)2), and the like. Yet other examples include tetraethoxysilane (Si(OCH2CH3)4), triethoxysilane (HSi(OCH2CH3)3), tetramethoxysilane (Si(OCH3)4), and trimethoxysilane (HSi(OCH3)3).
N-containing precursors include any that has at least one N atom, for example, nitrogen gas (N2), ammonia (NH3), hydrazine (N2H4), amines (amines bearing carbon) such as methylamine, dimethylamine, ethylmethylamine, ethylamine, isopropylamine, t-butylamine, di-t-butylamine, cyclopropylamine, sec-butylamine, cyclobutylamine, isoamylamine, 2-methylbutan-2-amine, trimethylamine, diisopropylamine, diethylisopropylamine, di-t-butylhydrazine, as well as aromatic containing amines such as anilines, pyridines, and benzylamines. Yet other N-containing precursors can include nitrile (e.g., acetonitrile), amides, N-containing heterocyclic compound, or amino alcohols (e.g., ethanolamine). Amines may be primary, secondary, tertiary, or quaternary (for example, tetraalkylammonium compounds). An N-containing precursor can contain heteroatoms other than N, for example, hydroxylamine, t-butyloxycarbonyl amine, and N-t-butyl hydroxylamine are N-containing precursors.
W-containing precursors include tungsten-containing halide precursors, which may include tungsten fluorides, such as tungsten(VI) fluoride (WF6); and tungsten chlorides, such as tungsten(VI) chloride (WCl6), tungsten(V) chloride (WCl5), and tungsten(VI) oxychloride (WOCl4). In some embodiments, metal-organic tungsten-containing precursors may be used, such as tungsten hexacarbonyl (W(CO)6), mesitylene tungsten tricarbonyl ([C6H3(CH3)3]W(CO)3), bis(t-butylimido)bis(dimethylamino)tungsten(VI) ([(CH3)3CN]2W[N(CH3)2]2), bis(cyclopentadienyl)tungsten(IV) dihydride (H2WCp2), or others.
B-containing precursors include boron halides (e.g., BCl3), boranes (e.g., B2H6), borates (e.g., B(OH)3), and organoboron compounds (e.g., B(CH3)3). Non-limiting B-containing precursors include diborane (B2H6), trimethylborate (B[OCH3]3), triethylborate (B[OCH2CH3]3), triisopropyl borate (B[OCH(CH3)2]3), trimethylborane (B(CH3)3), triethylborane (B(C2H5)3), triphenylborane (BPh3), tetrakis(dimethylamino)diboron (B2(N(CH3)2)4), boron trifluoride (BF3), boron trichloride (BCl3), boron tribromide (BBr3), and boron iodide (BI3).
I-containing precursors include iodinated hydrocarbon compounds, such as iodoacetylene (C2HI), diiodoacetylene (C2I2), vinyl iodide (C2H3I), iodomethane (CH3I), diiodomethane (CH2I2), 1,1-diiodoethene (C2H2I2), (E)-1,2-diiodoethylene (trans-C2H2I2), (Z)-1,2-diiodoethylene (cis-C2H2I2), allyl iodide (C3H5I), 1-iodo-1-propyne (C3H3I), iodocyclopropane (C3H5I), and 1,1-diiodocyclopropane (C3H4I2).
Cl-containing precursors include chlorinated hydrocarbon compounds, such as chloroacetylene (C2HCl), vinyl chloride (C2H3Cl), chloromethane (CH3Cl), dichloromethane (CH2Cl2), 1,1-dichloroethene (C2H2Cl2), (E)-1,2-dichloroethylene (trans-C2H2Cl2), (Z)-1,2-dichloroethylene (cis-C2H2Cl2), allyl chloride (C3H5Cl), 1-chloro-1-propyne (C3H3Cl), chlorocyclopropane (C3H5Cl), and 1,1-dichlorocyclopropane (C3H4Cl2).
Other heteroatoms may be included, such as phosphorous (P). P-containing precursors can include phosphates, phosphines, phosphorous halides, organophosphorus compounds, and others. Non-limiting P-containing precursors include triethyl phosphate (PO[OC2H5]3), trimethyl phosphate (PO[OCH3]3), trimethyl phosphite (P(OCH3)3), trisdimethylaminophosphorus (P[N(CH3)2]3), phosphorous trichloride (PCl3), trismethylsilyl phosphine (P[Si(CH3)3]3), and phosphorus oxychloride (POCl3).
Properties of Underlayers
Any of the processes and precursors herein can be employed to provide useful underlayers. The composition of the underlayer can be tuned to include particular atoms. In one embodiment, the underlayer include about 0-30 atomic % O (e.g., 1-30%, 2-30%, or 4-30%), about 20-50 atomic % H (e.g., 20-45%, 30-50%, or 30-45%), and/or 30-70 atomic % C (e.g., 30-60%, 30-65%, or 30-68%). In other embodiments, the underlayer includes the presence of unsaturated bonds (e.g., C═C, C≡C, and/or C≡N bonds). In yet other embodiments, the underlayer has a density of about 0.7 to 2.9 g/cm3.
The underlayer can be characterized by increased etch selectivity and/or decreased undercut, as compared to a control film. In other embodiments, the underlayer can be characterized decreased line edge and line width roughness and/or decreased dose to size, as compared to a control film. Non-limiting control films include those formed with a saturated hydrocarbon precursors, formed within pulsed bias, and/or formed without a dopant. In one instance, the control film is an AHM formed with methane. In another instance, the control film is an AHM formed with acetylene.
Patterning Structures
The patterning structures (or films) herein can include an imaging layer on a surface of a hardmask or a substrate, as well as an underlayer under the imaging layer. In particular embodiments, the presence of the underlayer provides increased radiation absorptivity and/or patterning performance of the imaging layer.
Generally, photon absorption through a layer is depth dependent. When a homogenous layer or film is exposed to radiation, the lower portion of the layer is exposed to a lower dose of radiation, as compared to the upper portion of that same layer, because fewer photons reach that lower portion. Thus, to ensure sufficient and uniform exposure through the entire depth of a layer, the layer must provide sufficient transmission of the radiation. In particular embodiments, the underlayer described herein provides increased radiation absorption through the imaging layer. Furthermore, in some instances, the underlayer can effectively generate more secondary electrons that can better expose lower portions of the patterning structure.
One or both of the underlayer and the imaging layer can include a high-absorbing element. In one instance, the underlayer and the imaging layer both include a high-absorbing element, such as equal to or greater than 1×107 cm2/mol for EUV absorption. The element in each of the absorbing and imaging layers can be the same or different. In particular embodiments, enhanced adhesion can lower the required radiation dose to provide desired patterned features within the imaging layer and/or the underlayer.
The imaging layer can include any useful resist, such as metal-organic based resists, as described herein. When the photoresist material being employed possesses a significant inorganic component, for example it exhibits a predominately metal oxide framework, the underlayer may advantageously be a carbon-based film. In cases where there are device features present on the substrate to be patterned which create significant topography, another important function of the underlayer can be to overcoat and planarize the existing topography so that the subsequent patterning step may be performed on a flat surface with all areas of the pattern in focus. For such applications, the underlayer (or at least one of multiple underlayers) may be applied using dry deposition or spin-coating techniques. The layer may include various AHM films with carbon- and hydrogen-based compositions, and may be doped with additional elements such as tungsten, boron, nitrogen, or fluorine.
The underlayer and imaging layer, either alone or together, can be considered a film. In some embodiments, the film is a radiation-sensitive film (e.g., an EUV-sensitive film). This film, in turn, can serve as an EUV resist, as further described herein. In particular embodiments, the layer or film can include one or more ligands (e.g., EUV labile ligands) that can be removed, cleaved, or cross-linked by radiation (e.g., EUV or DUV radiation).
Precursors can be used to provide a patternable film that is sensitive to radiation (or a patterning radiation-sensitive film or a photopatternable film). Such radiation can include EUV radiation, DUV radiation, or UV radiation that is provided by irradiating through a patterned mask, thereby being a patterned radiation. The film itself can be altered by being exposed to such radiation, such that the film is radiation-sensitive or photosensitive. In particular embodiments, the precursor is an organometallic compound, which includes at least one metal center.
The precursor can have any useful number and type of ligand(s). In some embodiments, the ligand can be characterized by its ability to react in the presence of a counter-reactant or in the presence of patterned radiation. For instance, the precursor can include a ligand that reacts with a counter-reactant, which can introduce linkages between metal centers (e.g., an —O— linkage). In another instance, the precursor can include a ligand that eliminates in the presence of patterned radiation. Such an EUV labile ligand can include branched or linear alkyl groups having a beta-hydrogen, as well as any described herein for R in formula (I) or (II).
The precursor can be any useful metal-containing precursor, such as an organometallic agent, a metal halide, or a capping agent (e.g., as described herein). In a non-limiting instance, the precursor includes a structure having formula (I):
MaRb (I),
wherein:
In another non-limiting instance, the precursor includes a structure having formula (II):
MaRbLc (II),
wherein:
In some embodiments, each ligand within the precursor can be one that is reactive with a counter-reactant. In one instance, the precursor includes a structure having formula (II), in which each R is, independently, L. In another instance, the precursor includes a structure having formula (IIa):
MaLc (IIa),
wherein:
For any formula herein, M can be a metal or a metalloid or an atom with a high patterning radiation absorption cross-section (e.g., an EUV absorption cross-section that is equal to or greater than 1×107 cm2/mol). In some embodiments, M is tin (Sn), bismuth (Bi), tellurium (Te), cesium (Cs), antimony (Sb), indium (In), molybdenum (Mo), hafnium (Hf), iodine (I), zirconium (Zr), iron (Fe), cobalt (Co), nickel (Ni), copper (Cu), zinc (Zn), silver (Ag), platinum (Pt), and lead (Pb). In further embodiments, M is Sn, a is 1, and c is 4 in formula (I), (II), or (IIa). In other embodiments, M is Sn, a is 1, and c is 2 in formula (I), (II), or (IIa). In particular embodiments, M is Sn(II) (e.g., in formula (I), (II), or (IIa)), thereby providing a precursor that is a Sn(II)-based compound. In other embodiments, M is Sn(IV) (e.g., in formula (I), (II), or (IIa)), thereby providing a precursor that is a Sn(IV)-based compound. In particular embodiments, the precursor includes iodine (e.g., as in periodate).
For any formula herein, each R is, independently, H, halo, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted cycloalkenyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted alkoxy (e.g., —OR1, in which R1 can be optionally substituted alkyl), optionally substituted alkanoyloxy, optionally substituted aryl, optionally substituted amino, optionally substituted bis(trialkylsilyl)amino, optionally substituted trialkylsilyl, oxo, an anionic ligand (e.g., oxido, chlorido, hydrido, acetate, iminodiacetate, propanoate, butanoate, benzoate, etc.), a neutral ligand, or a multidentate ligand.
In some embodiments, the optionally substituted amino is —NR1R2, in which each R1 and R2 is, independently, H or alkyl; or in which R1 and R2, taken together with the nitrogen atom to which each are attached, form a heterocyclyl group, as defined herein. In other embodiments, the optionally substituted bis(trialkylsilyl)amino is —N(SiR1R2R3)2, in which each R1, R2, and R3 is, independently, optionally substituted alkyl. In yet other embodiments, the optionally substituted trialkylsilyl is —SiR1R2R3, in which each R1, R2, and R3 is, independently, optionally substituted alkyl.
In other embodiments, the formula includes a first R (or first L) that is —NR1R2 and a second R (or second L) that is —NR1R2, in which each R1 and R2 is, independently, H or optionally substituted alkyl; or in which R1 from a first R (or first L) and R1 from a second R (or second L), taken together with the nitrogen atom and the metal atom to which each are attached, form a heterocyclyl group, as defined herein. In yet other embodiments, the formula includes a first R that is —OR1 and a second R that is —OR1, in which each R1 is, independently, H or optionally substituted alkyl; or in which R1 from a first R and R1 from a second R, taken together with the oxygen atom and the metal atom to which each are attached, form a heterocyclyl group, as defined herein.
In some embodiments, at least one of R or L (e.g., in formula (I), (II), or (IIa)) is optionally substituted alkyl. Non-limiting alkyl groups include, e.g., CnH2n+1, where n is 1, 2, 3, or greater, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, or t-butyl. In various embodiments, R or L has at least one beta-hydrogen or beta-fluorine. In other embodiments, at least one of R or L is a halo-substituted alkyl (e.g., a fluoro-substituted alkyl).
In some embodiments, each R or L or at least one R or L (e.g., in formula (I), (II), or (IIa)) is halo. In particular, the precursor can be a metal halide. Non-limiting metal halides include SnBr4, SnCl4, SnI4, and SbCl3.
In some embodiments, each R or L or at least one R or L (e.g., in formula (I), (II), or (IIa)) can include a nitrogen atom. In particular embodiments, one or more R or L can be optionally substituted amino, an optionally substituted monoalkylamino (e.g., —NR1H, in which R1 is optionally substituted alkyl), an optionally substituted dialkylamino (e.g., —NR1R2, in which each R1 and R2 is, independently, optionally substituted alkyl), or optionally substituted bis(trialkylsilyl)amino. Non-limiting R and L substituents can include, e.g., —NMe2, —NHMe, —NEt2, —NHEt, —NMeEt, —N(t-Bu)-[CHCH3]2—N(t-Bu)-(tbba), —N(SiMe3)2, and —N(SiEt3)2.
In some embodiments, each R or L or at least one R or L (e.g., in formula (I), (II), or (IIa)) can include a silicon atom. In particular embodiments, one or more R or L can be optionally substituted trialkylsilyl or optionally substituted bis(trialkylsilyl)amino. Non-limiting R or L substituents can include, e.g., —SiMe3, —SiEt3, —N(SiMe3)2, and —N(SiEt3)2.
In some embodiments, each R or L or at least one R or L (e.g., in formula (I), (II), or (IIa)) can include an oxygen atom. In particular embodiments, one or more R or L can be optionally substituted alkoxy or optionally substituted alkanoyloxy. Non-limiting R or L substituents include, e.g., methoxy, ethoxy, isopropoxy (i-PrO), t-butoxy (t-BuO), acetate (—OC(O)—CH3), and —O═C(CH3)—CH═C(CH3)—O— (acac).
Any formulas herein can include one or more neutral ligands. Non-limiting neutral ligands include an optionally substituted amine (e.g., NR3 or R2N-Ak-NR2, in which each R can be, independently, H, optionally substituted alkyl, optionally substituted hydrocarbyl, or optionally substituted aryl, and Ak is optionally substituted alkylene), an optionally substituted phosphine (e.g., PR3 or R2P-Ak-PR2, in which each R can be, independently, H, optionally substituted alkyl, optionally substituted hydrocarbyl, or optionally substituted aryl, and Ak is optionally substituted alkylene), an optionally substituted ether (e.g., OR2, in which each R can be, independently, H, optionally substituted alkyl, optionally substituted hydrocarbyl, or optionally substituted aryl), an optionally substituted alkyl, an optionally substituted alkene, an optionally substituted alkyne, an optionally substituted benzene, oxo, or carbon monoxide.
Any formulas herein can include one or more multidentate (e.g., bidentate) ligands. Non-limiting multidentate ligand include a diketonate (e.g., acetylacetonate (acac) or —OC(R1)-Ak-(R1)CO— or —OC(R1)—C(R2)—(R1)CO—), a bidentate chelating dinitrogen (e.g., —N(R1)-Ak-N(R1)— or —N(R3)—CR4—CR2═N(R1)—), an aromatic (e.g., —Ar—), an amidinate (e.g., —N(R1)—C(R2)—N(R1)—), an aminoalkoxide (e.g., —N(R1)-Ak-O— or —N(R1)2-Ak-O—), a diazadienyl (e.g., —N(R1)—C(R2)—C(R2)—N(R1)—), a cyclopentadienyl, a pyrazolate, an optionally substituted heterocyclyl, an optionally substituted alkylene, or an optionally substituted heteroalkylene. In particular embodiments, each R1 is, independently, H, optionally substituted alkyl, optionally substituted haloalkyl, or optionally substituted aryl; each R2 is, independently, H or optionally substituted alkyl; R3 and R4, taken together, forms an optionally substituted heterocyclyl; Ak is optionally substituted alkylene; and Ar is optionally substituted arylene.
In particular embodiments, the precursor includes tin. In some embodiments, the tin precursor includes SnR or SnR2 or SnR4 or R3SnSnR3, wherein each R is, independently, H, halo, optionally substituted C1-12 alkyl, optionally substituted C1-12 alkoxy, optionally substituted amino (e.g., —NR1R2), optionally substituted C2-12 alkenyl, optionally substituted C2-12 alkynyl, optionally substituted C3-8 cycloalkyl, optionally substituted aryl, cyclopentadienyl, optionally substituted bis(trialkylsilyl)amino (e.g., —N(SiR1R2R3)2), optionally substituted alkanoyloxy (e.g., acetate), a diketonate (e.g., —OC(R1)-Ak-(R2)CO—), or a bidentate chelating dinitrogen (e.g., —N(R1)-Ak-N(R1)—). In particular embodiments, each R1, R2, and R3 is, independently, H or C1-12 alkyl (e.g., methyl, ethyl, isopropyl, t-butyl, or neopentyl); and Ak is optionally substituted C1-6 alkylene. In particular embodiments, each R is, independently, halo, optionally substituted C1-12 alkoxy, optionally substituted amino, optionally substituted aryl, cyclopentadienyl, or a diketonate. Non-limiting tin precursors include SnF2, SnH4, SnBr4, SnCl4, SnI4, tetramethyl tin (SnMe4), tetraethyl tin (SnEt4), trimethyl tin chloride (SnMe3Cl), dimethyl tin dichloride (SnMe2Cl2), methyl tin trichloride (SnMeCl3), tetraallyltin, tetravinyl tin, hexaphenyl ditin (IV) (Ph3Sn—SnPh3, in which Ph is phenyl), dibutyldiphenyltin (SnBu2Ph2), trimethyl(phenyl) tin (SnMe3Ph), trimethyl(phenylethynyl) tin, tricyclohexyl tin hydride, tributyl tin hydride (SnBu3H), dibutyltin diacetate (SnBu2(CH3COO)2), tin(II) acetylacetonate (Sn(acac)2), SnBu3(OEt), SnBu2(OMe)2, SnBu3(OMe), Sn(t-BuO)4, Sn(n-Bu)(t-BuO)3, tetrakis(dimethylamino)tin (Sn(NMe2)4), tetrakis(ethylmethylamino)tin (Sn(NMeEt)4), tetrakis(diethylamino)tin(IV) (Sn(NEt2)4), (dimethylamino)trimethyl tin(IV) (Sn(Me)3(NMe2), Sn(i-Pr)(NMe2)3, Sn(n-Bu)(NMe2)3, Sn(s-Bu)(NMe2)3, Sn(i-Bu)(NMe2)3, Sn(t-Bu)(NMe2)3, Sn(t-Bu)2(NMe2)2, Sn(t-Bu)(NEt2)3, Sn(tbba), Sn(II) (1,3-bis(1,1-dimethylethyl)-4,5-dimethyl-(4R,5R)-1,3,2-diazastannolidin-2-ylidene), or bis[bis(trimethylsilyl)amino] tin (Sn[N(SiMe3)2]2).
In other embodiments, the precursor includes bismuth, such as in BiR3, wherein each R is, independently, halo, optionally substituted C1-12 alkyl, mono-C1-12 alkylamino (e.g., —NR1H), di-C1-12 alkylamino (e.g., —NR1R2), optionally substituted aryl, optionally substituted bis(trialkylsilyl)amino (e.g., —N(SiR1R2R3)2), or a diketonate (e.g., —OC(R4)-Ak-(R5)CO—). In particular embodiments, each R1, R2, and R3 is, independently, C1-12 alkyl (e.g., methyl, ethyl, isopropyl, t-butyl, or neopentyl); and each R4 and R5 is, independently, H or optionally substituted C1-12 alkyl (e.g., methyl, ethyl, isopropyl, t-butyl, or neopentyl). Non-limiting bismuth precursors include BiCl3, BiMe3, BiPh3, Bi(NMe2)3, Bi[N(SiMe3)2]3, and Bi(thd)3, in which thd is 2,2,6,6-tetramethyl-3,5-heptanedionate.
In other embodiments, the precursor includes tellurium, such as TeR2 or TeR4, wherein each R is, independently, halo, optionally substituted C1-12 alkyl (e.g., methyl, ethyl, isopropyl, t-butyl, and neopentyl), optionally substituted C1-12 alkoxy, optionally substituted aryl, hydroxyl, oxo, or optionally substituted trialkylsilyl. Non-limiting tellurium precursors include dimethyl tellurium (TeMe2), diethyl tellurium (TeEt2), di(n-butyl) tellurium (Te(n-Bu)2), di(isopropyl) tellurium (Te(i-Pr)2), di(t-butyl) tellurium (Te(t-Bu)2), t-butyl tellurium hydride (Te(t-Bu)(H)), Te(OEt)4, bis(trimethylsilyl)tellurium (Te(SiMe3)2), and bis(triethylsilyl) tellurium (Te(SiEt3)2).
The precursor can include antimony, such as in SbR3, wherein each R is, independently, halo, optionally substituted C1-12 alkyl (e.g., methyl, ethyl, isopropyl, t-butyl, and neopentyl), optionally substituted C1-12 alkoxy, or optionally substituted amino (e.g., —NR1R2, in which each R1 and R2 is, independently, H or optionally substituted C1-12 alkyl). Non-limiting antimony precursors include SbCl3, Sb(OEt)3, Sb(On-Bu)3, and Sb(NMe2)3.
Other precursors include indium precursors, such as in InR3, wherein each R is, independently, halo, optionally substituted C1-12 alkyl (e.g., methyl, ethyl, isopropyl, t-butyl, and neopentyl), or a diketonate (e.g., —OC(R4)-Ak-(R5)CO—, in which each R4 and R5 is, independently, H or C1-12 alkyl). Non-limiting indium precursors include InCp, in which Cp is cyclopentadienyl, InCl3, InMe3, In(acac)3, In(CF3COCHCOCH3)3, and In(thd)3.
The precursor can include iodine, such as RI, wherein R is iodo (I) or optionally substituted C1-12 alkyl, or periodate. Non-limiting iodine precursors include iodine gas (I2), diiodomethane (CH2I2), and periodate.
Yet other precursors and non-limiting substituents are described herein. For instance, precursors can be any having a structure of formulas (I), (II), and (IIa), as described above; or formulas (III), (IV), (V), (VI), (VII), or (VIII), as described below. Any of the substituents M, R, X, or L, as described herein, can be employed in any of formulas (I), (II), (IIa), (III), (IV), (V), (VI), (VII), or (VIII).
Yet other exemplary EUV-sensitive materials, as well as processing methods and apparatuses, are described in U.S. Pat. No. 9,996,004; Int. Pat. Pub. No. WO 2020/102085; and Int. Pat. Pub. No. WO 2019/217749, each of which is incorporated herein by reference in its entirety.
As described herein, the films, layers, and methods herein can be employed with any useful precursor. In some instances, the precursor includes a metal halide having the following formula (III):
MXn (III),
in which M is a metal, X is halo, and n is 2 to 4, depending on the selection of M. Exemplary metals for M include Sn, Te, Bi, or Sb. Exemplary metal halides include SnBr4, SnCl4, SnI4, and SbCl3.
Another non-limiting precursor includes a structure having formula (IV):
MRn (IV),
in which M is a metal; each R is independently H, an optionally substituted alkyl, amino (e.g., —NR2, in which each R is independently alkyl), optionally substituted bis(trialkylsilyl)amino (e.g., —N(SiR3)2, in which each R is independently alkyl), or an optionally substituted trialkylsilyl (e.g., —SiR3, in which each R is independently alkyl); and n is 2 to 4, depending on the selection of M. Exemplary metals for M include Sn, Te, Bi, or Sb. The alkyl group may be CnH2n+1, where n is 1, 2, 3, or greater. Exemplary organometallic agents include SnMe4, SnEt4, TeRn, RTeR, t-butyl tellurium hydride (Te(t-Bu)(H)), dimethyl tellurium (TeMe2), di(t-butyl) tellurium (Te(t-Bu)2), di(isopropyl)tellurium (Te(i-Pr)2), bis(trimethylsilyl)tellurium (Te(SiMe3)2), bis(triethylsilyl) tellurium (Te(SiEt3)2), tris(bis(trimethylsilyl)amido) bismuth (Bi[N(SiMe3)2]3), Sb(NMe2)3, and the like.
Another non-limiting precursor can include a capping agent having the following formula (V):
MLn (V),
in which M is a metal; each L is independently an optionally substituted alkyl, amino (e.g., —NR1R2, in which each of R1 and R2 can be H or alkyl, such as any described herein), alkoxy (e.g., —OR, in which R is alkyl, such as any described herein), halo, or other organic substituent; and n is 2 to 4, depending on the selection of M. Exemplary metals for M include Sn, Te, Bi, or Sb. Exemplary ligands include dialkylamino (e.g., dimethylamino, methylethylamino, and diethylamino), alkoxy (e.g., t-butoxy and isopropoxy), halo (e.g., F, Cl, Br, and I), or other organic substituents (e.g., acetylacetone or N2,N3-di-tertbutyl-butane-2,3-diamino). Non-limiting capping agents include SnCl4; SnI4; Sn(NR2)4, wherein each of R is independently methyl or ethyl; or Sn(t-BuO)4. In some embodiments, multiple types of ligands are present.
A precursor can include a hydrocarbyl-substituted capping agent having the following formula (VI):
RnMXm (VI),
wherein M is a metal, R is a C2-10 alkyl or substituted alkyl having a beta-hydrogen, and X is a suitable leaving group upon reaction with a hydroxyl group of the exposed hydroxyl groups. In various embodiments, n=1 to 3, and m=4−n, 3−n, or 2−n, so long as m>0 (or m≥1). For example, R may be t-butyl, t-pentyl, t-hexyl, cyclohexyl, isopropyl, isobutyl, sec-butyl, n-butyl, n-pentyl, n-hexyl, or derivatives thereof having a heteroatom substituent in the beta position. Suitable heteroatoms include halogen (F, Cl, Br, or I), or oxygen (—OH or —OR). X may be dialkylamino (e.g., dimethylamino, methylethylamino, or diethylamino), alkoxy (e.g., t-butoxy, isopropoxy), halo (e.g., F, Cl, Br, or I), or another organic ligand. Examples of hydrocarbyl-substituted capping agents include t-butyltris(dimethylamino)tin (Sn(t-Bu)(NMe2)3), n-butyltris(dimethylamino)tin (Sn(n-Bu)(NMe2)3), t-butyltris(diethylamino)tin (Sn(t-Bu)(NEt2)3), di(t-butyl)di(dimethylamino)tin (Sn(t-Bu)2(NMe2)2), sec-butyltris(dimethylamino)tin (Sn(s-Bu)(NMe2)3), n-pentyltris(dimethylamino)tin (Sn(n-pentyl)(NMe2)3), i-butyltris(dimethylamino) tin (Sn(i-Bu)(NMe2)3), i-propyltris(dimethylamino)tin (Sn(i-Pr)(NMe2)3), t-butyltris(t-butoxy)tin (Sn(t-Bu)(t-BuO)3), n-butyl(tris(t-butoxy)tin (Sn(n-Bu)(t-BuO)3), or isopropyltris(t-butoxy)tin (Sn(i-Pr)(t-BuO)3).
In various embodiments, a precursor includes at least one alkyl group on each metal atom that can survive the vapor-phase reaction, while other ligands or ions coordinated to the metal atom can be replaced by the counter-reactants. Accordingly, another non-limiting precursor includes an organometallic agent having the formula (VII):
MaRbLc (VII),
in which M is a metal; R is an optionally substituted alkyl; L is a ligand, ion, or other moiety which is reactive with the counter-reactant; a≥1; b≥1; and c≥1. In particular embodiments, a=1, and b+c=4. In some embodiments, M is Sn, Te, Bi, or Sb. In particular embodiments, each L is independently amino (e.g., —NR1R2, in which each of R1 and R2 can be H or alkyl, such as any described herein), alkoxy (e.g., —OR, in which R is alkyl, such as any described herein), or halo (e.g., F, Cl, Br, or I). Exemplary agents include SnMe3Cl, SnMe2Cl2, SnMeCl3, SnMe(NMe2)3, SnMe2(NMe2)2, SnMe3(NMe2), and the like.
In other embodiments, the non-limiting precursor includes an organometallic agent having the formula (VIII):
MaLc (VIII),
in which M is a metal; L is a ligand, ion, or other moiety which is reactive with the counter-reactant; a≥1; and c≥1. In particular embodiments, c=n−1, and n is 2, 3, or 4. In some embodiments, M is Sn, Te, Bi, or Sb. Counter-reactants preferably have the ability to replace the reactive moieties ligands or ions (e.g., L in formulas herein) so as to link at least two metal atoms via chemical bonding.
In any embodiment herein, R can be an optionally substituted alkyl (e.g., C1-10 alkyl). In one embodiment, alkyl is substituted with one or more halo (e.g., halo-substituted C1-10 alkyl, including one, two, three, four, or more halo, such as F, Cl, Br, or I). Exemplary R substituents include CnH2n+1, preferably wherein n≥3; and CnFxH(2n+1-x), wherein 2n+1≤x≤1. In various embodiments, R has at least one beta-hydrogen or beta-fluorine. For example, R may be selected from the group consisting of i-propyl, n-propyl, t-butyl, i-butyl, n-butyl, sec-butyl, n-pentyl, i-pentyl, t-pentyl, sec-pentyl, and mixtures thereof.
In any embodiment herein, L may be any moiety readily displaced by a counter-reactant to generate an M-OH moiety, such as a moiety selected from the group consisting of an amino (e.g., —NR1R2, in which each of R1 and R2 can be H or alkyl, such as any described herein), alkoxy (e.g., —OR, in which R is alkyl, such as any described herein), carboxylates, halo (e.g., F, Cl, Br, or I), and mixtures thereof.
Counter-reactants preferably have the ability to replace the reactive moieties, ligands, or ions (e.g., L in formulas herein) so as to link at least two metal atoms via chemical bonding. Exemplary counter-reactants include oxygen-containing counter-reactants, such as oxygen (O2), ozone (O3), water, peroxides (e.g., hydrogen peroxide), oxygen plasma, water plasma, alcohols, dihydroxy alcohols, polyhydroxy alcohols, fluorinated dihydroxy alcohol, fluorinated polyhydroxy alcohols, fluorinated glycols, formic acid, and other sources of hydroxyl moieties, as well as combinations thereof. In various embodiments, a counter-reactant reacts with the precursor by forming oxygen bridges between neighboring metal atoms. Other potential counter-reactants include hydrogen sulfide and hydrogen disulfide, which can crosslink metal atoms via sulfur bridges and bis(trimethylsilyl)tellurium, which can crosslink metal atoms via tellurium bridges. In addition, hydrogen iodide may be utilized to incorporate iodine into the film.
Yet other non-limiting counter-reactants include a chalcogenide precursor having the formula ZR2, wherein: Z is sulfur, selenium, or tellurium; and each R is, independently, H, optionally substituted alkyl (e.g., methyl, ethyl, n-propyl, isopropyl, n-butyl, t-butyl, etc.), optionally substituted alkenyl, optionally substituted aryl, optionally substituted amino, optionally substituted alkoxy, or optionally substituted trialkylsilyl.
Exemplary organometallic agents include SnMeCl3, (N2,N3-di-t-butyl-butane-2,3-diamido) tin(II) (Sn(tbba)), bis(bis(trimethylsilyl)amido) tin(II), tetrakis(dimethylamino) tin(IV) (Sn(NMe2)4), t-butyl tris(dimethylamino) tin (Sn(t-butyl)(NMe2)3), i-butyl tris(dimethylamino) tin (Sn(i-Bu)(NMe2)3), n-butyl tris(dimethylamino) tin (Sn(n-Bu)(NMe2)3), sec-butyl tris(dimethylamino) tin (Sn(s-Bu)(NMe2)3), i-propyl(tris)dimethylamino tin (Sn(i-Pr)(NMe2)3), n-propyl tris(diethylamino) tin (Sn(n-Pr)(NEt2)3), and analogous alkyl(tris)(t-butoxy) tin compounds, such as t-butyl tris(t-butoxy) tin (Sn(t-Bu)(t-BuO)3). In some embodiments, the organometallic agents are partially fluorinated.
In some embodiments, patterning structure can include a surface layer or film comprising exposed hydroxyl groups or hydroxyl-terminated SnOx. Without limiting the mechanism, function or utility of present technology, it is believed that the hydroxyl-terminated SnOx layer may offer benefits such as improved adhesion of materials deposited on the surface of the substrate and enhanced absorption of EUV (or other radiation) during patterning. Sensitivity to EUV or other irradiation and resolution may be dependent on the properties of the SnOx layer, such as thickness, density and short-range charge transfer characteristics. In various embodiments, the SnOx layer has a thickness of from 0.1 nm to 20 nm, or from 0.2 nm to 10 nm, or from 0.5 nm to 5 nm.
In some embodiments, the hydroxyl-terminated SnOx layer is deposited on a surface of the substrate by vapor deposition. In such methods, the deposition comprises reacting Sn—Xn with an oxygen-containing counter-reactant, wherein X is a ligand such as dialkylamino, (e.g., dimethylamino, methylethylamino, and diethylamino), alcohol (e.g., t-butoxy, and isopropoxy), halogen (e.g., F, Cl, Br, and I), or other organic substituent (e.g., acetylacetone, N2,N3-di-tertbutyl-butane-2,3-diamino). For example, Sn—Xn may be SnCl4, SnI4, or Sn(NR2)4 wherein R is methyl or ethyl, or Sn(t-BuO)4. In some embodiments, multiple types of ligands are present. The oxygen-containing counter-reactant may be selected from the group consisting of water, hydrogen peroxide, formic acid, alcohols, oxygen, ozone, and combinations thereof.
Suitable vapor deposition processes include chemical vapor deposition (CVD), atomic layer deposition (ALD), plasma-enhanced chemical vapor deposition (PECVD), or plasma-enhanced atomic layer deposition (PEALD). In some embodiments, the deposition is ALD, in a cyclical process of depositing the Sn—Xn and depositing the oxygen-containing counter-reactant. In some embodiments, the deposition is CVD, by simultaneously flowing the Sn—Xn and the oxygen-containing counter-reactant. Materials and processes among those useful herein for depositing SnOx layers are described in Nazarov et al., Atomic Layer Deposition of Tin Dioxide Nanofilms: A Review, 40 Rev. Adv. Mater. Sci. 262 (2015). A SnOx substrate may be deposited by a CVD or ALD process, as described herein.
A surface activation operation may be used to activate the surface for future operations. For example, for a SiOx surface, a water or oxygen/hydrogen plasma may be used to create hydroxyl groups on the surface. For a carbon- or hydrocarbon-based surface, a water, hydrogen/oxygen or CO2 plasma or ozone treatment may be used to create carboxylic acids/or hydroxyl groups. Such approaches can prove critical for improving the adhesion of resist features to the substrate, which might otherwise delaminate or lift off in the solvent used for development.
Adhesion may also be enhanced by inducing roughness in the substrate surface to increase the surface area available for interaction, as well as directly improve mechanical adhesion. For example, first a sputtering process using Ar or other non-reactive ion bombardment can be used to produce rough surfaces. Then, the surface can be terminated with a desired surface functionality as described above (e.g., hydroxyl and/or carboxylic acid groups). On carbon, a combination approach can be employed wherein a chemically reactive oxygen-containing plasma such as CO2, O2, H2O (or mixtures of H2 and O2) can be used to etch away a thin layer of film with local non-uniformity and simultaneously terminate with —OH, —OOH, or —COOH groups. This may be done with or without bias. In conjunction with the surface modification strategies mentioned above, this approach could serve the dual purpose of surface roughening and chemical activation of the substrate surface, either for direct adhesion to an inorganic metal-oxide based resist or as an intermediate surface modification for further functionalization.
The patterning structure can include any useful substrate. For instance, an incoming wafer can be prepared with a substrate surface of a desired material, with the uppermost material being the layer into which the resist pattern is transferred. While the material selection may vary depending on integration, it is generally desired to select a material which can be etched with high selectivity to (i.e., much faster than) the EUV resist or imaging layer. In some embodiments, the substrate is a hardmask, which is used in lithographic etching of an underlying semiconductor material. The hardmask may comprise any of a variety of materials, including amorphous carbon (a-C), tin oxide (e.g., SnOx), silicon oxide (e.g., SiOx, including SiO2), silicon oxynitride (e.g., SiOxNy), silicon oxycarbide (e.g., SiOxCy), silicon nitride (e.g., Si3N4), titanium oxide (e.g., TiO2), titanium nitride (e.g., TiN), tungsten (e.g., W), doped carbon (e.g., W-doped C), tungsten oxide (e.g., WOx), hafnium oxide (e.g., HfO2), zirconium oxide (e.g., ZrO2), and aluminum oxide (e.g., Al2O3). Suitable substrate materials can include various carbon-based films (e.g., ashable hardmask (AHM), silicon-based films (e.g., SiOx, SiCx, SiOxCy, SiOxNy, SiOxCyNz), a-Si:H, poly-Si, or SiN), or any other (generally sacrificial) film applied to facilitate the patterning process). For example, the substrate may preferably comprise SnOx, such as SnO2. In various embodiments, the layer may be from 1 nm to 100 nm thick, or from 2 nm to 10 nm thick.
In various embodiments, the surface (e.g., of the substrate and/or the film) comprises exposed hydroxyl groups on its surface. In general, the surface may be any surface that comprises, or has been treated to produce, an exposed hydroxyl surface. Such hydroxyl groups may be formed on the surface by surface treatment of a substrate using oxygen plasma, water plasma, or ozone. In other embodiments, the surface of the film can be treated to provide exposed hydroxyl groups, upon which a capping layer can be applied. In various embodiments, the hydroxyl-terminated metal oxide layer has a thickness of from 0.1 nm to 20 nm, or from 0.2 nm to 10 nm, or from 0.5 nm to 5 nm.
The implementations disclosed herein describe deposition of a material on a substrate such as a wafer, substrate, or other work piece. The work piece may be of various shapes, sizes, and materials. In this application, the terms “semiconductor wafer,” “wafer,” “substrate,” “wafer substrate,” and “partially fabricated integrated circuit” are used interchangeably. One of ordinary skill in the art would understand that the term “partially fabricated integrated circuit” can refer to a silicon wafer during any of many stages of integrated circuit fabrication thereon. A wafer or substrate used in the semiconductor device industry typically has a diameter of 200 mm, or 300 mm, or 450 mm. Unless otherwise stated, the processing details recited herein (e.g., flow rates, power levels, etc.) are relevant for processing 300 mm diameter substrates, or for treating chambers that are configured to process 300 mm diameter substrates, and can be scaled as appropriate for substrates or chambers of other sizes. In addition to semiconductor wafers, other work pieces that may be used implementations disclosed herein include various articles such as printed circuit boards and the like. The processes and apparatuses can be used in the fabrication of semiconductor devices, displays, and the like.
Lithographic Processes
EUV lithography makes use of EUV resists, which may be polymer-based chemically amplified resists produced by liquid-based spin-on techniques or metal oxide-based resists produced by dry vapor-deposited techniques. Such EUV resists can include any EUV-sensitive film or material described herein. Lithographic methods can include patterning the resist, e.g., by exposure of the EUV resist with EUV radiation to form a photo pattern, followed by developing the pattern by removing a portion of the resist according to the photo pattern to form a mask.
It should also be understood that while the present disclosure relates to lithographic patterning techniques and materials exemplified by EUV lithography, it is also applicable to other next generation lithographic techniques. In addition to EUV, which includes the standard 13.5 nm EUV wavelength currently in use and development, the radiation sources most relevant to such lithography are DUV (deep-UV), which generally refers to use of 248 nm or 193 nm excimer laser sources; X-ray, which formally includes EUV at the lower energy range of the X-ray range; as well as e-beam, which can cover a wide energy range. Such methods include those where a substrate (e.g., optionally having exposed hydroxyl groups) is contacted with a precursor (e.g., any described herein) to form a metal oxide (e.g., a layer including a network of metal oxide bonds, which may include other non-metal and non-oxygen groups) film as the imaging/PR layer on the surface of the substrate. The specific methods may depend on the particular materials and applications used in the semiconductor substrate and ultimate semiconducting device. Thus, the methods described in this application are merely exemplary of the methods and materials that may be used in present technology. In some embodiments, lithography includes use of a radiation source having a wavelength that is between 10 nm and 400 nm.
Directly photopatternable EUV resists may be composed of or contain metals and/or metal oxides. The metals/metal oxides are highly promising in that they can enhance the EUV photon absorption and generate secondary electrons and/or show increased etch selectivity to an underlying film stack and device layers. To date, these resists have been developed using a wet (solvent) approach, which requires the wafer to move to the track, where it is exposed to developing solvent, dried and baked. Wet development does not only limit productivity but can also lead to line collapse due to surface tension effects during the evaporation of solvent between fine features.
Dry development techniques have been proposed to overcome these issues by eliminating substrate delamination and interface failures. Dry development has its own challenges, including etch selectivity between unexposed and EUV exposed resist material which can lead to a higher dose to size requirement for effective resist exposure when compared to wet development. Suboptimal selectivity can also cause PR corner rounding due to longer exposures under etching gas, which may increase line CD variation in the following transfer etch step. Additional processes employed during lithography are described in detail below.
Deposition Processes, Including Dry Deposition
As discussed herein, the present disclosure provides methods for making underlayers and imaging layers on semiconductor substrates, which may be patterned using EUV or other next generation lithographic techniques. In some embodiments, dry deposition can employ any useful precursor (e.g., hydrocarbon precursors, dopant precursors, metal halides, capping agents, or organometallic agents described herein) to provide the underlayer and the imaging layer. Methods include those where polymerized organometallic materials are produced in a vapor and deposited above the underlayer. In other embodiments, a spin-on formulation may be used. Deposition processes can include applying a EUV-sensitive material as a resist film or an EUV-sensitive film.
Such EUV-sensitive films comprise materials which, upon exposure to EUV, undergo changes, such as the loss of bulky pendant ligands bonded to metal atoms in low density M-OH rich materials, allowing their crosslinking to denser M-O-M bonded metal oxide materials. In other embodiments, EUV exposure results in further cross-linking between ligands bonded to metal atoms, thereby providing denser M-L-M bonded organometallic materials, in which L is a ligand. In yet other embodiments, EUV exposure results in loss of ligands to provide M-OH materials that can be removed by positive tone developers.
Through EUV patterning, areas of the film are created that have altered physical or chemical properties relative to unexposed areas. These properties may be exploited in subsequent processing, such as to dissolve either unexposed or exposed areas or to selectively deposit materials on either the exposed or unexposed areas. In some embodiments, the unexposed film has a hydrophobic surface, and the exposed film has a hydrophilic surface (it being recognized that the hydrophilic properties of exposed and unexposed areas are relative to one another) under the conditions at which such subsequent processing is performed. For example, the removal of material may be performed by leveraging differences in chemical composition, density, and cross-linking of the film. Removal may be by wet processing or dry processing, as further described herein.
The thickness of the EUV-patternable film formed on the surface of the substrate may vary according to the surface characteristics, materials used, and processing conditions. In various embodiments, the film thickness may range from about 0.5 nm to about 100 nm. Preferably, the film has a sufficient thickness to absorb most of the EUV light under the conditions of EUV patterning. For example, the overall absorption of the resist film may be 30% or less (e.g., 10% or less, or 5% or less), so that the resist material at the bottom of the resist film is sufficiently exposed. In some embodiments, the film thickness is from 10 nm to 20 nm. Without limiting the mechanism, function, or utility of the present disclosure, it is believed that, unlike wet, spin-coating processes of the art, the processes of the present disclosure have fewer restrictions on the surface adhesion properties of the substrate, and therefore can be applied to a wide variety of substrates. Moreover, as discussed above, the deposited films may closely conform to surface features, providing advantages in forming masks over substrates, such as substrates having underlying features, without “filling in” or otherwise planarizing such features.
The film (e.g., underlayer and/or imaging layer) may be composed of a metal oxide layer deposited in any useful manner. Such a metal oxide layer can be deposited or applied by using any EUV-sensitive material described herein, such as a precursor (e.g., metal-containing precursor, a metal halide, a capping agent, or an organometallic agent) in combination with a counter-reactant. In exemplary processes, a polymerized organometallic material is formed in vapor phase or in situ on the surface of the substrate in order to provide the metal oxide layer. The metal oxide layer may be employed as a film, an adhesion layer, or a capping layer.
Optionally, the metal oxide layer can include a hydroxyl-terminated metal oxide layer, which can be deposited by employing a capping agent (e.g., any described herein) with an oxygen-containing counter-reactant. Such a hydroxyl-terminated metal oxide layer can be employed, e.g., as an adhesion layer between two other layers, such as between the substrate and the film and/or between the photoresist layer and the underlayer.
Exemplary deposition techniques (e.g., for a film, an underlayer, or an imaging layer) include any described herein, such as ALD (e.g., thermal ALD and plasma-enhanced ALD), spin-coat deposition, PVD including PVD co-sputtering, CVD (e.g., PE-CVD or LP-CVD), sputter deposition, e-beam deposition including e-beam co-evaporation, etc., or a combination thereof, such as ALD with a CVD component, such as a discontinuous, ALD-like process in which precursors and counter-reactants are separated in either time or space.
Further description of precursors and methods for their deposition as EUV photoresist films applicable to this disclosure may be found in International Appl. No. PCT/US19/31618, published as International Pub. No. WO2019/217749, filed May 9, 2019, and titled METHODS FOR MAKING EUV PATTERNABLE HARD MASKS. The thin films may include optional materials in addition to a precursor and a counter-reactant to modify the chemical or physical properties of the film, such as to modify the sensitivity of the film to EUV or enhancing etch resistance. Such optional materials may be introduced, such as by doping during vapor phase formation prior to deposition on the substrate, after deposition of the film, or both. In some embodiments, a gentle remote H2 plasma may be introduced so as to replace some Sn-L bonds with Sn—H, for example, which can increase reactivity of the resist under EUV.
In general, methods can include mixing a vapor stream of a precursor (e.g., a metal-containing precursor, such as an organometallic agent) with an optional vapor stream of a counter-reactant so as to form a polymerized organometallic material, and depositing the organometallic material onto the surface of the semiconductor substrate. In some embodiments, mixing the precursor and optional counter-reactant can form a polymerized organometallic material. As will be understood by one of ordinary skill in the art, the mixing and depositing aspects of the process may be concurrent, in a substantially continuous process.
In an exemplary continuous CVD process, two or more gas streams, in separate inlet paths, of sources of precursor and optional counter-reactant are introduced to the deposition chamber of a CVD apparatus, where they mix and react in the gas phase, to form agglomerated polymeric materials (e.g., via metal-oxygen-metal bond formation) or a film on the substrate. Gas streams may be introduced, for example, using separate injection inlets or a dual-plenum showerhead. The apparatus is configured so that the streams of precursor and optional counter-reactant are mixed in the chamber, allowing the precursor and optional counter-reactant to react to form a polymerized organometallic material or a film (e.g., a metal oxide coating or agglomerated polymeric materials, such as via metal-oxygen-metal bond formation).
For depositing metal oxide, the CVD process is generally conducted at reduced pressures, such as from 0.1 Torr to 10 Torr. In some embodiments, the process is conducted at pressures from 1 Torr to 2 Torr. The temperature of the substrate is preferably below the temperature of the reactant streams. For example, the substrate temperature may be from 0° C. to 250° C., or from ambient temperature (e.g., 23° C.) to 150° C.
For depositing agglomerated polymeric materials, the CVD process is generally conducted at reduced pressures, such as from 10 mTorr to 10 Torr. In some embodiments, the process is conducted at from 0.5 to 2 Torr. The temperature of the substrate is preferably at or below the temperature of the reactant streams. For example, the substrate temperature may be from 0° C. to 250° C., or from ambient temperature (e.g., 23° C.) to 150° C. In various processes, deposition of the polymerized organometallic material on the substrate occurs at rates inversely proportional to surface temperature. Without limiting the mechanism, function or utility of present technology, it is believed that the product from such vapor-phase reaction becomes heavier in molecular weight as metal atoms are crosslinked by counter-reactants, and is then condensed or otherwise deposited onto the substrate. In various embodiments, the steric hindrance of the bulky alkyl groups further prevents the formation of densely packed network and produces low density films having increased porosity.
A potential advantage of using dry deposition methods is ease of tuning the composition of the film as it grows. In a CVD process, this may be accomplished by changing the relative flows of a first precursor and a second precursor during deposition. Deposition may occur between 30° C. and 200° C. at pressures between 0.01 Torr to 100 Torr, but more generally between about 0.1 Torr and 10 Torr.
A film (e.g., a metal oxide coating or agglomerated polymeric materials, such as via metal-oxygen-metal bond formation) may also be deposited by an ALD process. For example, the precursor(s) and optional counter-reactant are introduced at separate times, representing an ALD cycle. The precursors react on the surface, forming up to a monolayer of material at a time for each cycle. This may allow for excellent control over the uniformity of film thickness across the surface. The ALD process is generally conducted at reduced pressures, such as from 0.1 Torr to 10 Torr. In some embodiments, the process is conducted from 1 Torr to 2 Torr. The substrate temperature may be from 0° C. to 250° C., or from ambient temperature (e.g., 23° C.) to 150° C. The process may be a thermal process or, preferably, a plasma-assisted deposition.
Any of the deposition methods herein can be modified to allow for use of two or more different precursors. In one embodiment, the precursors can include the same metal but different ligands. In another embodiment, the precursors can include different metal groups. In one non-limiting instance, alternating flows of various volatile precursors can provide a mixed metal-containing layer, such as use of a metal alkoxide precursor having a first metal (e.g., Sn) with a silyl-based precursor having a different second metal (e.g., Te).
Processes herein can be used to achieve a surface modification. In some iterations, a vapor of the precursor may be passed over the wafer. The wafer may be heated to provide thermal energy for the reaction to proceed. In some iterations, the heating can be between about 50° C. to about 250° C. In some cases, pulses of the precursor may be used, separated by pump and/or purging steps. For instance, a first precursor may be pulsed between pulses of a second precursor pulses resulting in ALD or ALD-like growth. In other cases, both precursors may be flowed at the same time. Examples of elements useful for surface modification include I, F, Sn, Bi, Sb, Te, and oxides or alloys of these compounds.
The processes herein can be used to deposit a thin metal oxide or metal by ALD or CVD. Examples include tin oxide (SnOx), bismuth oxide (BiOx), and Te. Following deposition, the film may be capped with an alkyl substituted precursor of the form MaRbLc, as described elsewhere herein. A counter-reactant may be used to better remove the ligands, and multiple cycles may be repeated to ensure complete saturation of the substrate surface. The surface can then ready for the EUV-sensitive film to be deposited. One possible method is to produce a thin film of SnOx. Possible chemistries include growth of SnO2 by cycling tetrakis(dimethylamino)tin and a counter-reactant such as water or O2 plasma. After the growth, a capping agent could be used. For example, isopropyltris(dimethylamino)tin vapor may be flown over the surface.
Deposition processes can be employed on any useful surface. As referred to herein, the “surface” is a surface onto which a film of the present technology is to be deposited or that is to be exposed to EUV during processing. Such a surface can be present on a substrate (e.g., upon which a film is to be deposited), on a film (e.g., upon which a capping layer can be deposited), on a hardmask, or on an underlayer.
Any useful substrate can be employed, including any material construct suitable for lithographic processing, particularly for the production of integrated circuits and other semiconducting devices. In some embodiments, substrates are silicon wafers. Substrates may be silicon wafers upon which features have been created (“underlying topographical features”), having an irregular surface topography.
Such underlying topographical features may include regions in which material has been removed (e.g., by etching) or regions in which materials have been added (e.g., by deposition) during processing prior to conducting a method of this technology. Such prior processing may include methods of this technology or other processing methods in an iterative process by which two or more layers of features are formed on the substrate. Without limiting the mechanism, function, or utility of the present technology, it is believed that, in some embodiments, methods of the present technology offer advantages relative to methods among those known in the art in which photolithographic films are deposited on the surface of substrates using spin casting methods. Such advantages may derive from the conformance of the films of the present technology to underlying features without “filling in” or otherwise planarizing such features, and the ability to deposit films on a wide variety of material surfaces.
EUV Exposure Processes
EUV exposure of the film can provide EUV exposed areas having activated reactive centers including a metal atom (M), which are produced by EUV-mediated cleavage events. Such reactive centers can include dangling metal bonds, M-H groups, cleaved M-ligand groups, dimerized M-M bonds, or M-O-M bridges.
EUV exposure can have a wavelength in the range of about 10 nm to about 20 nm in a vacuum ambient, such as a wavelength of from 10 nm to 15 nm, e.g., 13.5 nm. In particular, patterning can provide EUV exposed areas and EUV unexposed areas to form a pattern.
The present technology can include patterning using EUV, as well as DUV or e-beam. In such patterning, the radiation is focused on one or more regions of the imaging layer. The exposure is typically performed such that imaging layer film comprises one or more regions that are not exposed to the radiation. The resulting imaging layer may comprise a plurality of exposed and unexposed regions, creating a pattern consistent with the creation of transistor or other features of a semiconductor device, formed by addition or removal of material from the substrate in subsequent processing of the substrate. EUV, DUV and e-beam radiation methods and equipment among useful herein include methods and equipment known in the art.
In some EUV lithography techniques, an organic hardmask (e.g., an ashable hardmask of PECVD amorphous hydrogenated carbon) is patterned using a conventional photoresist process. During photoresist exposure, EUV radiation is absorbed in the resist and in the substrate below, producing highly energetic photoelectrons (e.g., about 100 eV) and in turn a cascade of low-energy secondary electrons (e.g., about 10 eV) that diffuse laterally by several nanometers. These electrons increase the extent of chemical reactions in the resist which increases its EUV dose sensitivity. However, a secondary electron pattern that is random in nature is superimposed on the optical image. This unwanted secondary electron exposure results in loss of resolution, observable line edge roughness (LER) and linewidth variation in the patterned resist. These defects are replicated in the material to be patterned during subsequent pattern transfer etching.
A vacuum-integrated metal hardmask process and related vacuum-integrated hardware that combines film formation (deposition/condensation) and optical lithography with the result of greatly improved EUV lithography (EUVL) performance—e.g. reduced line edge roughness—is disclosed herein.
In various embodiments described herein, a deposition (e.g., condensation) process (e.g., ALD or MOCVD carried out in a PECVD tool, such as the Lam Vector®) can be used to form a thin film of a metal-containing film, such a photosensitive metal salt or metal-containing organic compound (organometallic compound), with a strong absorption in the EUV (e.g., at wavelengths on the order of 10 nm to 20 nm), for example at the wavelength of the EUVL light source (e.g., 13.5 nm=91.8 eV). This film photo-decomposes upon EUV exposure and forms a metal mask that is the pattern transfer layer during subsequent etching (e.g., in a conductor etch tool, such as the Lam 2300® Kiyo®).
Following deposition, the EUV-patternable thin film is patterned by exposure to a beam of EUV light, typically under relatively high vacuum. For EUV exposure, the metal-containing film can then be deposited in a chamber integrated with a lithography platform (e.g., a wafer stepper such as the TWINSCAN NXE: 3300B® platform supplied by ASML of Veldhoven, NL) and transferred under vacuum so as not to react before exposure. Integration with the lithography tool is facilitated by the fact that EUVL also requires a greatly reduced pressure given the strong optical absorption of the incident photons by ambient gases such as H2O, O2, etc. In other embodiments, the photosensitive metal film deposition and EUV exposure may be conducted in the same chamber.
Development Processes, Including Dry Development
EUV exposed or unexposed areas can be removed by any useful development process. In one embodiment, the EUV exposed area can have activated reactive centers, such as dangling metal bonds, M-H groups, or dimerized M-M bonds. In particular embodiments, M-H groups can be selectively removed by employing one or more dry development processes (e.g., halide chemistry). In other embodiments, M-M bonds can be selectively removed by employing a wet development process, e.g., use of hot ethanol and water to provide soluble M(OH)n groups. In yet other embodiments, EUV exposed areas are removed by use of wet development (e.g., by using a positive tone developer). In some embodiments, EUV unexposed areas are removed by use of dry development.
Dry development processes can include use of halides, such as HCl- or HBr-based processes. While this disclosure is not limited to any particular theory or mechanism of operation, the approach is understood to leverage the chemical reactivity of the dry-deposited EUV photoresist films with the clean chemistry (e.g., HCl, HBr, and BCl3) to form volatile products using vapors or plasma. The dry-deposited EUV photoresist films can be removed with etch rates of up to 1 nm/s. The quick removal of dry-deposited EUV photoresist films by these chemistries is applicable to chamber cleaning, backside clean, bevel clean, and PR developing. Although the films can be removed using vapors at various temperatures (e.g., HCl or HBr at a temperature greater than −10° C., or BCl3 at a temperature greater than 80° C., for example), a plasma can also be used to further accelerate or enhance the reactivity.
Plasma processes include transformer coupled plasma (TCP), inductively coupled plasma (ICP), or capacitively coupled plasma (CCP), employing equipment and techniques among those known in the art. For example, a process may be conducted at a pressure of >0.5 mTorr (e.g., such as from 1 mTorr to 100 mTorr), at a power level of <1000 W (e.g., <500 W). Temperatures may be from 30° C. to 300° C. (e.g., 30° C. to 120° C.), at flow rate of 100 to 1000 standard cubic centimeters per minute (sccm), e.g., about 500 sccm, for from 1 to 3000 seconds (e.g., 10 seconds to 600 seconds).
Where the halide reactant flows are of hydrogen gas and halide gas, a remote plasma/UV radiation is used to generate radicals from the H2 and Cl2 and/or Br2, and the hydrogen and halide radicals are flowed to the reaction chamber to contact the patterned EUV photoresist on the substrate layer of the wafer. Suitable plasma power may range from 100 W to 500 W, with no bias. It should be understood that while these conditions are suitable for some processing reactors, e.g., a Kiyo etch tool available from Lam Research Corporation, Fremont, CA, a wider range of process conditions may be used according to the capabilities of the processing reactor.
In thermal development processes, the substrate is exposed to dry development chemistry (e.g., a Lewis Acid) in a vacuum chamber (e.g., oven). Suitable chambers can include a vacuum line, a dry development hydrogen halide chemistry gas (e.g., HBr, HCl) line, and heaters for temperature control. In some embodiments, the chamber interior can be coated with corrosion resistant films, such as organic polymers or inorganic coatings. One such coating is polytetrafluoroethylene ((PTFE), e.g., Teflon™). Such materials can be used in thermal processes of this disclosure without risk of removal by plasma exposure.
The process conditions for the dry development may be reactant flow of 100 sccm to 500 sccm (e.g., 500 sccm HBr or HCl), temperature of −10° C. to 120° C. (e.g., −10° C.), pressure of 1 mTorr to 500 mTorr (e.g., 300 mTorr) with no plasma and for a time of about 10 sec to 1 min, dependent on the photoresist film and their composition and properties.
In various embodiments, methods of the present disclosure combine all dry steps of film deposition, formation by vapor deposition, (EUV) lithographic photopatterning, and dry development. In such processes, a substrate may directly go to a dry development/etch chamber following photopatterning in an EUV scanner. Such processes may avoid material and productivity costs associated with a wet development. A dry process can also provide more tunability and give further CD control and/or scum removal.
In various embodiments, the EUV photoresist, containing some amount of metal, metal oxide and organic components, can be dry developed by a thermal, plasma (e.g., including possibly photoactivated plasma, such as lamp-heated or UV lamp heated), or a mixture of thermal and plasma methods while flowing a dry development gas including a compound of formula RxZy, where R=B, Al, Si, C, S, SO with x>0 and Z=Cl, H, Br, F, CH4 and y>0. The dry development can result in a positive tone, in which the RxZy species selectively removes the exposed material, leaving behind the unexposed counterpart as a mask. In some embodiments, the exposed portions of organotin oxide-based photoresist films are removed by dry development in accordance with this disclosure. Positive tone dry development may be achieved by the selective dry development (removal) of EUV exposed regions exposed to flows comprising hydrogen halides or hydrogen and halides, including HCl and/or HBr without striking a plasma, or flows of H2 and Cl2 and/or Br2 with a remote plasma or UV radiation generated from plasma to generate radicals.
Wet development methods can also be employed. In particular embodiments, such wet developments methods are used to remove EUV exposed regions to provide a positive tone photoresist or a negative tone resist. Exemplary, non-limiting wet development can include use of an alkaline developer (e.g., an aqueous alkaline developer), such as those including ammonium, e.g., ammonium hydroxide (NH4OH); ammonium-based ionic liquids, e.g., tetramethylammonium hydroxide (TMAH), tetraethylammonium hydroxide (TEAH), tetrapropylammonium hydroxide (TPAH), tetrabutylammonium hydroxide (TBAH), or other quaternary alkylammonium hydroxides; an organoamine, such as mono-, di-, and tri-organoamines (e.g., dimethylamine, diethylamine, ethylenediamine, triethylenetetramine); or an alkanolamine, such as monoethanolamine, diethanolamine, triethanolamine, or diethyleneglycolamine. In other embodiments, the alkaline developer can include nitrogen-containing bases, e.g., compounds having the formula RN1NH2, RN1RN2NH, RN1RN2RN3N, or RN1RN2RN3RN4N+XN1−, where each of RN1, RN2, RN3, and RN4 is, independently, an organo substituent (e.g., optionally substituted alkyl or any described herein), or two or more organo substituents that can be joined together, and XN1 may comprise OH−, F−, Cl−, Br−, I−, or other art-known quaternary ammonium cationic species. These bases may also comprise heterocyclyl nitrogen compounds known in the art, some of which are described herein.
Other development methodologies can include use of an acidic developer (e.g., an aqueous acidic developer or an acid developer in an organic solvent) that includes a halide (e.g., HCl or HBr), an organic acid (e.g., formic acid, acetic acid, or citric acid), or an organofluorine compound (e.g., trifluoroacetic acid); or use of an organic developer, such as a ketone (e.g., 2-heptanone, cyclohexanone, or acetone), an ester (e.g., γ-butyrolactone or ethyl 3-ethoxypropionate (EEP)), an alcohol (e.g., isopropyl alcohol (IPA)), or an ether, such as a glycol ether (e.g., propylene glycol methyl ether (PGME) or propylene glycol methyl ether acetate (PGMEA)), as well as combinations thereof.
In particular embodiments, the positive tone developer is an aqueous alkaline developer (e.g., including NH4OH, TMAH, TEAH, TPAH, or TBAH). In other embodiments, the negative tone developer is an aqueous acidic developer, an acidic developer in an organic solvent, or an organic developer (e.g., HCl, HBr, formic acid, trifluoroacetic acid, 2-heptanone, IPA, PGME, PGMEA, or combinations thereof).
Post-Application Processes
The methods herein can include any useful post-application processes, as described below.
For the backside and bevel clean process, the vapor and/or the plasma can be limited to a specific region of the wafer to ensure that only the backside and the bevel are removed, without any film degradation on the frontside of the wafer. The dry-deposited EUV photoresist films being removed are generally composed of Sn, O and C, but the same clean approaches can be extended to films of other metal oxide resists and materials. In addition, this approach can also be used for film strip and PR rework.
Suitable process conditions for a dry bevel edge and backside clean may be a reactant flow of 100 sccm to 500 sccm (e.g., 500 sccm HCl, HBr, or H2 and Cl2 or Br2, BCl3 or H2), temperature of −10° C. to 120° C. (e.g., 20° C.), pressure of 20 mTorr to 500 mTorr (e.g., 300 mTorr), plasma power of 0 to 500 W at high frequency (e.g., 13.56 MHz), and for a time of about 10 sec to 20 sec, dependent on the photoresist film and composition and properties. It should be understood that while these conditions are suitable for some processing reactors, e.g., a Kiyo® etch tool available from Lam Research Corporation, Fremont, CA, a wider range of process conditions may be used according to the capabilities of the processing reactor.
Photolithography processes typically involve one or more bake steps, to facilitate the chemical reactions required to produce chemical contrast between exposed and unexposed areas of the photoresist. For high volume manufacturing (HVM), such bake steps are typically performed on tracks where the wafers are baked on a hot-plate at a pre-set temperature under ambient air or in some cases N2 flow. More careful control of the bake ambient as well as introduction of additional reactive gas component in the ambient during these bake steps can help further reduce the dose requirement and/or improve pattern fidelity.
According to various aspects of this disclosure, one or more post treatments to metal and/or metal oxide-based photoresists after deposition (e.g., post-application bake (PAB)) and/or exposure (e.g., post-exposure bake (PEB)) and/or development (e.g., post-development bake (PDB)) are capable of increasing material property differences between exposed and unexposed photoresist and therefore decreasing dose to size (DtS), improving PR profile, and improving line edge and width roughness (LER/LWR) after subsequent dry development. Such processing can involve a thermal process with the control of temperature, gas ambient, and moisture, resulting in improved dry development performance in processing to follow. In some instances, a remote plasma might be used.
In the case of post-application processing (e.g., PAB), a thermal process with control of temperature, gas ambient (e.g., air, H2O, CO2, CO, O2, O3, CH4, CH3OH, N2, H2, NH3, N2O, NO, Ar, He, or their mixtures) or under vacuum, and moisture can be used after deposition and before exposure to change the composition of unexposed metal and/or metal oxide photoresist. The change can increase the EUV sensitivity of the material and thus lower dose to size and edge roughness can be achieved after exposure and dry development.
In the case of post-exposure processing (e.g., PEB), a thermal process with the control of temperature, gas atmosphere (e.g., air, H2O, CO2, CO, O2, O3, CH4, CH3OH, N2, H2, NH3, N2O, NO, Ar, He, or their mixtures) or under vacuum, and moisture can be used to change the composition of both unexposed and exposed photoresist. The change can increase the composition/material properties difference between the unexposed and exposed photoresist and the etch rate difference of dry development etch gas between the unexposed and exposed photoresist. A higher etch selectivity can thereby be achieved. Due to the improved selectivity, a squarer PR profile can be obtained with improved surface roughness, and/or less photoresist residual/scum. In particular embodiments, PEB can be performed in air and in the optional presence of moisture and CO2.
In the case of post-development processing (e.g., post development bake or PDB), a thermal process with the control of temperature, gas atmosphere (e.g., air, H2O, CO2, CO, O2, O3, CH4, CH3OH, N2, H2, NH3, N2O, NO, Ar, He, or their mixtures) or under vacuum (e.g., with UV), and moisture can be used to change the composition of the unexposed photoresist. In particular embodiments, the condition also includes use of plasma (e.g., including O2, O3, Ar, He, or their mixtures). The change can increase the hardness of material, which can be beneficial if the film will be used as a resist mask when etching the underlying substrate.
In these cases, in alternative implementations, the thermal process could be replaced by a remote plasma process to increase reactive species to lower the energy barrier for the reaction and increase productivity. Remote plasma can generate more reactive radicals and therefore lower the reaction temperature/time for the treatment, leading to increased productivity.
Accordingly, one or multiple processes may be applied to modify the photoresist itself to increase dry development selectivity. This thermal or radical modification can increase the contrast between unexposed and exposed material and thus increase the selectivity of the subsequent dry development step. The resulting difference between the material properties of unexposed and exposed material can be tuned by adjusting process conditions including temperature, gas flow, moisture, pressure, and/or RF power. The large process latitude enabled by dry development, which is not limited by material solubility in a wet developer solvent, allows more aggressive conditions to be applied further enhancing the material contrast that can be achieved. The resulting high material contrast feeds back a wider process window for dry development and thus enables increased productivity, lower cost, and better defectivity performance.
A substantial limitation of wet-developed resist films is limited temperature bakes. Since wet development relies on material solubility, heating to or beyond 220° C., for example, can greatly increase the degree of cross-linking in both exposed and unexposed regions of a metal-containing PR film such that both become insoluble in the wet development solvents, so that the film can no longer by reliably wet developed. For dry-developed resist films, in which the etch rate difference (i.e., selectivity) between the exposed and unexposed regions of the PR is relied upon for removal of just the exposed or unexposed portion of the resist, the treatment temperature in a PAB, PEB, or PDB can be varied across a much broader window to tune and optimize the treatment process, for example from about 90° C. to 250° C., such as 90° C. to 190° C., for PAB, and about 170° C. to 250° C. or more, such as 190° C. to 240° C., for PEB and/or PDB. Decreasing etch rate and greater etch selectivity has been found to occur with higher treatment temperatures in the noted ranges.
In particular embodiments, the PAB, PEB, and/or PDB treatments may be conducted with gas ambient flow in the range of 100 sccm to 10000 sccm, moisture content in the amount of a few percent up to 100% (e.g., 20%-50%), at a pressure between atmospheric and vacuum, and for a duration of about 1 to 15 minutes, for example about 2 minutes.
These findings can be used to tune the treatment conditions to tailor or optimize processing for particular materials and circumstances. For example, the selectivity achieved for a given EUV dose with a 220° C. to 250° C. PEB thermal treatment in air at about 20% humidity for about 2 minutes can be made similar to that for about a 30% higher EUV dose with no such thermal treatment. So, depending on the selectivity requirements/constraints of the semiconductor processing operation, a thermal treatment such as described herein can be used to lower the EUV dose needed. Or, if higher selectivity is required and higher dose can be tolerated, much higher selectivity, up to 100 times exposed vs. unexposed, can be obtained than would be possible in a wet development context.
Yet other steps can include in situ metrology, in which physical and structural characteristics (e.g., critical dimension, film thickness, etc.) can be assessed during the photolithography process. Modules to implement in situ metrology include, e.g., scatterometry, ellipsometry, downstream mass spectroscopy, and/or plasma enhanced downstream optical emission spectroscopy modules.
Apparatus
The present disclosure also includes any apparatus configured to perform any methods described herein. In one embodiment, the apparatus for depositing a film includes a deposition module comprising a chamber for depositing one or more precursor(s) to provide an underlayer and/or an imaging layer; a patterning module comprising an EUV photolithography tool with a source of sub-30 nm wavelength radiation; and a development module comprising a chamber for developing a film including such layers.
The apparatus can further include a controller having instructions for such modules. In one embodiment, the controller includes one or more memory devices, one or more processors, and system control software coded with instructions for conducting deposition of the film. Such includes can include for, in the deposition module, depositing one or more precursor(s) to provide an underlayer and/or an imaging layer; in the patterning module, patterning the layer(s) with sub-30 nm resolution directly by EUV exposure, thereby forming a pattern within the film; and in the development module, developing the film. In particular embodiments, the development module provides for removal of the EUV exposed or EUV unexposed area(s), thereby providing a pattern within the film.
A process station may be configured as a module in a cluster tool.
In some embodiments, certain of the processing functions can be performed consecutively in the same module, for example vapor deposition (e.g., PECVD), dry development and etch. And embodiments of this disclosure are directed to apparatus for processing a substrate, the apparatus having a process chamber comprising a substrate support, a process gas source connected with the process chamber and associated flow-control hardware, substrate handling hardware connected with the process chamber, and a controller having a processor and a memory. In some implementations, the processer and the memory are communicatively connected with one another, the processor is at least operatively connected with the flow-control and substrate handling hardware, and the memory stores computer-executable instructions for conducting the operations in the methods of making a pattering structure described herein.
For example, the memory may store computer-executable instructions for providing a hardmask disposed on a substrate, for example by chemical vapor deposition (e.g., PECVD). As described above, suitable hardmasks may be amorphous carbon ashable hardmask films, undoped or doped with B or W, for example.
The memory may further store instructions for depositing an underlayer on the substrate and/or the hardmask, where the underlayer is configured to increase adhesion between the substrate and/or the hardmask and a subsequently formed EUV-sensitive inorganic photoresist, and to reduce EUV dose for effective EUV exposure of the photoresist. For example, as described above the underlayer may be or include a vapor deposited film of hydronated carbon doped with a non-carbon heteroatom (e.g., any herein, such as O, Si, N, W, B, I, Cl, etc.), the film having a thickness of no more than about 25 nm, and may include about 0-30% O. In some implementations, the underlayer may be vapor deposited on the substrate and/or the hardmask by PECVD or ALD using a hydrocarbon precursor and/or a dopant precursor. In other implementations, the underlayer may be vapor deposited on the substrate and/or the hardmask by PECVD or ALD using an oxocarbon precursor that co-reacts with H2 or a hydrocarbon. In variations on this implementation, the oxocarbon precursor may further co-react with a Si source dopant during the deposition. In other implementations, the underlayer may be vapor deposited on the substrate and/or the hardmask by PECVD or ALD using a Si-containing precursor that co-reacts with an oxidizer (e.g., any O-containing precursor described herein). In variations on this implementation, the Si-containing precursor further co-reacts with a C source dopant. In some implementations, the underlayer may be vapor deposited on the substrate and/or the hardmask by PECVD as a termination operation of a vapor deposition on the substrate or vapor deposition of the hardmask on the substrate, for example by adjusting the precursor flows entering the PECVD process chamber to achieve the desired composition of the underlayer.
The memory may further store instructions for forming an EUV-sensitive inorganic photoresist is formed on the photoresist underlayer. A suitable EUV-sensitive inorganic photoresist may be a metal oxide film, such as a EUV-sensitive tin oxide-based photoresist, such as described above.
Returning to
Showerhead 306 distributes process gases toward substrate 312. In the embodiment shown in
In some embodiments, pedestal 308 may be raised or lowered to expose substrate 312 to a volume between the substrate 312 and the showerhead 306. It will be appreciated that, in some embodiments, pedestal height may be adjusted programmatically by a suitable computer controller 350.
In some embodiments, pedestal 308 may be temperature controlled via heater 310. In some embodiments, the pedestal 308 may be heated to a temperature of greater than 0° C. and up to 300° C. or more, for example 50 to 120° C., such as about 65 to 80° C., during non-plasma thermal exposure of a photopatterned resist to hydrogen halide dry development chemistry, such as HBr or HCl.
Further, in some embodiments, pressure control for process station 300 may be provided by a butterfly valve 318. As shown in the embodiment of
In some embodiments, a position of showerhead 306 may be adjusted relative to pedestal 308 to vary a volume between the substrate 312 and the showerhead 306. Further, it will be appreciated that a vertical position of pedestal 308 and/or showerhead 306 may be varied by any suitable mechanism within the scope of the present disclosure. In some embodiments, pedestal 308 may include a rotational axis for rotating an orientation of substrate 312. It will be appreciated that, in some embodiments, one or more of these example adjustments may be performed programmatically by one or more suitable computer controllers 350.
Where plasma may be used, for example in gentle plasma-based dry development embodiments and/or etch operations conducted in the same chamber, showerhead 306 and pedestal 308 electrically communicate with a RF power supply 314 and matching network 316 for powering a plasma. In some embodiments, the plasma energy may be controlled by controlling one or more of a process station pressure, a gas concentration, an RF source power, an RF source frequency, and a plasma power pulse timing. For example, RF power supply 314 and matching network 316 may be operated at any suitable power to form a plasma having a desired composition of radical species. Examples of suitable powers are up to about 500 W. Likewise, RF power supply 314 may provide RF power of any suitable frequency. In some embodiments, RF power supply 314 may be configured to control high- and low-frequency RF power sources independently of one another. Examples of low-frequency RF frequencies may include, but are not limited to, frequencies between 50 kHz and 1000 kHz. Examples of high-frequency RF frequencies may include, but are not limited to, frequencies between 1.8 MHz and 2.45 GHz (e.g., about 13.56 MHz). It will be appreciated that any suitable parameters may be modulated discretely or continuously to provide plasma energy for the surface reactions. In one non-limiting example, the plasma power may be intermittently pulsed to reduce ion bombardment with the substrate surface relative to continuously powered plasmas. The RF power supply may be operated at any suitable duty cycle. Examples of suitable duty cycles include, but are not limited to, duty cycles of between about 5% and 90%. Acceptable process pressures are between about 20 mTorr to 5 Torr.
In some examples, RF power can be continuous or pulsed between one or more levels. If pulsed operation is used, pulsing can be performed at a frequency in a range from 1 Hz to 1 MHz. In some examples, chamber pressure is maintained at a predetermined pressure in a range from 5 mTorr to 450 mTorr. In other examples, deposition and treatment are performed at a pressure in a range from 5 mTorr to 150 mTorr. In still other examples, deposition and treatment are performed at a pressure in a range from 5 mTorr to 35 mTorr.
In some deposition processes, plasma strikes last on the order of a few seconds or more in duration. In certain implementations, much shorter plasma strikes may be used. These may be on the order of 10 ms to 1 second, typically, about 20 to 80 ms, with 50 ms being a specific example. Such very short RF plasma strikes require extremely quick stabilization of the plasma. To accomplish this, the plasma generator may be configured such that the impedance match is set preset to a particular voltage, while the frequency is allowed to float. Conventionally, high-frequency plasmas are generated at an RF frequency at about 13.56 MHz. In various embodiments disclosed herein, the frequency is allowed to float to a value that is different from this standard value. By permitting the frequency to float while fixing the impedance match to a predetermined voltage, the plasma can stabilize much more quickly, a result which may be important when using the very short plasma strikes associated with some types of deposition cycles.
In some embodiments, instructions for a controller 350 may be provided via input/output control (IOC) sequencing instructions. In one example, the instructions for setting conditions for a process phase may be included in a corresponding recipe phase of a process recipe. In some cases, process recipe phases may be sequentially arranged, so that all instructions for a process phase are executed concurrently with that process phase. In some embodiments, instructions for setting one or more reactor parameters may be included in a recipe phase. For example, a recipe phase may include instructions for setting a flow rate of a photoresist underlayer oxocarbon precursor and H2 or hydrocarbon co-reactants and optional dopants. In some embodiments, the controller 350 may include any of the features described below with respect to system controller 450 of
As described above, one or more process stations may be included in a multi station processing tool.
The depicted processing chamber 414 includes four process stations, numbered from 1 to 4 in the embodiment shown in
In some embodiments, system controller 450 controls all of the activities of process tool 400. System controller 450 executes system control software 458 stored in mass storage device 454, loaded into memory device 456, and executed on processor 452. Alternatively, the control logic may be hard coded in the controller 450. Applications Specific Integrated Circuits, Programmable Logic Devices (e.g., field-programmable gate arrays, or FPGAs) and the like may be used for these purposes. In the following discussion, wherever “software” or “code” is used, functionally comparable hard coded logic may be used in its place. System control software 458 may include instructions for controlling the timing, mixture of gases, gas flow rates, chamber and/or station pressure, chamber and/or station temperature, wafer temperature, target power levels, RF power levels, substrate pedestal, chuck and/or susceptor position, and other parameters of a particular process performed by process tool 400. System control software 458 may be configured in any suitable way. For example, various process tool component subroutines or control objects may be written to control operation of the process tool components used to carry out various process tool processes. System control software 458 may be coded in any suitable computer readable programming language.
In some embodiments, system control software 458 may include input/output control (IOC) sequencing instructions for controlling the various parameters described above. Other computer software and/or programs stored on mass storage device 454 and/or memory device 456 associated with system controller 450 may be employed in some embodiments. Examples of programs or sections of programs for this purpose include a substrate positioning program, a process gas control program, a pressure control program, a heater control program, and a plasma control program.
A substrate positioning program may include program code for process tool components that are used to load the substrate onto pedestal 418 and to control the spacing between the substrate and other parts of process tool 400.
A process gas control program may include code for controlling hydrogen halide gas composition (e.g., HBr or HCl gas as described herein) and flow rates and optionally for flowing gas into one or more process stations prior to deposition in order to stabilize the pressure in the process station. A pressure control program may include code for controlling the pressure in the process station by regulating, for example, a throttle valve in the exhaust system of the process station, a gas flow into the process station, etc.
A heater control program may include code for controlling the current to a heating unit that is used to heat the substrate. Alternatively, the heater control program may control delivery of a heat transfer gas (such as helium) to the substrate.
A plasma control program may include code for setting RF power levels applied to the process electrodes in one or more process stations in accordance with the embodiments herein.
A pressure control program may include code for maintaining the pressure in the reaction chamber in accordance with the embodiments herein.
In some embodiments, there may be a user interface associated with system controller 450. The user interface may include a display screen, graphical software displays of the apparatus and/or process conditions, and user input devices such as pointing devices, keyboards, touch screens, microphones, etc.
In some embodiments, parameters adjusted by the system controller 450 may relate to process conditions. Non-limiting examples include process gas composition and flow rates, temperature, pressure, plasma conditions (such as RF bias power levels, frequency, and exposure time), etc. These parameters may be provided to the user in the form of a recipe, which may be entered utilizing the user interface.
Signals for monitoring the process may be provided by analog and/or digital input connections of system controller 450 from various process tool sensors. The signals for controlling the process may be output on the analog and digital output connections of process tool 400. Non-limiting examples of process tool sensors that may be monitored include mass flow controllers, pressure sensors (such as manometers), thermocouples, etc. Appropriately programmed feedback and control algorithms may be used with data from these sensors to maintain process conditions.
System controller 450 may provide program instructions for implementing the above-described deposition processes. The program instructions may control a variety of process parameters, such as direct current (DC) power level, RF bias power level, pressure, temperature, etc. The instructions may control the parameters to operate photoresist underlayer deposition processes according to various embodiments described herein.
The system controller 450 will typically include one or more memory devices and one or more processors configured to execute the instructions so that the apparatus will perform a method in accordance with disclosed embodiments. Machine-readable media containing instructions for controlling process operations in accordance with disclosed embodiments may be coupled to the system controller 450.
In some implementations, the system controller 450 is part of a system, which may be part of the above-described examples. Such systems can include semiconductor processing equipment, including a processing tool or tools, chamber or chambers, a platform or platforms for processing, and/or specific processing components (a wafer pedestal, a gas flow system, etc.). These systems may be integrated with electronics for controlling their operation before, during, and after processing of a semiconductor wafer or substrate. The electronics may be referred to as the “controller,” which may control various components or subparts of the system or systems. The system controller 450, depending on the processing conditions and/or the type of system, may be programmed to control any of the processes disclosed herein, including the delivery of processing gases, temperature settings (e.g., heating and/or cooling), pressure settings, vacuum settings, power settings, radio frequency (RF) generator settings, RF matching circuit settings, frequency settings, flow rate settings, fluid delivery settings, positional and operation settings, wafer transfers into and out of a tool and other transfer tools and/or load locks connected to or interfaced with a specific system.
Broadly speaking, the system controller 450 may be defined as electronics having various integrated circuits, logic, memory, and/or software that receive instructions, issue instructions, control operation, enable cleaning operations, enable endpoint measurements, and the like. The integrated circuits may include chips in the form of firmware that store program instructions, digital signal processors (DSPs), chips defined as application specific integrated circuits (ASICs), and/or one or more microprocessors, or microcontrollers that execute program instructions (e.g., software). Program instructions may be instructions communicated to the system controller 450 in the form of various individual settings (or program files), defining operational parameters for carrying out a particular process on or for a semiconductor wafer or to a system. The operational parameters may, in some embodiments, be part of a recipe defined by process engineers to accomplish one or more processing steps during the fabrication of one or more layers, materials, metals, oxides, silicon, silicon dioxide, surfaces, circuits, and/or dies of a wafer.
The system controller 450, in some implementations, may be a part of or coupled to a computer that is integrated with, coupled to the system, otherwise networked to the system, or a combination thereof. For example, the system controller 450 may be in the “cloud” or all or a part of a fab host computer system, which can allow for remote access of the wafer processing. The computer may enable remote access to the system to monitor current progress of fabrication operations, examine a history of past fabrication operations, examine trends or performance metrics from a plurality of fabrication operations, to change parameters of current processing, to set processing steps to follow a current processing, or to start a new process. In some examples, a remote computer (e.g. a server) can provide process recipes to a system over a network, which may include a local network or the Internet. The remote computer may include a user interface that enables entry or programming of parameters and/or settings, which are then communicated to the system from the remote computer. In some examples, the system controller 450 receives instructions in the form of data, which specify parameters for each of the processing steps to be performed during one or more operations. It should be understood that the parameters may be specific to the type of process to be performed and the type of tool that the system controller 450 is configured to interface with or control. Thus, as described above, the system controller 450 may be distributed, such as by including one or more discrete controllers that are networked together and working towards a common purpose, such as the processes and controls described herein. An example of a distributed controller for such purposes would be one or more integrated circuits on a chamber in communication with one or more integrated circuits located remotely (such as at the platform level or as part of a remote computer) that combine to control a process on the chamber.
Without limitation, example systems may include a plasma etch chamber or module, a deposition chamber or module, a spin-rinse chamber or module, a metal plating chamber or module, a clean chamber or module, a bevel edge etch chamber or module, a physical vapor deposition (PVD) chamber or module, a chemical vapor deposition (CVD) chamber or module, an ALD chamber or module, an atomic layer etch (ALE) chamber or module, an ion implantation chamber or module, a track chamber or module, an EUV lithography chamber (scanner) or module, a dry development chamber or module, and any other semiconductor processing systems that may be associated or used in the fabrication and/or manufacturing of semiconductor wafers.
As noted above, depending on the process step or steps to be performed by the tool, the system controller 450 might communicate with one or more of other tool circuits or modules, other tool components, cluster tools, other tool interfaces, adjacent tools, neighboring tools, tools located throughout a factory, a main computer, another controller, or tools used in material transport that bring containers of wafers to and from tool locations and/or load ports in a semiconductor manufacturing factory.
Inductively coupled plasma (ICP) reactors which, in certain embodiments, may be suitable for etch operations suitable for implementation of some embodiments, are now described. Although ICP reactors are described herein, in some embodiments, it should be understood that capacitively coupled plasma reactors may also be used.
The inductively coupled plasma apparatus 500 includes an overall process chamber 524 structurally defined by chamber walls 501 and a window 511. The chamber walls 501 may be fabricated from stainless steel or aluminum. The window 511 may be fabricated from quartz or other dielectric material. An optional internal plasma grid 550 divides the overall process chamber into an upper sub-chamber 502 and a lower sub chamber 503. In most embodiments, plasma grid 550 may be removed, thereby utilizing a chamber space made of sub chambers 502 and 503. A chuck 517 is positioned within the lower sub-chamber 503 near the bottom inner surface. The chuck 517 is configured to receive and hold a semiconductor wafer 519 upon which the etching and deposition processes are performed. The chuck 517 can be an electrostatic chuck for supporting the wafer 519 when present. In some embodiments, an edge ring (not shown) surrounds chuck 517 and has an upper surface that is approximately planar with a top surface of the wafer 519, when present over chuck 517. The chuck 517 also includes electrostatic electrodes for chucking and dechucking the wafer 519. A filter and DC clamp power supply (not shown) may be provided for this purpose. Other control systems for lifting the wafer 519 off the chuck 517 can also be provided. The chuck 517 can be electrically charged using an RF power supply 523. The RF power supply 523 is connected to matching circuitry 521 through a connection 527. The matching circuitry 521 is connected to the chuck 517 through a connection 525. In this manner, the RF power supply 523 is connected to the chuck 517. In various embodiments, a bias power of the electrostatic chuck may be set at about 50V or may be set at a different bias power depending on the process performed in accordance with disclosed embodiments. For example, the bias power may be between about 20 V and about 100 V, or between about 30 V and about 150 V.
Elements for plasma generation include a coil 533 is positioned above window 511. In some embodiments, a coil is not used in disclosed embodiments. The coil 533 is fabricated from an electrically conductive material and includes at least one complete turn. The example of a coil 533 shown in
Process gases may be flowed into the process chamber through one or more main gas flow inlets 560 positioned in the upper sub-chamber 502 and/or through one or more side gas flow inlets 570. Likewise, though not explicitly shown, similar gas flow inlets may be used to supply process gases to a capacitively coupled plasma processing chamber. A vacuum pump, e.g., a one or two stage mechanical dry pump and/or turbomolecular pump 540, may be used to draw process gases out of the process chamber 524 and to maintain a pressure within the process chamber 524. For example, the vacuum pump may be used to evacuate the lower sub-chamber 503 during a purge operation of ALD. A valve-controlled conduit may be used to fluidically connect the vacuum pump to the process chamber 524 so as to selectively control application of the vacuum environment provided by the vacuum pump. This may be done employing a closed loop-controlled flow restriction device, such as a throttle valve (not shown) or a pendulum valve (not shown), during operational plasma processing. Likewise, a vacuum pump and valve controlled fluidic connection to the capacitively coupled plasma processing chamber may also be employed.
During operation of the apparatus 500, one or more process gases may be supplied through the gas flow inlets 560 and/or 570. In certain embodiments, process gas may be supplied only through the main gas flow inlet 560, or only through the side gas flow inlet 570. In some cases, the gas flow inlets shown in the figure may be replaced by more complex gas flow inlets, one or more showerheads, for example. The Faraday shield 549a and/or optional grid 550 may include internal channels and holes that allow delivery of process gases to the process chamber 524. Either or both of Faraday shield 549a and optional grid 550 may serve as a showerhead for delivery of process gases. In some embodiments, a liquid vaporization and delivery system may be situated upstream of the process chamber 524, such that once a liquid reactant or precursor is vaporized, the vaporized reactant or precursor is introduced into the process chamber 524 via a gas flow inlet 560 and/or 570.
Radio frequency power is supplied from the RF power supply 541 to the coil 533 to cause an RF current to flow through the coil 533. The RF current flowing through the coil 533 generates an electromagnetic field about the coil 533. The electromagnetic field generates an inductive current within the upper sub-chamber 502. The physical and chemical interactions of various generated ions and radicals with the wafer 519 etch features of and selectively deposit layers on the wafer 519.
If the plasma grid 550 is used such that there is both an upper sub-chamber 502 and a lower sub-chamber 503, the inductive current acts on the gas present in the upper sub-chamber 502 to generate an electron-ion plasma in the upper sub-chamber 502. The optional internal plasma grid 550 limits the amount of hot electrons in the lower sub-chamber 503. In some embodiments, the apparatus 500 is designed and operated such that the plasma present in the lower sub-chamber 503 is an ion-ion plasma.
Both the upper electron-ion plasma and the lower ion-ion plasma may contain positive and negative ions, though the ion-ion plasma will have a greater ratio of negative ions to positive ions. Volatile etching and/or deposition byproducts may be removed from the lower sub-chamber 503 through port 522. The chuck 517 disclosed herein may operate at elevated temperatures ranging between about 10° C. and about 250° C. The temperature will depend on the process operation and specific recipe.
Apparatus 500 may be coupled to facilities (not shown) when installed in a clean room or a fabrication facility. Facilities include plumbing that provide processing gases, vacuum, temperature control, and environmental particle control. These facilities are coupled to apparatus 500, when installed in the target fabrication facility. Additionally, apparatus 500 may be coupled to a transfer chamber that allows robotics to transfer semiconductor wafers into and out of apparatus 500 using typical automation.
In some embodiments, a system controller 530 (which may include one or more physical or logical controllers) controls some or all of the operations of a process chamber 524. The system controller 530 may include one or more memory devices and one or more processors. In some embodiments, the apparatus 500 includes a switching system for controlling flow rates and durations when disclosed embodiments are performed. In some embodiments, the apparatus 500 may have a switching time of up to about 500 ms, or up to about 750 ms. Switching time may depend on the flow chemistry, recipe chosen, reactor architecture, and other factors.
In some implementations, the system controller 530 is part of a system, which may be part of the above-described examples. Such systems can include semiconductor processing equipment, including a processing tool or tools, chamber or chambers, a platform or platforms for processing, and/or specific processing components (a wafer pedestal, a gas flow system, etc.). These systems may be integrated with electronics for controlling their operation before, during, and after processing of a semiconductor wafer or substrate. The electronics may be integrated into the system controller 530, which may control various components or subparts of the system or systems. The system controller, depending on the processing parameters and/or the type of system, may be programmed to control any of the processes disclosed herein, including the delivery of processing gases, temperature settings (e.g., heating and/or cooling), pressure settings, vacuum settings, power settings, radio frequency (RF) generator settings, RF matching circuit settings, frequency settings, flow rate settings, fluid delivery settings, positional and operation settings, wafer transfers into and out of a tool and other transfer tools and/or load locks connected to or interfaced with a specific system.
Broadly speaking, the system controller 530 may be defined as electronics having various integrated circuits, logic, memory, and/or software that receive instructions, issue instructions, control operation, enable cleaning operations, enable endpoint measurements, and the like. The integrated circuits may include chips in the form of firmware that store program instructions, digital signal processors (DSPs), chips defined as application specific integrated circuits (ASICs), and/or one or more microprocessors, or microcontrollers that execute program instructions (e.g., software). Program instructions may be instructions communicated to the controller in the form of various individual settings (or program files), defining operational parameters for carrying out a particular process on or for a semiconductor wafer or to a system. The operational parameters may, in some embodiments, be part of a recipe defined by process engineers to accomplish one or more processing steps during the fabrication or removal of one or more layers, materials, metals, oxides, silicon, silicon dioxide, surfaces, circuits, and/or dies of a wafer.
The system controller 530, in some implementations, may be a part of or coupled to a computer that is integrated with, coupled to the system, otherwise networked to the system, or a combination thereof. For example, the controller may be in the “cloud” or all or a part of a fab host computer system, which can allow for remote access of the wafer processing. The computer may enable remote access to the system to monitor current progress of fabrication operations, examine a history of past fabrication operations, examine trends or performance metrics from a plurality of fabrication operations, to change parameters of current processing, to set processing steps to follow a current processing, or to start a new process. In some examples, a remote computer (e.g. a server) can provide process recipes to a system over a network, which may include a local network or the Internet. The remote computer may include a user interface that enables entry or programming of parameters and/or settings, which are then communicated to the system from the remote computer. In some examples, the system controller 530 receives instructions in the form of data, which specify parameters for each of the processing steps to be performed during one or more operations. It should be understood that the parameters may be specific to the type of process to be performed and the type of tool that the controller is configured to interface with or control. Thus, as described above, the system controller 530 may be distributed, such as by including one or more discrete controllers that are networked together and working towards a common purpose, such as the processes and controls described herein. An example of a distributed controller for such purposes would be one or more integrated circuits on a chamber in communication with one or more integrated circuits located remotely (such as at the platform level or as part of a remote computer) that combine to control a process on the chamber.
Without limitation, example systems may include a plasma etch chamber or module, a deposition chamber or module, a spin-rinse chamber or module, a metal plating chamber or module, a clean chamber or module, a bevel edge etch chamber or module, a physical vapor deposition (PVD) chamber or module, a chemical vapor deposition (e.g., PECVD) chamber or module, an ALD chamber or module, an ALE chamber or module, an ion implantation chamber or module, a track chamber or module, an EUV lithography chamber (scanner) or module, a dry development chamber or module, and any other semiconductor processing systems that may be associated or used in the fabrication and/or manufacturing of semiconductor wafers.
As noted above, depending on the process step or steps to be performed by the tool, the controller might communicate with one or more of other tool circuits or modules, other tool components, cluster tools, other tool interfaces, adjacent tools, neighboring tools, tools located throughout a factory, a main computer, another controller, or tools used in material transport that bring containers of wafers to and from tool locations and/or load ports in a semiconductor manufacturing factory.
EUVL patterning may be conducted using any suitable tool, often referred to as a scanner, for example the TWINSCAN NXE: 3300B® platform supplied by ASML of Veldhoven, NL). The EUVL patterning tool may be a standalone device from which the substrate is moved into and out of for deposition and etching as described herein. Or, as described below, the EUVL patterning tool may be a module on a larger multi-component tool.
A vacuum transport module (VTM) 638 interfaces with four processing modules 620a-620d, which may be individually optimized to perform various fabrication processes. By way of example, processing modules 620a-620d may be implemented to perform deposition, evaporation, ELD, dry development, etch, strip, and/or other semiconductor processes. For example, module 620a may be an ALD reactor that may be operated to perform in a non-plasma, thermal atomic layer depositions as described herein, such as Vector tool, available from Lam Research Corporation, Fremont, CA And module 620b may be a PECVD tool, such as the Lam Vector®. It should be understood that the figure is not necessarily drawn to scale.
Airlocks 642 and 646, also known as a loadlocks or transfer modules, interface with the VTM 638 and a patterning module 640. For example, as noted above, a suitable patterning module may be the TWINSCAN NXE: 3300B® platform supplied by ASML of Veldhoven, NL). This tool architecture allows for work pieces, such as semiconductor substrates or wafers, to be transferred under vacuum so as not to react before exposure. Integration of the deposition modules with the lithography tool is facilitated by the fact that EUVL also requires a greatly reduced pressure given the strong optical absorption of the incident photons by ambient gases such as H2O, O2, etc.
As noted above, this integrated architecture is just one possible embodiment of a tool for implementation of the described processes. The processes may also be implemented with a more conventional stand-alone EUVL scanner and a deposition reactor, such as a Lam Vector tool, either stand alone or integrated in a cluster architecture with other tools, such as etch, strip etc. (e.g., Lam Kiyo or Gamma tools), as modules, for example as described with reference to
Airlock 642 may be an “outgoing” loadlock, referring to the transfer of a substrate out from the VTM 638 serving a deposition module 620a to the patterning module 640, and airlock 646 may be an “ingoing” loadlock, referring to the transfer of a substrate from the patterning module 640 back in to the VTM 638. The ingoing loadlock 646 may also provide an interface to the exterior of the tool for access and egress of substrates. Each process module has a facet that interfaces the module to VTM 638. For example, deposition process module 620a has facet 636. Inside each facet, sensors, for example, sensors 1-18 as shown, are used to detect the passing of wafer 626 when moved between respective stations. Patterning module 640 and airlocks 642 and 646 may be similarly equipped with additional facets and sensors, not shown.
Main VTM robot 622 transfers wafer 626 between modules, including airlocks 642 and 646. In one embodiment, robot 622 has one arm, and in another embodiment, robot 622 has two arms, where each arm has an end effector 624 to pick wafers such as wafer 626 for transport. Front-end robot 644, in is used to transfer wafers 626 from outgoing airlock 642 into the patterning module 640, from the patterning module 640 into ingoing airlock 646. Front-end robot 644 may also transport wafers 626 between the ingoing loadlock and the exterior of the tool for access and egress of substrates. Because ingoing airlock module 646 has the ability to match the environment between atmospheric and vacuum, the wafer 626 is able to move between the two pressure environments without being damaged.
It should be noted that a EUVL tool typically operates at a higher vacuum than a deposition tool. If this is the case, it is desirable to increase the vacuum environment of the substrate during the transfer between the deposition to the EUVL tool to allow the substrate to degas prior to entry into the patterning tool. Outgoing airlock 642 may provide this function by holding the transferred wafers at a lower pressure, no higher than the pressure in the patterning module 640, for a period of time and exhausting any off-gassing, so that the optics of the patterning tool 640 are not contaminated by off-gassing from the substrate. A suitable pressure for the outgoing, off-gassing airlock is no more than 1E-8 Torr.
In some embodiments, a system controller 650 (which may include one or more physical or logical controllers) controls some or all of the operations of the cluster tool and/or its separate modules. It should be noted that the controller can be local to the cluster architecture, or can be located external to the cluster architecture in the manufacturing floor, or in a remote location and connected to the cluster architecture via a network. The system controller 650 may include one or more memory devices and one or more processors. The processor may include a central processing unit (CPU) or computer, analog and/or digital input/output connections, stepper motor controller boards, and other like components. Instructions for implementing appropriate control operations are executed on the processor. These instructions may be stored on the memory devices associated with the controller or they may be provided over a network. In certain embodiments, the system controller executes system control software.
The system control software may include instructions for controlling the timing of application and/or magnitude of any aspect of tool or module operation. System control software may be configured in any suitable way. For example, various process tool component subroutines or control objects may be written to control operations of the process tool components necessary to carry out various process tool processes. System control software may be coded in any suitable compute readable programming language. In some embodiments, system control software includes input/output control (IOC) sequencing instructions for controlling the various parameters described above. For example, each phase of a semiconductor fabrication process may include one or more instructions for execution by the system controller. The instructions for setting process conditions for condensation, deposition, evaporation, patterning and/or etching phase may be included in a corresponding recipe phase, for example.
In various embodiments, an apparatus for forming a negative pattern mask is provided. The apparatus may include a processing chamber for patterning, deposition and etch, and a controller including instructions for forming a negative pattern mask. The instructions may include code for, in the processing chamber, patterning a feature in a chemically amplified (CAR) resist on a semiconductor substrate by EUV exposure to expose a surface of the substrate, dry developing the photopatterned resist, and etching the underlying layer or layer stack using the patterned resist as a mask.
It should be noted that the computer controlling the wafer movement can be local to the cluster architecture or can be located external to the cluster architecture in the manufacturing floor, or in a remote location and connected to the cluster architecture via a network. A controller as described above with respect to any of
The wafer support 724 may include an ESC 726 to provide a wafer support surface for the substrate 722. The ESC 726 may include a base plate 734 that is bonded to a top surface of the top plate 728. In the depicted example, the top plate 728 has two separate electrical systems embedded within it. One such system is an electrostatic clamping electrode system having one or more clamping electrodes 732 to generate an electric charge within the substrate 722 that causes the substrate 722 to be drawn against the wafer support surface of the top plate 728.
The other system is a thermal control system to control the temperature of the substrate 722 during processing conditions. In
The ESC 726 may also include a base plate 734 to provide structural support to the underside of the top plate 728 and which may also act as a heat dispersion system. For example, the base plate 734 may include one or more heat exchange passages 736; and a heat exchange medium, e.g., water or inert fluorinated liquid, may be circulated through the heat exchange passages 736 during use.
The ESC 726 may be supported by a wafer support housing 742 that is connected with, and supported by, a wafer support column 744. The wafer support column 744 may have a routing passage 748 other pass-throughs for routing cabling (e.g., for providing electrical power), fluid flow conduits (e.g., for conveying heat exchange medium), and other equipment to the underside of the base plate 734 and/or the top plate 728.
The apparatus 700 of
The wafer support 724 may also include one or more edge rings that may be used to control and/or fine-tune various process conditions. In
The apparatus 700 may also include a system for removing process gases from the processing chamber 702 during and after processing concludes. For example, the processing chamber 702 may include an annular plenum 756 that encircles the wafer support column 744. The annular plenum 756 may, in turn, be fluidically connected with a vacuum foreline 752 that may be connected with a vacuum pump. A regulator valve 754 may be provided in between the vacuum foreline 752 and the processing chamber 702 and actuated to control the flow into the vacuum foreline 752. In some implementations, a baffle 750, e.g., an annular plate or other structure that may serve to make the flow into the annular plenum 756 more evenly distributed about the circumference of the wafer support column 744, may be provided to reduce the chances of flow non-uniformities developing in reactants flowed across the substrate 722.
The showerhead 710, as shown, is a dual-plenum showerhead 710 and includes a first plenum 712 that is provided process gas via a first inlet 716 and a second plenum 714 that is provided process gas via a second inlet 718. Two or more plenums can be employed to maintain separation between the precursor(s) and the counter-reactant(s) prior to release of the precursor and the counter-reactant. In some instances, a single plenum is used to deliver the precursor(s) into the reaction space 720 of the processing chamber 702. Each plenum may have a corresponding set of gas distribution ports that fluidically connect the respective plenum with the reaction space 720 through the faceplate of the showerhead 710 (the faceplate being the portion of the showerhead 710 that is interposed between the lowermost plenum and the reaction space 720).
The first inlet 716 and the second inlet 718 of the showerhead 710 may be provided processing gases via a gas supply system, which may be configured to provide one or more precursor(s) and/or counter-reactant(s), as discussed herein. A first valve manifold 768a may be configured to provide one or more precursor(s) to the first inlet 716, while a second valve manifold 768b may be configured to provide other precursor(s) or other reactant to the second inlet 718. In this example, the first valve manifold 768a, for example, includes multiple valves A1-A5. Valve A2 may, for example, be a three-way valve that has one port fluidically connected with a first vaporizer 772a, another port fluidically connected with a bypass line 770a, and a third port fluidically connected with a port on another 3-way valve A3. Similarly, valve A4 may be another three-way valve that has one port fluidically connected with a second vaporizer 772b, another port fluidically connected with the bypass line 770a, and a third port fluidically connected with a port on another 3-way valve A5. One of the other ports on valve A5 may be fluidically connected with the first inlet 716 while the remaining port on valve A5 may be fluidically connected with one of the remaining ports on the valve A3. The remaining port on the valve A3 may, in turn, be fluidically connected with the valve A1 which may be fluidically interposed between the valve A3 and a purge gas source 774, e.g., nitrogen, argon, or other suitably inert gas (with respect to precursor(s) and/or counter-reactant(s)). In some embodiments, only the first valve manifold is employed.
For the purposes of this disclosure, the term “fluidically connected” is used with respect to volumes, plenums, holes, etc., that may be connected with one another in order to form a fluidic connection, similar to how the term “electrically connected” is used with respect to components that are connected together to form an electric connection. The term “fluidically interposed,” if used, may be used to refer to a component, volume, plenum, or hole that is fluidically connected with at least two other components, volumes, plenums, or holes such that fluid flowing from one of those other components, volumes, plenums, or holes to the other or another of those components, volumes, plenums, or holes would first flow through the “fluidically interposed” component before reaching that other or another of those components, volumes, plenums, or holes. For example, if a pump is fluidically interposed between a reservoir and an outlet, fluid that flowed from the reservoir to the outlet would first flow through the pump before reaching the outlet.
The first valve manifold 768a may, for example, be controllable to cause vapors from one or both of the vaporizers 772a and 772b to be flowed either to the processing chamber 702 or through the first bypass line 770a and into the vacuum foreline 752, such as by controlled actuation of valves A1-A5. The first valve manifold 768a may also be controllable to cause a purge gas to be flowed from the purge gas source 774 and into the first inlet 716.
It will be appreciated that the second valve manifold 768b may be controlled in a similar manner, e.g., by controlling valves B1-B5, to provide vapors from vaporizers 772c and 772d to the second inlet 718 or to the second bypass line 770b. It will be further appreciated that different manifold arrangements may be utilized as well, including a single unitary manifold that includes valves for controlling flow of the precursor(s), counter-reactant(s), or other reactants to the first inlet 716 and the second inlet 718.
As mentioned earlier, some apparatuses 700 may feature a lesser number of vapor sources, e.g., only two vaporizers 772, in which case the valve manifold(s) 768 may be modified to have a lesser number of valves, e.g., only valves A1-A3.
As discussed above, apparatuses such as apparatus 700, which may be used to provide for dry deposition of films, may be configured to maintain particular temperature profiles within the processing chamber 702. In particular, such apparatuses 700 may be configured to maintain the substrate 722 at a lower temperature, e.g., at least 25° C. to 50° C. lower, than most of the equipment of the apparatus 702 that comes into direct contact with the precursor(s) and/or counter-reactant(s).
To provide for temperature control, various heating systems may be included in the apparatus 700. For example, the processing chamber 702 may have receptacles for receiving cartridge heaters 758, e.g., vertical holes for receiving cartridge heaters 758 may be bored into the four corners of the chamber 702 housing. In some implementations, the showerhead 710 may be covered with heater blankets 760, which may be used to apply heat across the exposed upper surface of the showerhead 710 to keep the showerhead temperature elevated. It may also be beneficial to heat various gas lines that are used to conduct the vaporized reactants from the vaporizers 772 to the showerhead 710. For example, resistive heater tape may be wound around such gas lines and used to heat them to an elevated temperature. Any of the gas lines and even the fate valve 706 in
The various operational systems of the apparatus 700 may be controlled by a controller 784, which may include one or more processors 786 and one or more memory devices 788 that are operatively connected with each other and that are communicatively connected with various systems and subsystems of the apparatus 700 so as to provide for control functionality for those systems. For example, the controller 784 may be configured to control the valves A1-A5 and B1-B5, the various heaters 758, 760, the vaporizers 772, the regulator valve 754, the gate valve 706, the wafer support z-actuator, and so forth.
Another feature that the apparatus 700 may include is shown in
The controller 784 may be configured, e.g., via execution of computer-executable instructions, to cause the apparatus 700 to perform various operations consistent with the disclosure provided above.
Once the imaging layer and/or underlayer has been deposited on the substrate 722, the substrate 722 may, as noted above, be transferred to one or more subsequent processing chambers or tool for additional operations (e.g., any described herein). Further deposition apparatuses are described in International Patent Application No. PCT/US2020/038968, filed Jun. 22, 2020, titled “APPARATUS FOR PHOTORESIST DRY DEPOSITION,” which is herein incorporated by reference in its entirety.
By “acyloxy” or “alkanoyloxy,” as used interchangeably herein, is meant an acyl or alkanoyl group, as defined herein, attached to the parent molecular group through an oxy group. In particular embodiments, the alkanoyloxy is —O—C(O)-Ak, in which Ak is an alkyl group, as defined herein. In some embodiments, an unsubstituted alkanoyloxy is a C2-7 alkanoyloxy group. Exemplary alkanoyloxy groups include acetoxy.
By “aliphatic” is meant a hydrocarbon group having at least one carbon atom to 50 carbon atoms (C1-50), such as one to 25 carbon atoms (C1-25), or one to ten carbon atoms (C1-10), and which includes alkanes (or alkyl), alkenes (or alkenyl), alkynes (or alkynyl), including cyclic versions thereof, and further including straight- and branched-chain arrangements, and all stereo and position isomers as well. Such an aliphatic can be unsubstituted or substituted with one or more groups, such as groups described herein for an alkyl group.
By “alkenyl” is meant an optionally substituted C2-24 alkyl group having one or more double bonds. The alkenyl group can be cyclic (e.g., C3-24 cycloalkenyl) or acyclic. The alkenyl group can also be substituted or unsubstituted. For example, the alkenyl group can be substituted with one or more substitution groups, as described herein for alkyl.
By “alkenylene” is meant a multivalent (e.g., bivalent) form of an alkenyl group, which is an optionally substituted C2-24 alkyl group having one or more double bonds. The alkenylene group can be cyclic (e.g., C3-24 cycloalkenyl) or acyclic. The alkenylene group can be substituted or unsubstituted. For example, the alkenylene group can be substituted with one or more substitution groups, as described herein for alkyl. Exemplary, non-limiting alkenylene groups include —CH═CH— or —CH═CHCH2—.
By “alkoxy” is meant —OR, where R is an optionally substituted alkyl group, as described herein. Exemplary alkoxy groups include methoxy, ethoxy, butoxy, trihaloalkoxy, such as trifluoromethoxy, etc. The alkoxy group can be substituted or unsubstituted. For example, the alkoxy group can be substituted with one or more substitution groups, as described herein for alkyl. Exemplary unsubstituted alkoxy groups include C1-3, C1-6, C1-12, C1-16, C1-18, C1-20, or C1-24 alkoxy groups.
By “alkyl” and the prefix “alk” is meant a branched or unbranched saturated hydrocarbon group of 1 to 24 carbon atoms, such as methyl (Me), ethyl (Et), n-propyl (n-Pr), isopropyl (i-Pr), cyclopropyl, n-butyl (n-Bu), isobutyl (i-Bu), s-butyl (s-Bu), t-butyl (t-Bu), cyclobutyl, n-pentyl, isopentyl, s-pentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, dodecyl, tetradecyl, hexadecyl, eicosyl, tetracosyl, and the like. The alkyl group can be cyclic (e.g., C3-24 cycloalkyl) or acyclic. The alkyl group can be branched or unbranched. The alkyl group can also be substituted or unsubstituted. For example, the alkyl group can include haloalkyl, in which the alkyl group is substituted by one or more halo groups, as described herein. In another example, the alkyl group can be substituted with one, two, three or, in the case of alkyl groups of two carbons or more, four substituents independently selected from the group consisting of: (1) C1-6 alkoxy (e.g., —O-Ak, wherein Ak is optionally substituted C1-6 alkyl); (2) amino (e.g., —NRN1RN2, where each of RN1 and RN2 is, independently, H or optionally substituted alkyl, or RN1 and RN2, taken together with the nitrogen atom to which each are attached, form a heterocyclyl group); (3) aryl; (4) arylalkoxy (e.g., —O-Lk-Ar, wherein Lk is a bivalent form of optionally substituted alkyl and Ar is optionally substituted aryl); (5) aryloyl (e.g., —C(O)—Ar, wherein Ar is optionally substituted aryl); (6) cyano (e.g., —CN); (7) carboxyaldehyde (e.g., —C(O)H); (8) carboxyl (e.g., —CO2H); (9) C3-8 cycloalkyl (e.g., a monovalent saturated or unsaturated non-aromatic cyclic C3-8 hydrocarbon group); (10) halo (e.g., F, Cl, Br, or I); (11) heterocyclyl (e.g., a 5-, 6- or 7-membered ring, unless otherwise specified, containing one, two, three, or four non-carbon heteroatoms, such as nitrogen, oxygen, phosphorous, sulfur, or halo); (12) heterocyclyloxy (e.g., —O-Het, wherein Het is heterocyclyl, as described herein); (13) heterocyclyloyl (e.g., —C(O)—Het, wherein Het is heterocyclyl, as described herein); (14) hydroxyl (e.g., —OH); (15) N-protected amino; (16) nitro (e.g., —NO2); (17) oxo (e.g., ═O); (18) —CO2RA, where RA is selected from the group consisting of (a) C1-6 alkyl, (b) C4-18 aryl, and (c) (C4-18 aryl) C1-6 alkyl (e.g., -Lk-Ar, wherein Lk is a bivalent form of optionally substituted alkyl group and Ar is optionally substituted aryl); (19) —C(O)NRBRC, where each of RB and RC is, independently, selected from the group consisting of (a) hydrogen, (b) C1-6 alkyl, (c) C4-18 aryl, and (d) (C4-18 aryl) C1-6 alkyl (e.g., -Lk-Ar, wherein Lk is a bivalent form of optionally substituted alkyl group and Ar is optionally substituted aryl); and (20) —NRGRH, where each of RG and RH is, independently, selected from the group consisting of (a) hydrogen, (b) an N-protecting group, (c) C1-6 alkyl, (d) C2-6 alkenyl (e.g., optionally substituted alkyl having one or more double bonds), (e) C2-6 alkynyl (e.g., optionally substituted alkyl having one or more triple bonds), (f) C4-18 aryl, (g) (C4-18 aryl) C1-6 alkyl (e.g., Lk-Ar, wherein Lk is a bivalent form of optionally substituted alkyl group and Ar is optionally substituted aryl), (h) C3-8 cycloalkyl, and (i) (C3-8 cycloalkyl) C1-6 alkyl (e.g., -Lk-Cy, wherein Lk is a bivalent form of optionally substituted alkyl group and Cy is optionally substituted cycloalkyl, as described herein), wherein in one embodiment no two groups are bound to the nitrogen atom through a carbonyl group. The alkyl group can be a primary, secondary, or tertiary alkyl group substituted with one or more substituents (e.g., one or more halo or alkoxy). In some embodiments, the unsubstituted alkyl group is a C1-3, C1-6, C1-12, C1-16, C1-18, C1-20, or C1-24 alkyl group.
By “alkylene” is meant a multivalent (e.g., bivalent) form of an alkyl group, as described herein. Exemplary alkylene groups include methylene, ethylene, propylene, butylene, etc. In some embodiments, the alkylene group is a C1-3, C1-6, C1-12, C1-16, C1-18, C1-20, C1-24, C2-3, C2-6, C2-12, C2-16, C2-18, C2-20, or C2-24 alkylene group. The alkylene group can be branched or unbranched. The alkylene group can also be substituted or unsubstituted. For example, the alkylene group can be substituted with one or more substitution groups, as described herein for alkyl.
By “alkynyl” is meant an optionally substituted C2-24 alkyl group having one or more triple bonds. The alkynyl group can be cyclic or acyclic and is exemplified by ethynyl, 1-propynyl, and the like. The alkynyl group can also be substituted or unsubstituted. For example, the alkynyl group can be substituted with one or more substitution groups, as described herein for alkyl.
By “alkynylene” is meant a multivalent (e.g., bivalent) form of an alkynyl group, which is an optionally substituted C2-24 alkyl group having one or more triple bonds. The alkynylene group can be cyclic or acyclic. The alkynylene group can be substituted or unsubstituted. For example, the alkynylene group can be substituted with one or more substitution groups, as described herein for alkyl. Exemplary, non-limiting alkynylene groups include —C≡C— or —C≡CCH2—.
By “amino” is meant —NRN1RN2, where each of RN1 and RN2 is, independently, H, optionally substituted alkyl, or optionally substituted aryl, or RN1 and RN2, taken together with the nitrogen atom to which each are attached, form a heterocyclyl group, as defined herein.
By “aromatic” is meant a cyclic, conjugated group or moiety of, unless specified otherwise, from 5 to 15 ring atoms having a single ring (e.g., phenyl) or multiple condensed rings in which at least one ring is aromatic (e.g., naphthyl, indolyl, or pyrazolopyridinyl); that is, at least one ring, and optionally multiple condensed rings, have a continuous, delocalized π-electron system. Typically, the number of out of plane π-electrons corresponds to the Huckel rule (4n+2). The point of attachment to the parent structure typically is through an aromatic portion of the condensed ring system. Such an aromatic can be unsubstituted or substituted with one or more groups, such as groups described herein for an alkyl or aryl group. Yet other substitution groups can include aliphatic, haloaliphatic, halo, nitrate, cyano, sulfonate, sulfonyl, or others.
By “aryl” is meant a group that contains any carbon-based aromatic group including, but not limited to, phenyl, benzyl, anthracenyl, anthryl, benzocyclobutenyl, benzocyclooctenyl, biphenylyl, chrysenyl, dihydroindenyl, fluoranthenyl, indacenyl, indenyl, naphthyl, phenanthryl, phenoxybenzyl, picenyl, pyrenyl, terphenyl, and the like, including fused benzo-C4-8 cycloalkyl radicals (e.g., as defined herein) such as, for instance, indanyl, tetrahydronaphthyl, fluorenyl, and the like. The term aryl also includes heteroaryl, which is defined as a group that contains an aromatic group that has at least one heteroatom incorporated within the ring of the aromatic group. Examples of heteroatoms include, but are not limited to, nitrogen, oxygen, sulfur, and phosphorus. Likewise, the term non-heteroaryl, which is also included in the term aryl, defines a group that contains an aromatic group that does not contain a heteroatom. The aryl group can be substituted or unsubstituted. The aryl group can be substituted with one, two, three, four, or five substituents, such as any described herein for alkyl.
By “arylene” is meant a multivalent (e.g., bivalent) form of an aryl group, as described herein. Exemplary arylene groups include phenylene, naphthylene, biphenylene, triphenylene, diphenyl ether, acenaphthenylene, anthrylene, or phenanthrylene. In some embodiments, the arylene group is a C4-18, C4-14, C4-12, C4-10, C6-18, C6-14, C6-12, or C6-10 arylene group. The arylene group can be branched or unbranched. The arylene group can also be substituted or unsubstituted. For example, the arylene group can be substituted with one or more substitution groups, as described herein for alkyl or aryl.
By “(aryl)(alkyl)ene” is meant a bivalent form including an arylene group, as described herein, attached to an alkylene or a heteroalkylene group, as described herein. In some embodiments, the (aryl)(alkyl)ene group is -L-Ar— or -L-Ar-L- or —Ar-L-, in which Ar is an arylene group and each L is, independently, an optionally substituted alkylene group or an optionally substituted heteroalkylene group.
By “carbonyl” is meant a —C(O)— group, which can also be represented as >C═O, or a —CO group.
By “carboxyl” is meant a —CO2H group.
By “carboxyalkyl” is meant an alkyl group, as defined herein, substituted by one or more carboxyl groups, as defined herein.
By “carboxyaryl” is meant an aryl group, as defined herein, substituted by one or more carboxyl groups, as defined herein.
By “cyclic anhydride” is meant a 3-, 4-, 5-, 6- or 7-membered ring (e.g., a 5-, 6- or 7-membered ring), unless otherwise specified, having a —C(O)—O—C(O)— group within the ring. The term “cyclic anhydride” also includes bicyclic, tricyclic and tetracyclic groups in which any of the above rings is fused to one, two, or three rings independently selected from the group consisting of an aryl ring, a cyclohexane ring, a cyclohexene ring, a cyclopentane ring, a cyclopentene ring, and another monocyclic heterocyclic ring. Exemplary cyclic anhydride groups include a radical formed from succinic anhydride, glutaric anhydride, maleic anhydride, phthalic anhydride, isochroman-1,3-dione, oxepanedione, tetrahydrophthalic anhydride, hexahydrophthalic anhydride, pyromellitic dianhydride, naphthalic anhydride, 1,2-cyclohexanedicarboxylic anhydride, etc., by removing one or more hydrogen. Other exemplary cyclic anhydride groups include dioxotetrahydrofuranyl, dioxodihydroisobenzofuranyl, etc. The cyclic anhydride group can also be substituted or unsubstituted. For example, the cyclic anhydride group can be substituted with one or more groups including those described herein for heterocyclyl.
By “cycloalkenyl” is meant a monovalent unsaturated non-aromatic or aromatic cyclic hydrocarbon group of from three to eight carbons, unless otherwise specified, having one or more double bonds. The cycloalkenyl group can also be substituted or unsubstituted. For example, the cycloalkenyl group can be substituted with one or more groups including those described herein for alkyl.
By “cycloalkyl” is meant a monovalent saturated or unsaturated non-aromatic or aromatic cyclic hydrocarbon group of from three to eight carbons, unless otherwise specified, and is exemplified by cyclopropyl, cyclobutyl, cyclopentyl, cyclopentadienyl, cyclohexyl, cycloheptyl, bicyclo[2.2.1.]heptyl, and the like. The cycloalkyl group can also be substituted or unsubstituted. For example, the cycloalkyl group can be substituted with one or more groups including those described herein for alkyl.
By “halo” is meant F, Cl, Br, or I.
By “haloalkyl” is meant an alkyl group, as defined herein, substituted with one or more halo.
By “heteroalkyl” is meant an alkyl group, as defined herein, containing one, two, three, or four non-carbon heteroatoms (e.g., independently selected from the group consisting of nitrogen, oxygen, phosphorous, sulfur, selenium, or halo).
By “heteroalkylene” is meant a bivalent form of an alkylene group, as defined herein, containing one, two, three, or four non-carbon heteroatoms (e.g., independently selected from the group consisting of nitrogen, oxygen, phosphorous, sulfur, selenium, or halo). The heteroalkylene group can be substituted or unsubstituted. For example, the heteroalkylene group can be substituted with one or more substitution groups, as described herein for alkyl.
By “heterocyclyl” is meant a 3-, 4-, 5-, 6- or 7-membered ring (e.g., a 5-, 6- or 7-membered ring), unless otherwise specified, containing one, two, three, or four non-carbon heteroatoms (e.g., independently selected from the group consisting of nitrogen, oxygen, phosphorous, sulfur, selenium, or halo). The 3-membered ring has zero to one double bonds, the 4- and 5-membered ring has zero to two double bonds, and the 6- and 7-membered rings have zero to three double bonds. The term “heterocyclyl” also includes bicyclic, tricyclic and tetracyclic groups in which any of the above heterocyclic rings is fused to one, two, or three rings independently selected from the group consisting of an aryl ring, a cyclohexane ring, a cyclohexene ring, a cyclopentane ring, a cyclopentene ring, and another monocyclic heterocyclic ring, such as indolyl, quinolyl, isoquinolyl, tetrahydroquinolyl, benzofuryl, benzothienyl and the like. The heterocyclyl group can be substituted or unsubstituted. For example, the heterocyclyl group can be substituted with one or more substitution groups, as described herein for alkyl.
By “hydrocarbyl” is meant a univalent group formed by removing a hydrogen atom from a hydrocarbon. Non-limiting unsubstituted hydrocarbyl groups include alkyl, alkenyl, alkynyl, and aryl, as defined herein, in which these groups include only carbon and hydrogen atoms. The hydrocarbyl group can be substituted or unsubstituted. For example, the hydrocarbyl group can be substituted with one or more substitution groups, as described herein for alkyl. In other embodiments, any alkyl or aryl group herein can be replaced with a hydrocarbyl group, as defined herein.
By “hydroxyl” is meant —OH.
By “hydroxyalkyl” is meant an alkyl group, as defined herein, substituted by one to three hydroxyl groups, with the proviso that no more than one hydroxyl group may be attached to a single carbon atom of the alkyl group and is exemplified by hydroxymethyl, dihydroxypropyl, and the like.
By “hydroxyaryl” is meant an aryl group, as defined herein, substituted by one to three hydroxyl groups, with the proviso that no more than one hydroxyl group may be attached to a single carbon atom of the aryl group and is exemplified by hydroxyphenyl, dihydroxyphenyl, and the like.
By “isocyanato” is meant —NCO.
By “oxido” is meant an —O− group.
By “oxo” is meant an ═O group.
By “phosphine” is meant a trivalent or tetravalent phosphorous having hydrocarbyl moieties. In some embodiments, phosphine is a —PRP3 group, where each RP is, independently, H, optionally substituted alkyl, or optionally substituted aryl. The phosphine group can be substituted or unsubstituted. For example, the phosphine group can be substituted with one or more substitution groups, as described herein for alkyl.
By “selenol” is meant an —SeH group.
By “tellurol” is meant an —TeH group.
By “thioisocyanato” is meant —NCS.
By “thiol” is meant an —SH group.
As used herein, the terms “top,” “bottom,” “upper,” “lower,” “above,” and “below” are used to provide a relative relationship between structures. The use of these terms does not indicate or require that a particular structure must be located at a particular location in the apparatus.
Pattering structures and schemes, and associated process and apparatus for incorporating a photoresist underlayer configured to increase adhesion between a substrate (e.g., a hardmask) and the photoresist and/or to reduce EUV dose for effective photoresist exposure during EUV lithography, are disclosed and described.
It is understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art. Although various details have been omitted for clarity's sake, various design alternatives may be implemented. Therefore, the present examples are to be considered as illustrative and not restrictive, and the disclosure is not to be limited to the details given herein but may be modified within the scope of the disclosure.
The following sample claims are provided for further illustration of certain embodiments of the disclosure. The disclosure is not necessarily limited to these embodiments.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3442648 | Smith et al. | May 1969 | A |
| 3513010 | Notley et al. | May 1970 | A |
| 3529963 | Marchese et al. | Sep 1970 | A |
| 3576755 | Patella et al. | Apr 1971 | A |
| 3720515 | Stanley | Mar 1973 | A |
| 4061829 | Taylor | Dec 1977 | A |
| 4241165 | Hughes et al. | Dec 1980 | A |
| 4292384 | Straughan et al. | Sep 1981 | A |
| 4328298 | Nester | May 1982 | A |
| 4341592 | Shortes et al. | Jul 1982 | A |
| 4396704 | Taylor | Aug 1983 | A |
| 4590149 | Nakane et al. | May 1986 | A |
| 4738748 | Kisa | Apr 1988 | A |
| 4806456 | Katoh | Feb 1989 | A |
| 4814243 | Ziger | Mar 1989 | A |
| 4834834 | Ehrlich et al. | May 1989 | A |
| 4842989 | Taniguchi et al. | Jun 1989 | A |
| 4845053 | Zajac | Jul 1989 | A |
| 4940854 | Debe | Jul 1990 | A |
| 5077085 | Schnur et al. | Dec 1991 | A |
| 5094936 | Misium et al. | Mar 1992 | A |
| 5322765 | Clecak et al. | Jun 1994 | A |
| 5399464 | Lee | Mar 1995 | A |
| 5445988 | Schwalke | Aug 1995 | A |
| 5534312 | Hill et al. | Jul 1996 | A |
| 5761023 | Lue et al. | Jun 1998 | A |
| 5914278 | Boitnott et al. | Jun 1999 | A |
| 5925494 | Horn | Jul 1999 | A |
| 6013418 | Ma et al. | Jan 2000 | A |
| 6017553 | Burrell et al. | Jan 2000 | A |
| 6045877 | Gleason et al. | Apr 2000 | A |
| 6162577 | Felter et al. | Dec 2000 | A |
| 6179922 | Ishikawa et al. | Jan 2001 | B1 |
| 6261938 | Beauvais et al. | Jul 2001 | B1 |
| 6290779 | Saleh et al. | Sep 2001 | B1 |
| 6313035 | Sandhu et al. | Nov 2001 | B1 |
| 6319654 | Kim et al. | Nov 2001 | B1 |
| 6348239 | Hill et al. | Feb 2002 | B1 |
| 6410421 | Ghandehari et al. | Jun 2002 | B1 |
| 6448097 | Singh et al. | Sep 2002 | B1 |
| 6573030 | Fairbairn et al. | Jun 2003 | B1 |
| 6607867 | Kim et al. | Aug 2003 | B1 |
| 6666986 | Vaartstra | Dec 2003 | B1 |
| 6797439 | Alpay | Sep 2004 | B1 |
| 6833306 | Lyding et al. | Dec 2004 | B2 |
| 6841341 | Fairbairn et al. | Jan 2005 | B2 |
| 6841943 | Vahedi et al. | Jan 2005 | B2 |
| 7169440 | Balasubramaniam et al. | Jan 2007 | B2 |
| 7223526 | Fairbairn et al. | May 2007 | B2 |
| 7307695 | Hazenberg et al. | Dec 2007 | B2 |
| 7335462 | Fairbairn et al. | Feb 2008 | B2 |
| 7608367 | Aigeldinger et al. | Oct 2009 | B1 |
| 8383316 | Cooper et al. | Feb 2013 | B2 |
| 8465903 | Weidman et al. | Jun 2013 | B2 |
| 8536068 | Weidman et al. | Sep 2013 | B2 |
| 8552334 | Tappan et al. | Oct 2013 | B2 |
| 8664124 | Graff | Mar 2014 | B2 |
| 8664513 | Pfenninger et al. | Mar 2014 | B2 |
| 8703386 | Bass et al. | Apr 2014 | B2 |
| 8808561 | Kanarik | Aug 2014 | B2 |
| 8883028 | Kanarik | Nov 2014 | B2 |
| 8883405 | Shiobara | Nov 2014 | B2 |
| 9023731 | Ji et al. | May 2015 | B2 |
| 9261784 | Wuister et al. | Feb 2016 | B2 |
| 9281207 | Stowers et al. | Mar 2016 | B2 |
| 9310684 | Meyers et al. | Apr 2016 | B2 |
| 9551924 | Burkhardt et al. | Jan 2017 | B2 |
| 9576811 | Kanarik et al. | Feb 2017 | B2 |
| 9632411 | Michaelson et al. | Apr 2017 | B2 |
| 9719169 | Mohn et al. | Aug 2017 | B2 |
| 9778561 | Marks et al. | Oct 2017 | B2 |
| 9823564 | Stowers et al. | Nov 2017 | B2 |
| 9829805 | Michaelson et al. | Nov 2017 | B2 |
| 9996004 | Smith et al. | Jun 2018 | B2 |
| 10025179 | Meyers et al. | Jul 2018 | B2 |
| 10228618 | Meyers et al. | Mar 2019 | B2 |
| 10416554 | Meyers et al. | Sep 2019 | B2 |
| 10514598 | Marks et al. | Dec 2019 | B2 |
| 10566212 | Kanarik | Feb 2020 | B2 |
| 10580585 | Snaith et al. | Mar 2020 | B2 |
| 10627719 | Waller et al. | Apr 2020 | B2 |
| 10642153 | Meyers et al. | May 2020 | B2 |
| 10649328 | Stowers et al. | May 2020 | B2 |
| 10732505 | Meyers et al. | Aug 2020 | B1 |
| 10763083 | Yang et al. | Sep 2020 | B2 |
| 10775696 | Meyers et al. | Sep 2020 | B2 |
| 10782610 | Stowers et al. | Sep 2020 | B2 |
| 10787466 | Edson et al. | Sep 2020 | B2 |
| 10796912 | Shamma et al. | Oct 2020 | B2 |
| 10831096 | Marks et al. | Nov 2020 | B2 |
| 11209729 | Marks et al. | Dec 2021 | B2 |
| 11257674 | Shamma et al. | Feb 2022 | B2 |
| 11314168 | Tan | Apr 2022 | B2 |
| 20010024769 | Donoghue et al. | Sep 2001 | A1 |
| 20010055731 | Irie | Dec 2001 | A1 |
| 20020015855 | Sajoto et al. | Feb 2002 | A1 |
| 20020017243 | Pyo | Feb 2002 | A1 |
| 20020123221 | Jost et al. | Sep 2002 | A1 |
| 20020180372 | Yamazaki | Dec 2002 | A1 |
| 20020185067 | Upham | Dec 2002 | A1 |
| 20030008246 | Cheng et al. | Jan 2003 | A1 |
| 20030027060 | Lederer | Feb 2003 | A1 |
| 20030049571 | Hallock et al. | Mar 2003 | A1 |
| 20030183244 | Rossman | Oct 2003 | A1 |
| 20040067444 | Wakabayashi et al. | Apr 2004 | A1 |
| 20040097388 | Brask et al. | May 2004 | A1 |
| 20040113087 | Ikeda et al. | Jun 2004 | A1 |
| 20040175631 | Crocker et al. | Sep 2004 | A1 |
| 20040191423 | Ruan et al. | Sep 2004 | A1 |
| 20040203256 | Yang et al. | Oct 2004 | A1 |
| 20040209201 | Nakano et al. | Oct 2004 | A1 |
| 20040213563 | Irie | Oct 2004 | A1 |
| 20040229169 | Sandstrom | Nov 2004 | A1 |
| 20040233401 | Irie | Nov 2004 | A1 |
| 20050142885 | Shinriki | Jun 2005 | A1 |
| 20050167617 | Derra et al. | Aug 2005 | A1 |
| 20050208389 | Ishibashi et al. | Sep 2005 | A1 |
| 20050253077 | Ikeda et al. | Nov 2005 | A1 |
| 20050257747 | Wakabayashi et al. | Nov 2005 | A1 |
| 20060001064 | Hill et al. | Jan 2006 | A1 |
| 20060046470 | Becknell et al. | Mar 2006 | A1 |
| 20060068173 | Kajiyama et al. | Mar 2006 | A1 |
| 20060128127 | Seo et al. | Jun 2006 | A1 |
| 20060147818 | Lee | Jul 2006 | A1 |
| 20060151462 | Lee et al. | Jul 2006 | A1 |
| 20060166537 | Thompson et al. | Jul 2006 | A1 |
| 20060172530 | Cheng et al. | Aug 2006 | A1 |
| 20060175558 | Bakker et al. | Aug 2006 | A1 |
| 20060246713 | Tsai et al. | Nov 2006 | A1 |
| 20060287207 | Park et al. | Dec 2006 | A1 |
| 20070017386 | Kamei | Jan 2007 | A1 |
| 20070037410 | Chang et al. | Feb 2007 | A1 |
| 20070074541 | Badding et al. | Apr 2007 | A1 |
| 20070117040 | Brock et al. | May 2007 | A1 |
| 20070181816 | Ikeda et al. | Aug 2007 | A1 |
| 20070212889 | Abatchev et al. | Sep 2007 | A1 |
| 20070259492 | Roh, II et al. | Nov 2007 | A1 |
| 20070287073 | Goodwin | Dec 2007 | A1 |
| 20080070128 | Wu et al. | Mar 2008 | A1 |
| 20080157011 | Nagai et al. | Jul 2008 | A1 |
| 20090134119 | Matsumaru et al. | May 2009 | A1 |
| 20090153826 | Sewell et al. | Jun 2009 | A1 |
| 20090197086 | Rathi et al. | Aug 2009 | A1 |
| 20090208880 | Nemani et al. | Aug 2009 | A1 |
| 20090239155 | Levinson et al. | Sep 2009 | A1 |
| 20090286402 | Xia et al. | Nov 2009 | A1 |
| 20090305174 | Shiobara et al. | Dec 2009 | A1 |
| 20090317742 | Toriumi et al. | Dec 2009 | A1 |
| 20090321707 | Metz et al. | Dec 2009 | A1 |
| 20090325387 | Chen et al. | Dec 2009 | A1 |
| 20100009274 | Yamamoto | Jan 2010 | A1 |
| 20100022078 | Rockenberger et al. | Jan 2010 | A1 |
| 20100051446 | Wang et al. | Mar 2010 | A1 |
| 20100068660 | Shibazaki et al. | Mar 2010 | A1 |
| 20100086880 | Saito et al. | Apr 2010 | A1 |
| 20100131093 | Yokoyama et al. | May 2010 | A1 |
| 20100197135 | Ishizaka | Aug 2010 | A1 |
| 20100260994 | Groenen et al. | Oct 2010 | A1 |
| 20100266969 | Shiraishi et al. | Oct 2010 | A1 |
| 20100297847 | Cheng et al. | Nov 2010 | A1 |
| 20100304027 | Lee et al. | Dec 2010 | A1 |
| 20100310790 | Chang et al. | Dec 2010 | A1 |
| 20110104595 | Hayashi et al. | May 2011 | A1 |
| 20110195142 | Mitamura et al. | Aug 2011 | A1 |
| 20110198756 | Thenappan et al. | Aug 2011 | A1 |
| 20110200953 | Arima et al. | Aug 2011 | A1 |
| 20110209725 | Kim et al. | Sep 2011 | A1 |
| 20110242508 | Kobayashi | Oct 2011 | A1 |
| 20110244680 | Tohnoe et al. | Oct 2011 | A1 |
| 20110292356 | Tsukinoki et al. | Dec 2011 | A1 |
| 20120024388 | Burrows et al. | Feb 2012 | A1 |
| 20120068347 | Isobayashi et al. | Mar 2012 | A1 |
| 20120088193 | Weidman et al. | Apr 2012 | A1 |
| 20120088369 | Weidman et al. | Apr 2012 | A1 |
| 20120090547 | Wang et al. | Apr 2012 | A1 |
| 20120126358 | Arnold et al. | May 2012 | A1 |
| 20120161405 | Mohn et al. | Jun 2012 | A1 |
| 20120183689 | Suzuki et al. | Jul 2012 | A1 |
| 20120193762 | Lin et al. | Aug 2012 | A1 |
| 20120202357 | Sato et al. | Aug 2012 | A1 |
| 20120208125 | Hatakeyama | Aug 2012 | A1 |
| 20120223418 | Stowers et al. | Sep 2012 | A1 |
| 20120322011 | Wu et al. | Dec 2012 | A1 |
| 20130023124 | Nemani et al. | Jan 2013 | A1 |
| 20130129995 | Ouattara et al. | May 2013 | A1 |
| 20130157177 | Yu et al. | Jun 2013 | A1 |
| 20130164691 | Shiobara | Jun 2013 | A1 |
| 20130177847 | Chatterjee et al. | Jul 2013 | A1 |
| 20130183609 | Seon et al. | Jul 2013 | A1 |
| 20130224652 | Bass et al. | Aug 2013 | A1 |
| 20130273733 | Tang et al. | Oct 2013 | A1 |
| 20130299089 | Kim et al. | Nov 2013 | A1 |
| 20130319466 | Mizoguchi et al. | Dec 2013 | A1 |
| 20130330928 | Ishikawa et al. | Dec 2013 | A1 |
| 20130330932 | Rangarajan et al. | Dec 2013 | A1 |
| 20140014745 | Burrows et al. | Jan 2014 | A1 |
| 20140120688 | Booth, Jr. et al. | May 2014 | A1 |
| 20140134827 | Swaminathan et al. | May 2014 | A1 |
| 20140170563 | Hatakeyama | Jun 2014 | A1 |
| 20140170853 | Shamma et al. | Jun 2014 | A1 |
| 20140175617 | Antonelli et al. | Jun 2014 | A1 |
| 20140193580 | Tiron et al. | Jul 2014 | A1 |
| 20140209015 | Yamada et al. | Jul 2014 | A1 |
| 20140220489 | Kozuma et al. | Aug 2014 | A1 |
| 20140239462 | Shamma et al. | Aug 2014 | A1 |
| 20140261568 | Delgado et al. | Sep 2014 | A1 |
| 20140263172 | Xie et al. | Sep 2014 | A1 |
| 20140268082 | Michaelson et al. | Sep 2014 | A1 |
| 20140272726 | Chang | Sep 2014 | A1 |
| 20150020848 | Kim et al. | Jan 2015 | A1 |
| 20150041809 | Arnold et al. | Feb 2015 | A1 |
| 20150056542 | Meyers et al. | Feb 2015 | A1 |
| 20150077733 | Huang et al. | Mar 2015 | A1 |
| 20150079393 | Freedman et al. | Mar 2015 | A1 |
| 20150125679 | Ishikawa | May 2015 | A1 |
| 20150132965 | Devilliers et al. | May 2015 | A1 |
| 20150152551 | Yamaguchi et al. | Jun 2015 | A1 |
| 20150170957 | Tsao | Jun 2015 | A1 |
| 20150194343 | Chi et al. | Jul 2015 | A1 |
| 20150217330 | Haukka et al. | Aug 2015 | A1 |
| 20150218695 | Odedra | Aug 2015 | A1 |
| 20150221519 | Marks et al. | Aug 2015 | A1 |
| 20150243520 | Park et al. | Aug 2015 | A1 |
| 20150303064 | Singer et al. | Oct 2015 | A1 |
| 20150332922 | Chien et al. | Nov 2015 | A1 |
| 20150355549 | Xie et al. | Dec 2015 | A1 |
| 20160011505 | Stowers et al. | Jan 2016 | A1 |
| 20160011516 | Devilliers | Jan 2016 | A1 |
| 20160035631 | Lee et al. | Feb 2016 | A1 |
| 20160041471 | Briend et al. | Feb 2016 | A1 |
| 20160086864 | Fischer et al. | Mar 2016 | A1 |
| 20160116839 | Meyers et al. | Apr 2016 | A1 |
| 20160118246 | Kang et al. | Apr 2016 | A1 |
| 20160135274 | Fischer et al. | May 2016 | A1 |
| 20160179005 | Shamma et al. | Jun 2016 | A1 |
| 20160216606 | Meyers et al. | Jul 2016 | A1 |
| 20160284559 | Kikuchi et al. | Sep 2016 | A1 |
| 20160293405 | Matsumoto et al. | Oct 2016 | A1 |
| 20160314964 | Tang et al. | Oct 2016 | A1 |
| 20160343544 | Watanabe et al. | Nov 2016 | A1 |
| 20160357103 | Nagahara et al. | Dec 2016 | A1 |
| 20160357107 | Buchberger, Jr. et al. | Dec 2016 | A1 |
| 20160365248 | Mebarki et al. | Dec 2016 | A1 |
| 20160379824 | Wise et al. | Dec 2016 | A1 |
| 20170010535 | Fujitani et al. | Jan 2017 | A1 |
| 20170069462 | Kanarik et al. | Mar 2017 | A1 |
| 20170102612 | Meyers et al. | Apr 2017 | A1 |
| 20170146909 | Smith et al. | May 2017 | A1 |
| 20170154766 | Ogihara et al. | Jun 2017 | A1 |
| 20170168398 | Zi et al. | Jun 2017 | A1 |
| 20170176858 | Hirano | Jun 2017 | A1 |
| 20170184961 | Nakagawa et al. | Jun 2017 | A1 |
| 20170192357 | Carcasi et al. | Jul 2017 | A1 |
| 20170261850 | Stowers et al. | Sep 2017 | A1 |
| 20170342553 | Yu et al. | Nov 2017 | A1 |
| 20180004083 | Marks et al. | Jan 2018 | A1 |
| 20180012759 | Smith et al. | Jan 2018 | A1 |
| 20180039172 | Stowers et al. | Feb 2018 | A1 |
| 20180039182 | Zi et al. | Feb 2018 | A1 |
| 20180046086 | Waller et al. | Feb 2018 | A1 |
| 20180061663 | Chandrashekar et al. | Mar 2018 | A1 |
| 20180093306 | Kang et al. | Apr 2018 | A1 |
| 20180096840 | Jeong et al. | Apr 2018 | A1 |
| 20180122648 | Kim et al. | May 2018 | A1 |
| 20180149976 | Liu et al. | May 2018 | A1 |
| 20180151350 | Li | May 2018 | A1 |
| 20180164689 | Sano et al. | Jun 2018 | A1 |
| 20180166278 | Belyansky et al. | Jun 2018 | A1 |
| 20180173096 | Zi et al. | Jun 2018 | A1 |
| 20180224744 | Bae et al. | Aug 2018 | A1 |
| 20180233362 | Glodde et al. | Aug 2018 | A1 |
| 20180233398 | Van Cleemput et al. | Aug 2018 | A1 |
| 20180307137 | Meyers et al. | Oct 2018 | A1 |
| 20180308687 | Smith et al. | Oct 2018 | A1 |
| 20180314167 | Chang et al. | Nov 2018 | A1 |
| 20180323064 | Jung et al. | Nov 2018 | A1 |
| 20180330930 | Murakami et al. | Nov 2018 | A1 |
| 20180337046 | Shamma et al. | Nov 2018 | A1 |
| 20180337243 | Li et al. | Nov 2018 | A1 |
| 20180354804 | Venkatasubramanian et al. | Dec 2018 | A1 |
| 20180356731 | Tagawa | Dec 2018 | A1 |
| 20190027357 | Girard et al. | Jan 2019 | A1 |
| 20190041755 | Tanaka et al. | Feb 2019 | A1 |
| 20190043731 | Bristol et al. | Feb 2019 | A1 |
| 20190094685 | Marks et al. | Mar 2019 | A1 |
| 20190129307 | Kwon et al. | May 2019 | A1 |
| 20190131130 | Smith et al. | May 2019 | A1 |
| 20190137870 | Meyers et al. | May 2019 | A1 |
| 20190153001 | Cardineau et al. | May 2019 | A1 |
| 20190163056 | Maes et al. | May 2019 | A1 |
| 20190172714 | Bobek et al. | Jun 2019 | A1 |
| 20190187556 | Park et al. | Jun 2019 | A1 |
| 20190198338 | Kim et al. | Jun 2019 | A1 |
| 20190244809 | Ono | Aug 2019 | A1 |
| 20190259601 | De Silva et al. | Aug 2019 | A1 |
| 20190308998 | Cardineau et al. | Oct 2019 | A1 |
| 20190315781 | Edson et al. | Oct 2019 | A1 |
| 20190315782 | Edson et al. | Oct 2019 | A1 |
| 20190332014 | Ookubo et al. | Oct 2019 | A1 |
| 20190333777 | Hsieh et al. | Oct 2019 | A1 |
| 20190348292 | Dutta et al. | Nov 2019 | A1 |
| 20190352776 | Parikh | Nov 2019 | A1 |
| 20190369489 | Meyers et al. | Dec 2019 | A1 |
| 20190382890 | Lerner et al. | Dec 2019 | A1 |
| 20190391486 | Jiang et al. | Dec 2019 | A1 |
| 20200041897 | Moon et al. | Feb 2020 | A1 |
| 20200050109 | Ho et al. | Feb 2020 | A1 |
| 20200064733 | Meyers et al. | Feb 2020 | A1 |
| 20200066536 | Yaegashi | Feb 2020 | A1 |
| 20200089104 | Marks et al. | Mar 2020 | A1 |
| 20200124970 | Kocsis et al. | Apr 2020 | A1 |
| 20200133131 | Ouyang | Apr 2020 | A1 |
| 20200166845 | Berendsen et al. | May 2020 | A1 |
| 20200174374 | Liao et al. | Jun 2020 | A1 |
| 20200176246 | Huotari et al. | Jun 2020 | A1 |
| 20200209756 | Waller et al. | Jul 2020 | A1 |
| 20200239498 | Clark et al. | Jul 2020 | A1 |
| 20200241413 | Clark et al. | Jul 2020 | A1 |
| 20200257196 | Meyers et al. | Aug 2020 | A1 |
| 20200292937 | Stowers et al. | Sep 2020 | A1 |
| 20200326627 | Jiang et al. | Oct 2020 | A1 |
| 20200393765 | Sakanishi | Dec 2020 | A1 |
| 20210005425 | Yang et al. | Jan 2021 | A1 |
| 20210013034 | Wu et al. | Jan 2021 | A1 |
| 20210013037 | Sun et al. | Jan 2021 | A1 |
| 20210041784 | Chen et al. | Feb 2021 | A1 |
| 20210271170 | Telecky et al. | Sep 2021 | A1 |
| 20210302833 | Weng et al. | Sep 2021 | A1 |
| 20210305040 | Kuo et al. | Sep 2021 | A1 |
| 20210397085 | Weidman et al. | Dec 2021 | A1 |
| 20220002882 | Kalutarage et al. | Jan 2022 | A1 |
| 20220020584 | Volosskiy et al. | Jan 2022 | A1 |
| 20220035247 | Tan et al. | Feb 2022 | A1 |
| 20220075260 | Marks et al. | Mar 2022 | A1 |
| 20220122846 | Shamma et al. | Apr 2022 | A1 |
| 20220157617 | Zhou et al. | May 2022 | A1 |
| 20220179328 | Xia et al. | Jun 2022 | A1 |
| 20220216050 | Yu et al. | Jul 2022 | A1 |
| 20220244645 | Tan et al. | Aug 2022 | A1 |
| 20220299877 | Weidman et al. | Sep 2022 | A1 |
| 20220308454 | Weidman et al. | Sep 2022 | A1 |
| 20220308462 | Berney et al. | Sep 2022 | A1 |
| 20220342301 | Weidman et al. | Oct 2022 | A1 |
| 20220344136 | Peter et al. | Oct 2022 | A1 |
| 20220365434 | Nardi et al. | Nov 2022 | A1 |
| 20230031955 | Yu et al. | Feb 2023 | A1 |
| 20230045336 | Yu et al. | Feb 2023 | A1 |
| 20230107357 | Dictus et al. | Apr 2023 | A1 |
| 20230152701 | Kanakasabapathy | May 2023 | A1 |
| 20230230811 | Yu et al. | Jul 2023 | A1 |
| 20230259025 | Hansen et al. | Aug 2023 | A1 |
| 20230266662 | Marks et al. | Aug 2023 | A1 |
| 20230266664 | Hansen et al. | Aug 2023 | A1 |
| 20230266670 | Hansen et al. | Aug 2023 | A1 |
| 20230273516 | Marks et al. | Aug 2023 | A1 |
| 20230288798 | Hansen et al. | Sep 2023 | A1 |
| 20230290657 | Yu et al. | Sep 2023 | A1 |
| 20230314946 | Hansen et al. | Oct 2023 | A1 |
| 20230314954 | Peter et al. | Oct 2023 | A1 |
| 20230416606 | Dictus et al. | Dec 2023 | A1 |
| 20240036483 | Dictus et al. | Feb 2024 | A1 |
| Number | Date | Country |
|---|---|---|
| 102610516 | Jul 2012 | CN |
| 103119695 | May 2013 | CN |
| 103243310 | Aug 2013 | CN |
| 105579906 | May 2016 | CN |
| 106876251 | Jun 2017 | CN |
| 107153326 | Sep 2017 | CN |
| 108351594 | Jul 2018 | CN |
| 108388079 | Aug 2018 | CN |
| 109521657 | Mar 2019 | CN |
| 109976097 | Jul 2019 | CN |
| 111258190 | Jun 2020 | CN |
| 0197286 | Oct 1986 | EP |
| 0197286 | Sep 1991 | EP |
| 0465064 | Jan 1992 | EP |
| 1123423 | Aug 2007 | EP |
| 2608247 | Jun 2013 | EP |
| 3230294 | Oct 2017 | EP |
| 3258317 | Dec 2017 | EP |
| 3451059 | Mar 2019 | EP |
| S5119974 | Feb 1976 | JP |
| S57205736 | Dec 1982 | JP |
| S58108744 | Jun 1983 | JP |
| S6112653 | Jan 1986 | JP |
| S61234035 | Oct 1986 | JP |
| H04226462 | Aug 1992 | JP |
| H0637050 | Feb 1994 | JP |
| H06169021 | Jun 1994 | JP |
| H06232041 | Aug 1994 | JP |
| H07106224 | Apr 1995 | JP |
| H0869959 | Mar 1996 | JP |
| H08316237 | Nov 1996 | JP |
| H08339950 | Dec 1996 | JP |
| H1041206 | Feb 1998 | JP |
| H10209133 | Aug 1998 | JP |
| 2000305273 | Nov 2000 | JP |
| 2000347413 | Dec 2000 | JP |
| 2000356857 | Dec 2000 | JP |
| 2002100558 | Apr 2002 | JP |
| 2002118096 | Apr 2002 | JP |
| 2003131364 | May 2003 | JP |
| 2003213001 | Jul 2003 | JP |
| 2003280155 | Oct 2003 | JP |
| 2003532303 | Oct 2003 | JP |
| 2004006798 | Jan 2004 | JP |
| 2004513515 | Apr 2004 | JP |
| 2004259786 | Sep 2004 | JP |
| 2005504146 | Feb 2005 | JP |
| 2005260015 | Sep 2005 | JP |
| 2006253282 | Sep 2006 | JP |
| 2006310681 | Nov 2006 | JP |
| 2007027617 | Feb 2007 | JP |
| 2008091215 | Apr 2008 | JP |
| 2009192350 | Aug 2009 | JP |
| 2009212404 | Sep 2009 | JP |
| 2010016083 | Jan 2010 | JP |
| 2010016314 | Jan 2010 | JP |
| 2010500762 | Jan 2010 | JP |
| 2010067979 | Mar 2010 | JP |
| 2010123732 | Jun 2010 | JP |
| 2010531931 | Sep 2010 | JP |
| 2010239087 | Oct 2010 | JP |
| 2011520242 | Jul 2011 | JP |
| 2011529126 | Dec 2011 | JP |
| 2012142481 | Jul 2012 | JP |
| 2012173315 | Sep 2012 | JP |
| 2012185485 | Sep 2012 | JP |
| 5055743 | Oct 2012 | JP |
| 2012191242 | Oct 2012 | JP |
| 2013033291 | Feb 2013 | JP |
| 2013047848 | Mar 2013 | JP |
| 2013096011 | May 2013 | JP |
| 2013526061 | Jun 2013 | JP |
| 2013145874 | Jul 2013 | JP |
| 2013151627 | Aug 2013 | JP |
| 2014504004 | Feb 2014 | JP |
| 5544914 | Jul 2014 | JP |
| 2014521111 | Aug 2014 | JP |
| 2015012198 | Jan 2015 | JP |
| 2015504604 | Feb 2015 | JP |
| 5705103 | Apr 2015 | JP |
| 2015201622 | Nov 2015 | JP |
| 2016072557 | May 2016 | JP |
| 2016517633 | Jun 2016 | JP |
| 2016131238 | Jul 2016 | JP |
| 2016208027 | Dec 2016 | JP |
| 2017045869 | Mar 2017 | JP |
| 2017108053 | Jun 2017 | JP |
| 2017116923 | Jun 2017 | JP |
| 2018006742 | Jan 2018 | JP |
| 2018502173 | Jan 2018 | JP |
| 2018025686 | Feb 2018 | JP |
| 2018098229 | Jun 2018 | JP |
| 2018518688 | Jul 2018 | JP |
| 2018164076 | Oct 2018 | JP |
| 2018200930 | Dec 2018 | JP |
| 2019500490 | Jan 2019 | JP |
| 2019024129 | Feb 2019 | JP |
| 2019506730 | Mar 2019 | JP |
| 2019053305 | Apr 2019 | JP |
| 2019056730 | Apr 2019 | JP |
| 2019135755 | Aug 2019 | JP |
| 2019192814 | Oct 2019 | JP |
| 2021523403 | Sep 2021 | JP |
| 890015374 | Oct 1989 | KR |
| 900001238 | Mar 1990 | KR |
| 950001406 | Jan 1995 | KR |
| 960000375 | Jan 1996 | KR |
| 19990029141 | Apr 1999 | KR |
| 20000073111 | Dec 2000 | KR |
| 20020000292 | Jan 2002 | KR |
| 20050112115 | Nov 2005 | KR |
| 20070003657 | Jan 2007 | KR |
| 20080046577 | May 2008 | KR |
| 100841495 | Jun 2008 | KR |
| 20090042059 | Apr 2009 | KR |
| 20100090643 | Aug 2010 | KR |
| 20110007192 | Jan 2011 | KR |
| 20130007389 | Jan 2013 | KR |
| 20130093038 | Aug 2013 | KR |
| 101426105 | Aug 2014 | KR |
| 20140106442 | Sep 2014 | KR |
| 20150091260 | Aug 2015 | KR |
| 20150127145 | Nov 2015 | KR |
| 20160035995 | Apr 2016 | KR |
| 20170066218 | Jun 2017 | KR |
| 20170066225 | Jun 2017 | KR |
| 20180036263 | Apr 2018 | KR |
| 20180054917 | May 2018 | KR |
| 20180116438 | Oct 2018 | KR |
| 20190085654 | Jul 2019 | KR |
| 20190139594 | Dec 2019 | KR |
| 20210142118 | Nov 2021 | KR |
| 201224190 | Jun 2012 | TW |
| I365354 | Jun 2012 | TW |
| 201241555 | Oct 2012 | TW |
| 201330093 | Jul 2013 | TW |
| 201430164 | Aug 2014 | TW |
| I494689 | Aug 2015 | TW |
| 201631377 | Sep 2016 | TW |
| 201729006 | Aug 2017 | TW |
| 201734025 | Oct 2017 | TW |
| 201811876 | Apr 2018 | TW |
| 201830472 | Aug 2018 | TW |
| 201837066 | Oct 2018 | TW |
| 201930323 | Aug 2019 | TW |
| WO-03029015 | Apr 2003 | WO |
| WO-2004095551 | Nov 2004 | WO |
| WO-2007123539 | Nov 2007 | WO |
| WO-2008019362 | Feb 2008 | WO |
| WO-2008088076 | Jul 2008 | WO |
| WO-2011081151 | Jul 2011 | WO |
| WO-2011137059 | Nov 2011 | WO |
| WO-2012075249 | Jun 2012 | WO |
| WO-2012048094 | Jul 2012 | WO |
| WO-2013007442 | Jan 2013 | WO |
| WO-2013078211 | May 2013 | WO |
| WO-2014152023 | Sep 2014 | WO |
| WO-2016065120 | Apr 2016 | WO |
| WO-2016144960 | Sep 2016 | WO |
| WO-2017066319 | Apr 2017 | WO |
| WO-2017109040 | Jun 2017 | WO |
| WO-2017153725 | Sep 2017 | WO |
| WO-2017198418 | Nov 2017 | WO |
| WO-2018004551 | Jan 2018 | WO |
| WO-2018004646 | Jan 2018 | WO |
| WO-2018061670 | Apr 2018 | WO |
| WO-2018173446 | Sep 2018 | WO |
| WO-2019023797 | Feb 2019 | WO |
| WO-2019163455 | Aug 2019 | WO |
| WO-2019217749 | Nov 2019 | WO |
| WO-2019222320 | Nov 2019 | WO |
| WO-2019230462 | Dec 2019 | WO |
| WO-2019241402 | Dec 2019 | WO |
| WO-2020014179 | Jan 2020 | WO |
| WO-2020030855 | Feb 2020 | WO |
| WO-2020033602 | Feb 2020 | WO |
| WO-2020050035 | Mar 2020 | WO |
| WO-2020102085 | May 2020 | WO |
| WO-2020132281 | Jun 2020 | WO |
| WO-2020190941 | Sep 2020 | WO |
| WO-2020223011 | Nov 2020 | WO |
| WO-2020223152 | Nov 2020 | WO |
| WO-2020263750 | Dec 2020 | WO |
| WO-2020264158 | Dec 2020 | WO |
| WO-2020264557 | Dec 2020 | WO |
| WO-2020264571 | Dec 2020 | WO |
| WO-2021067632 | Apr 2021 | WO |
| WO-2021072042 | Apr 2021 | WO |
| WO-2021146138 | Jul 2021 | WO |
| WO-2021202681 | Oct 2021 | WO |
| WO-2021262371 | Dec 2021 | WO |
| WO-2021262529 | Dec 2021 | WO |
| Entry |
|---|
| Cardineau, B. et al., “EUV Resists Based on Tin-oxo Clusters”, Advances in Patterning Materials and Processes XXXI, Proceedings of Spie, Apr. 4, 2014, vol. 9051, pp. 335-346. |
| KR Office Action dated Feb. 8, 2022, in Application No. KR10-2021-7030794 with English Translation. |
| U.S. Notice of Allowance dated Feb. 22, 2022 in U.S. Appl. No. 17/310,635. |
| U.S. Appl. No. 17/753,110, inventors Weidman et al., filed on Feb. 18, 2022. |
| European Search Report dated Feb. 15, 2022, in Application No. EP21741104. |
| Extended European Search Report dated Dec. 23, 2021, in Application No. EP19800353.5. |
| International Preliminary Report on Patentability dated Jan. 6, 2022 in PCT Application No. PCT/US2020/038968. |
| International Preliminary Report on Patentability dated Jan. 6, 2022 in PCT Application No. PCT/US2020/039615. |
| International Preliminary Report on Patentability dated Jan. 6, 2022 in PCT Application No. PCT/US2020/070171. |
| International Preliminary Report on Patentability dated Jan. 6, 2022 in PCT Application No. PCT/US2020/070172. |
| International Preliminary Report on Patentability dated Jan. 6, 2022 in PCT Application No. PCT/US2020/070187. |
| Korean Office Action, dated Feb. 8, 2022, with machine translation, issued in Application No. KR 10-2015-0015184. |
| Co-pending U.S. Appl. No. 17/596,858, filed Dec. 20, 2021. |
| Co-pending U.S. Appl. No. 17/596,928, filed Dec. 21, 2021. |
| Co-pending U.S. Appl. No. 17/754,019, filed Mar. 21, 2022. |
| European Office Action dated Feb. 25, 2022 in U.S. Appl. No. 21/741,104. |
| International Preliminary Report on Patentability dated Apr. 14, 2022 issued in Application No. PCT/US2020/053856. |
| International Preliminary Report on Patentability dated Jan. 27, 2021 in Application PCT/US2020/054730. |
| KR Office Action dated May 9, 2022, in Application No. KR1020217030794 with English translation. |
| TW Office Action dated Apr. 29, 2022 in Application No. TW110118172. |
| TW Office Action dated Mar. 7, 2022, in Application No. TW110101388 with English translation. |
| U.S. Appl. No. 17/596,648, inventors Tan et al., filed on Dec. 15, 2021. |
| U.S. Appl. No. 17/596,651, filed Dec. 15, 2021. |
| U.S. Appl. No. 17/596,722, filed Dec. 16, 2021. |
| Chinese First Office Action dated May 24, 2017 issued in Application No. CN 201510053668.7. |
| Chinese Second Office Action dated Feb. 28, 2018 issued in Application No. CN 201510053668.7. |
| Coons et al., (2010) “Comparison of EUV spectral and ion emission features from laser-produced Sn and Li plasmas,” Extreme Ultraviolet (EUV) Lithography, Proc. of SPIE, 7636:763636-1 to 763636-7. |
| Gerritsen et al., (Apr. 1, 1986) “Laser-generated plasma as soft x-ray source,” J. Appl. Phys., 59(7):2337-2344. |
| Hamley, I.W., “Nanostructure fabrication using block copolymers”, Nanotechnology. Sep. 2003. 17;14(10):R39-R54. |
| Hench, L.L. and West, J.K., “The sol-gel process,” Chemical reviews, Jan. 1, 1990; 90(1) pp. 33-72. |
| International Preliminary Report on Patentability dated Jul. 1, 2021 issued in Application No. PCT/US2019/067540. |
| International Preliminary Report on Patentability dated May 27, 2021 issued in Application No. PCT/US2019/060742. |
| International Search Report and Written Opinion dated May 17, 2021 issued in Application No. PCT/US2021/015656. |
| International Search Report and Written Opinion dated May 12, 2021 issued in Application No. PCT/US2021/012953. |
| International Search Report and Written Opinion dated Apr. 10, 2020 issued in Application No. PCT/US2019/060742. |
| International Search Report and Written Opinion dated Apr. 24, 2020 issued in Application No. PCT/US2019/067540. |
| International Search Report and Written Opinion dated Aug. 22, 2019 issued in Application No. PCT/US2019/031618. |
| International Search Report and Written Opinion dated Jan. 27, 2021 issued in Application No. PCT/US2020/054730. |
| International Search Report and Written Opinion dated Mar. 23, 2021 issued in Application No. PCT/US2020/053856. |
| International Search Report and Written Opinion dated Oct. 16, 2020 issued in Application No. PCT/US2020/039615. |
| International Search Report and Written Opinion dated Oct. 16, 2020 issued in Application No. PCT/US2020/070171. |
| International Search Report and Written Opinion dated Oct. 16, 2020 issued in Application No. PCT/US2020/070172. |
| International Search Report and Written Opinion dated Oct. 16, 2020 issued in Application No. PCT/US2020/070187. |
| International Search Report and Written Opinion dated Oct. 8, 2020 issued in Application No. PCT/US2020/038968. |
| Japanese Decision to Grant dated Feb. 12, 2019 issued in Application No. JP 2015-016254. |
| Japanese Decision to Grant dated May 3, 2021 issued in Application No. JP 2016-220096. |
| Japanese First Office Action dated Oct. 30, 2018 issued in Application No. JP 2015-016254. |
| Japanese First Office Action dated Sep. 15, 2020 issued in Application No. JP 2016-220096. |
| Korean Decision for Grant dated Sep. 2, 2021 issued in Application No. KR 10-2015-0015184. |
| Korean First Office Action dated Dec. 22, 2020 issued in Application No. KR 10-2015-0015184. |
| Korean Second Office Action dated Jul. 27, 2021 issued in Application No. KR 10-2015-0015184. |
| Kwon, J., et al., “Substrate Selectivity of (tBu-Allyl)Co(C0)3 during Thermal Atomic Layer Deposition of Cobalt,” Chemistry of Materials, Mar. 27, 2012; 24(6): pp. 1025-1030. |
| Lemaire, P.C., et al., “Understanding inherent substrate selectivity during atomic layer deposition: Effect of surface preparation, hydroxyl density, and metal oxide composition on nucleation mechanisms during tungsten ALD” The Journal of chemical physics, Feb. 7, 2017, 146(5):052811. |
| Lu, Y., et al., “Continuous formation of supported cubic and hexagonal mesoporous films by sol-gel dip-coating” Nature, Sep. 1997, 389(6649), pp. 364-368. |
| Mackus, A.J., et al. “The use of atomic layer deposition in advanced nanopatterning”, Nanoscale. Jul. 25, 2014; 6(19):10941-60. |
| McGinniss, Vincent D., (1978) “Light Sources,” Edited by: Pappas, S. Peter, UV Curing: Science and Technology; technology marketing corporation, 642 Westover Rd., Stamford, CT, USA; pp. 96-129. |
| Nazarov, D.V., et al., “Atomic layer deposition of tin dioxide nanofilms: A review”, Rev. Adv. Mater. Sci. Jun. 1, 2015; 40(3):262-75. |
| Notice of Allowance dated Dec. 9, 2021 in U.S. Appl. No. 17/310,635. |
| Rantala, et al., “New resist and underlayer approaches toward EUV lithography,” Proc. SPIE 10809, International Conference on Extreme Ultraviolet Lithography 2018, pp. 108090X-1-108090X-8. (Oct. 11, 2018). |
| Spitzer et al., (Mar. 1, 1986) “Conversion efficiencies from laser-produced plasmas in the extreme ultraviolet regime,” J. Appl. Phys., 79(5):2251-2258. |
| Stowers et al.; “Directly patterned inorganic hard mask for EUV lithography”; proceedings of the SPIE 7969; Extreme Ultraviolet (EUV) Lithography 11, 796915-1-11 (Apr. 7, 2011), event: SPI E Advanced Lithography, 2011, San Jose California. |
| Taiwanese First Office Action dated Aug. 10, 2020 issued in Application No. TW 105137362. |
| Taiwanese First Office Action dated May 31, 2018 issued in Application No. TW 104103153. |
| Taiwanese Second Office Action dated Nov. 18, 2020 issued in Application No. TW 105137362. |
| U.S. Final Office Action, dated May 11, 2017, issued in U.S. Appl. No. 14/610,038. |
| U.S. Final Office Action, dated Sep. 10, 2018, issued in U.S. Appl. No. 15/691,659. |
| U.S. Notice of Allowance, dated Apr. 25, 2018 issued in U.S. Appl. No. 14/948,109. |
| U.S. Notice of Allowance, dated Aug. 22, 2017, issued in U.S. Appl. No. 14/610,038. |
| U.S. Notice of Allowance, dated Jul. 28, 2020, issued in U.S. Appl. No. 16/206,959. |
| U.S. Notice of Allowance dated Sep. 15, 2021, issued in U.S. Appl. No. 16/691,508. |
| U.S. Notice of Allowance, dated Sep. 19, 2019, issued in U.S. Appl. No. 15/691,659. |
| U.S. Notice of Allowance dated Sep. 9, 2021, issued in U.S. Appl. No. 16/691,508. |
| U.S. Office Action, dated Apr. 9, 2019, issued in U.S. Appl. No. 15/691,659. |
| U.S. Office Action, dated Jan. 23, 2017, issued in U.S. Appl. No. 14/610,038. |
| U.S. Office Action, dated Mar. 5, 2020, issued in U.S. Appl. No. 16/206,959. |
| U.S. Office Action dated May 14, 2021, issued in U.S. Appl. No. 16/691,508. |
| U.S. Office Action, dated May 21, 2018, issued in U.S. Appl. No. 15/691,659. |
| U.S. Office Action, dated Nov. 2, 2017, issued in U.S. Appl. No. 14/948,109. |
| U.S. Appl. No. 17/309,247, Weidman et al., filed on May 11, 2021. |
| U.S. Appl. No. 17/309,587, Volosskiy et al., filed on Jun. 8, 2021. |
| U.S. Appl. No. 17/310,635, Tan et al., filed on Aug. 13, 2021. |
| Xu, et al., “Underlayer designs to enhance the performance of EUV resists,” Proceedings of SPIE, vol. 7273, 2009, pp. 727311-1-727311-11. |
| Banerjee, D. et al., “Potential of Metal-Organic Frameworks for Separation of Xenon and Krypton”, Accounts of Chemical Research, 2015, vol. 48, No. 2, pp. 211-219. |
| CN Office Action dated Jun. 8, 2022 in Application No. CN202180002531.2 With English Translation. |
| CN Office Action dated Jun. 1, 2023, in application No. CN201810783756 with English translation. |
| CN Office Action dated Nov. 16, 2022, in Application No. CN202180002531.2 with English translation. |
| CN Office Action dated Nov. 18, 2022, in Application No. CN201810783756.6 with English translation. |
| Danilo D.E., et al., “Metal Containing Resist Readiness for HVM EUV Lithography”, Journal of Photopolymer Science and Technology, 2016, vol. 29(3), pp. 501-507. |
| EP Extended European Search Report dated Jul. 13, 2023, in Application No. EP20831843.6. |
| EP Extended European Search report dated Jun. 26, 2023, in Application No. 20831242.1. |
| EP Extended European Search Report dated Jun. 26, 2023, in Application No. 20831343.7. |
| EP Extended European Search report dated Jun. 28, 2023, in Application No. EP 20832501.9. |
| Fan, Y. et al., (2016) “Benchmarking Study of EUV Resists for NXE:3300B,” Proc. of SPIE, 9776:97760W-1 to 97760W-11 [Downloaded From http://proceedings.spiedigitallibrary.org/ on Mar. 30, 2017]. |
| Fujifilm Corp., (Presentation) “Negative tone development process for double patterning,” 5th International Symposium on Immersion Lithography, Sep. 2008, Presentation Slides No. p. 1-p. 27. |
| Fujifilm Corp., (Safety Data Sheet) Name of Substance: n-Butyl acetate; Trade Name of Substance: FN-DP001 Ultra Pure Developer, Revision Date: Nov. 25, 2013, MSDS file: 16328_GB_EN_V2.0, pp. 1-9. |
| Gangnaik, A.S. et al., (Jan. 12, 2017) “New Generation Electron Beam Resists: A Review,” Chem. Mater., 29:1898-1917. |
| Gross, R.A. et al., “Biodegradable Polymers for the Environment”, Science, Aug. 2, 2002, vol. 297, No. 5582, pp. 803-807. |
| Harrisson, S. et al., “RAFT Polymerization of Vinyl Esters: Synthesis and Applications”, Polymers, 2014, vol. 6, No. 5, pp. 1437-1488. |
| International Preliminary Report on Patentability dated Oct. 13, 2022, in PCT Application No. PCT/US2021/023493. |
| International Preliminary Report on Patentability dated Oct. 13, 2022, in PCT Application No. PCT/US2021/025111. |
| International Search Report and Written Opinion dated Aug. 4, 2021, in PCT Application No. PCT/US2021/023493. |
| International Search Report and Written Opinion dated Jul. 20, 2021, in PCT Application No. PCT/US2021/025111. |
| International Search Report and Written Opinion dated Mar. 4, 2022, in Application No. PCT/US2021/058647. |
| International Search Report and Written Opinion dated Nov. 11, 2022 in PCT Application No. PCT/US2022/037733. |
| International Search Report and Written Opinion dated Oct. 8, 2020 in Application No. WO2020US38968. |
| International Preliminary Report on Patentability dated Aug. 18, 2022 in PCT Application No. PCT/US2021/015656. |
| International Preliminary Report on Patentability dated Jan. 5, 2023 in PCT Application No. PCT/US2021/034019. |
| International Preliminary Report on Patentability dated Jan. 5, 2023 in PCT Application No. PCT/US2021/037924. |
| International Preliminary Report on Patentability dated Jan. 19, 2023 in PCT Application No. PCT/US2021/040381. |
| International Preliminary Report on Patentability dated Jan. 26, 2023 in PCT Application No. PCT/US2021/042103. |
| International Preliminary Report on Patentability dated Jan. 26, 2023 in PCT Application No. PCT/US2021/042104. |
| International Preliminary Report on Patentability dated Jan. 26, 2023 in PCT Application No. PCT/US2021/042106. |
| International Preliminary Report on Patentability dated Jan. 26, 2023 in PCT Application No. PCT/US2021/042107. |
| International Preliminary Report on Patentability dated Jan. 26, 2023 in PCT Application No. PCT/US2021/042108. |
| International Preliminary Report on Patentability dated Jul. 28, 2022 in PCT Application No. PCT/US2021/012953. |
| International Preliminary Report on Patentability dated Jun. 22, 2023, in Application No. PCT/US2021/061751. |
| International Preliminary Report on Patentability dated Nov. 11, 2021, for International Application No. PCT/US2020/028151. |
| International Preliminary Report on Patentability dated Nov. 28, 2019 issued in Application No. PCT/US2018/032783. |
| International Preliminary Report on Patentability dated Nov. 7, 2019 issued in Application No. PCT/US2018/028192. |
| International Preliminary Report on Patentability dated Sep. 9, 2022, in PCT Application No. PCT/US2021/019245. |
| International Preliminary Report on Patentability dated Sep. 30, 2021 issued in Application No. PCT/US2020/023146. |
| International Search Report and Written Opinion dated Apr. 17, 2023, in Application No. PCT/US2022/081390. |
| International Search Report and Written Opinion dated Apr. 17, 2023 in PCT Application No. PCT/US2022/081376. |
| International Search Report and Written Opinion dated Apr. 19, 2023, in Application No. PCT/US2022/081845. |
| International Search Report and Written Opinion dated Aug. 8, 2018 issued in Application No. PCT/US2018/028192. |
| International Search Report and Written Opinion dated Jul. 17, 2020 issued in Application No. PCT/US2020/023146. |
| International Search Report and Written Opinion dated Jul. 31, 2020, in PCT Application No. PCT/US2020/028151. |
| International Search Report and Written Opinion dated Mar. 24, 2022, for International Application No. PCT/US2021/061751. |
| International Search Report and Written Opinion dated May 3, 2023, in Application No. PCT/US2023/060306. |
| International Search Report and Written Opinion dated Nov. 3, 2021, in PCT Application No. PCT/US2021/042108. |
| International Search Report and Written Opinion dated Nov. 4, 2021 in PCT Application No. PCT/US2021/042103. |
| International Search Report and Written Opinion dated Nov. 4, 2021 in PCT Application No. PCT/US2021/042106. |
| International Search Report and Written Opinion dated Nov. 4, 2021 in PCT Application No. PCT/US2021/042107. |
| International Search Report and Written Opinion dated Nov. 10, 2021, in PCT Application No. PCT/US2021/042104. |
| International Search Report and Written Opinion dated Oct. 13, 2021, in application No. PCT/US2021/037924. |
| International Search Report and Written Opinion dated Oct. 16, 2018 issued in Application No. PCT/US2018/032783. |
| International Search Report and Written Opinion dated Oct. 28, 2021 in PCT Application No. PCT/US2021/040381. |
| International Search Report and Written Opinion dated Sep. 15, 2021, in PCT Application No. PCT/US2021/034019. |
| Joo, W. et al., “Synthesis of Unzipping Polyester and a Study of its Photochemistry”, Journal of the American Chemical Society, 2019, vol. 141, No. 37, pp. 14736-14741. |
| JP Office Action dated Jul. 26, 2022 in Application No. JP2021102822 With English translation. |
| JP Office Action dated Nov. 15, 2022, in Application No. JP2021-176082 with English translation. |
| JP Office Action dated Apr. 11, 2023 in Application No. JP2021-176082 with English translation. |
| JP Office Action dated Apr. 27, 2023 in Application No. JP2021-575910 with English translation. |
| JP Office Action dated Feb. 28, 2023 in Application No. JP2020-562160 with English translation. |
| JP Office Action dated Jan. 17, 2023, in Application No. JP2022-552422 with English translation. |
| JP Office Action dated Jun. 14, 2022, in Application No. JP20190563508 with English translation. |
| JP Office Action dated Jun. 27, 2023, in Application No. JP2022-552422 with English translation. |
| JP Office Action dated Jun. 28, 2022 in Application No. JP2021560945 with English translation. |
| Klepper, K.B. et al., “Atomic Layer Deposition of Organic-inorganic Hybrid Materials Based on Saturated Linear Carboxylic Acids”, Dalton Transactions, May 7, 2011, vol. 40, No. 17, pp. 4337-4748. |
| KR Office Action dated Jan. 2, 2023 in Application No. KR10-2022-7027233 with English translation. |
| KR Office Action dated Sep. 28, 2022, in Application No. KR10-2022-7027233 with English translation. |
| Mai, L. et al., “Atomic/molecular Layer Deposition of Hybrid Inorganic-organic Thin Films from Erbium Guanidinate Precursor”, Journal of Materials Science, 2017, vol. 52, No. 11, pp. 6216-6224. https://doi.org/10.1007/s10853-017-0855-6. |
| Meng, X., “An Overview of Molecular Layer Deposition for Organic and Organic-inorganic Hybrid Materials: Mechanisms, Growth Characteristics, and Promising Applications”, Journal of Materials Chemistry A, 2017, vol. 5, pp. 18326-18378. |
| Molloy, K. C., “Precursors for the Formation of Tin (IV) Oxide and Related Materials”, Journal of Chemical Research, 2008, vol. 2008, No. 10, pp. 549-554. |
| Rothschild, et al., “Liquid immersion lithography: Why, how, and when?” Journal Vacuum Science Technology, Nov./Dec. 2004, pp. 2877-2881. |
| Santillan et al., “In Situ analysis of negative-tone resist pattern formation using organic-solvent-based developer process,” Applied Physics Express, vol. 7 (2014), pp. 016501-1-016501-4. [retrieved Sep. 20, 2017] URL: http:dx.doi.org/10.7567/APEX.7.016501. |
| Stulen, et al., “Extreme Ultraviolet Lithography” IEEE Journal of Quantum Electronics, vol. 35, No. 5, May 1999, pp. 694-699. |
| Sundberg, P. et al., “Organic and Inorganic-organic Thin Film Structures by Molecular Layer Deposition: A Review”, Beilstein Journal of Nanotechnology, 2014, vol. 5, pp. 1104-1136. |
| Taiwanese Office Action dated Apr. 10, 2023 in TW Application No. TW108140940 with English translation. |
| TW Office Action dated Jan. 9, 2023 in Application No. TW20190116155 with English translation. |
| TW Office Action dated Sep. 5, 2022, in Application No. TW110101388 with English translation. |
| TW Office Action dated Sep. 8, 2022 in Application No. TW111123386 with English translation. |
| TW First Office Action dated Oct. 6, 2021, in application No. TW20180116415 with English translation. |
| TW Office Action dated Apr. 29, 2022 in Application No. TW110118172 with English translation. |
| TW Office Action dated Jan. 13, 2023, in Application No. TW110124741 with English translation. |
| TW Office Action dated Jan. 19, 2023 in Application No. TW110141961 with English translation. |
| TW Office Action dated Jun. 3, 2022, in Application No. TW110143913 with English translation. |
| TW Office Action dated May 16, 2023, in Application No. TW20190146890 with English translation. |
| U.S. Final Office Action, dated Feb. 5, 2019 issued in U.S. Appl. No. 15/495,701. |
| U.S. Final Office Action dated May 12, 2023 in U.S. Appl. No. 17/455,185. |
| U.S. Non-Final office Action dated Feb. 7, 2023 in U.S. Appl. No. 17/455,185. |
| U.S. Notice of Allowance, dated Jun. 10, 2020 issued in U.S. Appl. No. 15/979,340. |
| U.S. Notice of Allowance, dated Sep. 30, 2021 issued in U.S. Appl. No. 17/008,095. |
| U.S. Office Action, dated Aug. 9, 2018 issued in U.S. Appl. No. 15/495,701. |
| U.S. Office Action, dated Mar. 18, 2021 issued in U.S. Appl. No. 17/008,095. |
| U.S. Office Action, dated Nov. 6, 2019 issued in U.S. Appl. No. 15/979,340. |
| U.S. Appl. No. 17/759,896, inventors Nagabhirava et al., filed on Aug. 1, 2022. |
| U.S. Appl. No. 17/905,754, inventors Kanakasabapathy et al., filed on Sep. 6, 2022. |
| U.S. Appl. No. 18/005,169, inventors Hansen et al., filed on Jan. 11, 2023. |
| U.S. Appl. No. 18/005,328, inventors Hansen et al., filed on Jan. 12, 2023. |
| U.S. Appl. No. 18/005,571 inventors Hansen et al., filed on Jan. 13, 2023. |
| U.S. Appl. No. 18/005,594, inventors Hansen et al., filed on Jan. 13, 2023. |
| U.S. Appl. No. 18/005,595, inventors Hansen et al., filed on Jan. 13, 2023. |
| U.S. Appl. No. 18/011,707, inventors Peter et al., filed on Dec. 20, 2022. |
| U.S. Appl. No. 18/184,545, inventors Yu et al., filed on Mar. 15, 2023. |
| U.S. Appl. No. 18/254,787, inventors Dictus D, et al., filed on May 26, 2023. |
| U.S. Appl. No. 18/297,989, inventors Marks et al., filed on Apr. 10, 2023. |
| U.S. Appl. No. 18/298,003, inventors Marks et al., filed on Apr. 10, 2023. |
| U.S. Restriction Requirement dated Nov. 14, 2022 in U.S. Appl. No. 17/455,185. |
| U.S. Supplemental Notice of Allowability dated Jan. 26, 2022, in U.S. Appl. No. 17/008,095. |
| Wang, et al., “Lithography Simulation for the Fabrication of Silicon Photonic Devices with Deep-Ultraviolet Lithography” IEEE, (2012) pp. 288-290. |
| Yoon, K. et al., “Fabrication of a New Type of Organic-inorganic Hybrid Superlattice Films Combined With Titanium Oxide and Polydiacetylene”, Nanoscale Research Letters, Jan. 5, 2012, vol. 7, No. 71, 6 pages. |
| Zhou, H. et al., “Molecular Layer Deposition of Functional Thin Films for Advanced Lithographic Patterning”, ACS Applied Materials & Interfaces, 2011, vol. 3, No. 2, pp. 505-511. |
| Bespalov I., et al., “Key Role of Very Low Energy Electrons in Tin-Based Molecular Resists for Extreme Ultraviolet Nanolithography,” ACS Applied Materials & Interfaces, 2020, vol. 12, pp. 9881-9889. |
| Chiang C L., et al., “Secondary Electron Emission Characteristics of Oxide Electrodes In Flat Electron Emission Lamp,” AIP Advances, 2016, vol. 6, 015317, 9 Pages. |
| Cui L F., et al., “Endohedral Stannaspherenes M@Sn12: A Rich Class of Stable Molecular Cage Clusters,” Endohedral Tin Cages, 2007, vol. 46, pp. 742-745. |
| EP Extended European Search report dated Jun. 23, 2023, in Application No. EP20831420.3. |
| EP Extended European Search report dated Oct. 25, 2023, in Application No. EP21837274.6. |
| EP Extended European Search report dated Sep. 25, 2023, in Application No. EP20870849.5. |
| EP Partial European Search Report dated Aug. 29, 2023, in Application No. 23173688.5. |
| Fitzgerald C B., et al., “Magnetism in Dilute Magnetic Oxide Thin Films Based on SnO2,” The American Physical Society, 2006, vol. 74, 115307, 10 Pages. |
| International Search Report and Written Opinion dated Jul. 13, 2021, in PCT Application No. PCT/US2021/023901. |
| International Search Report and Written Opinion dated May 18, 2022, in International Application No. PCT/US2022/014984. |
| International Preliminary Report on Patentability dated Aug. 24, 2023, in PCT Application No. PCT/US2022/014984. |
| International Preliminary Report on Patentability dated May 25, 2023, in Application No. PCT/US2021/058647. |
| International Preliminary Report on Patentability dated Oct. 13, 2022, in PCT Application No. PCT/US2021/023901. |
| International Preliminary Report on Patentability dated Sep. 7, 2023, in PCT Application No. PCT/US2022/014281. |
| International Search Report and Written Opinion dated Aug. 17, 2023, in Application No. PCT/US2023/019871. |
| International Search Report and Written Opinion dated May 16, 2022, In International Application No. PCT/US2022/014281. |
| International Search Report and Written Opinion dated Oct. 13, 2023 in PCT Application No. PCT/US2023/069419. |
| Jalife S., et al., “Noble Gas Endohedral Fullerenes,” Chemical Science, 2020, vol. 11, pp. 6642-6652. |
| JP Office Action dated Jun. 27, 2023, in application No. JP2023-63868 with English translation. |
| JP Office Action dated Nov. 14, 2023, in JP Application No. 2021-0575910 with English Translation. |
| JP Office Action dated Nov. 14, 2023 in JP Application No. 2022-559416, with English Translation. |
| JP Office Action dated Oct. 3, 2023 in Application No. JP2021-176082 with English Translation. |
| JP Office Action dated Oct. 10, 2023 in Application No. JP2022-552422 with English Translation. |
| JP Office Action dated Sep. 19, 2023 in Application No. JP2020-562160 with English translation. |
| Komen C V., et al., “Structure-Magnetic Property Relationship Intransition Metal (M=V,Cr, Mn, Fe, Co, Ni) Doped Sno2 Nanoparticles,” Journal of Applied Physics, 2008, vol. 103, 5 Pages. |
| KR Office Action dated Aug. 11, 2023, in Application No. KR10-2023-7011840 with English translation. |
| KR Search Report dated Aug. 25, 2023, in Application No. KR10-2021-7022858. |
| Kvon V., et al., “Secondary Electron Emission Of Tin And Tin-Lithium Under Low Energy Helium Plasma Exposure,” Nuclear Materials and Energy, 2017, vol. 13, pp. 21-27. |
| Lin Y., et al., “A New Examination Of Secondary Electron Yield Data,” Surface And Interface Analysis, 2005, vol. 37, pp. 895-900. |
| Ogale S B., et al., “High Temperature Ferromagnetism with Giant Magnetic Moment in Transparent Co-doped SnO2- δ,” Physical Review Letters, 2003, 17 Pages. |
| Pedersen A., et al., “Lithiation of Tin Oxide: A Computational Study,” Integrated Systems Laboratory, 2014, 20 Pages. |
| Saunders M., et al., “Noble Gas Atoms Inside Fullerenes,” Science, 1996, vol. 271, pp. 1693-1697. |
| Singh R ., “Unexpected Magnetism In Nanomaterials,” Journal of Magnetism and Magnetic Materials, 2013, vol. 346, pp. 58-73. |
| Tian Y F., et al., “Oxide Magnetic Semiconductors: Materials, Properties, And Devices,” Magnetism, Magnetic Materials, And Interdisciplinary Research, 2013, vol. 22(8), 2 Pages. |
| TW Office Action dated Aug. 17, 2023, in application No. TW110124741 with Translation. |
| TW Office Action dated Oct. 13, 2023, in application No. TW109121680 with English Translation. |
| TW Office Action dated Oct. 30, 2023, in application No. TW108116155 with English Translation. |
| U.S. Final Office Action dated Nov. 9, 2023 in U.S. Appl. No. 17/455,185. |
| U.S. Non-Final Office Action dated Nov. 6, 2023, in U.S. Appl. No. 17/309,587. |
| U.S. Non-Final Office Action dated Oct. 13, 2023, in U.S. Appl. No. 18/184,545. |
| U.S. Non-Final Office Action dated Oct. 20, 2023, in U.S. Appl. No. 18/297,989. |
| U.S. Non-Final Office Action dated Oct. 20, 2023, in U.S. Appl. No. 18/298,003. |
| U.S. Non-Final Office Action dated Oct. 26, 2023, in U.S. Appl. No. 17/596,648. |
| U.S. Non-Final Office Action dated Oct. 26, 2023, in U.S. Appl. No. 17/596,928. |
| U.S. Non-Final Office Action dated Sep. 13, 2023, in U.S. Appl. No. 17/596,651. |
| U.S. Non-Final Office Action dated Sep. 28, 2023, in U.S. Appl. No. 15/733,598. |
| U.S. Notice of Allowance dated Oct. 18, 2023 in U.S. Appl. No. 17/309,247. |
| U.S. Appl. No. 18/264,391, inventors Kanakasabapathy S K, et al., filed on Aug. 4, 2023. |
| U.S. Appl. No. 18/377,245, inventors Dictus D, et al., filed on Oct. 5, 2023. |
| U.S. Appl. No. 18/377,267, inventors Yu J, et al., filed on Oct. 5, 2023. |
| U.S. Appl. No. 18/546,879, inventors Weidman T W, et al., filed on Aug. 17, 2023. |
| U.S. Restriction requirement dated Aug. 4, 2023, in U.S. Appl. No. 18/297,989. |
| U.S Restriction requirement dated Aug. 18, 2023 in U.S. Appl. No. 18/298,003. |
| U.S. Restriction requirement dated Sep. 7, 2023 in U.S. Appl. No. 17/309,587. |
| CN Office Action dated Dec. 13, 2023 in CN Application No. 201810783756.6 with English translation. |
| CN Office Action dated Dec. 26, 2023 in CN Application No. 201980028279.5, with English Translation. |
| CN Office Action dated Jan. 3, 2024 in CN Application No. 202310318757.4 with English Translation. |
| CN Office Action dated Jan. 22, 2024 in CN Application No. 202080047683.X, with English Translation. |
| CN Office Action dated Jan. 23, 2024 in CN Application No. 202080046943.1 with English Translation. |
| Dahuang, D., et al., Functional Thin Films and Their Deposition Preparation Techniques, Metallurgy Industrial Press, Jan. 31, 2013, pp. 450-454. [with English Translation]. |
| EP Extended European Search report dated Nov. 29, 2023 in EP Application No. 23173688.5. |
| International Preliminary Report on Patentability and Written Opinion dated Feb. 8, 2024 in PCT Application No. PCT/US2022/037393. |
| International Preliminary Report on Patentability and Written Opinion dated Feb. 8, 2024 in PCT Application No. PCT/US2022/037733. |
| International Search Report and Written Opinion dated Feb. 1, 2024 in PCT Application No. PCT/US2023/034545. |
| International Search Report and Written Opinion dated Jan. 10, 2024 in PCT Application No. PCT/US2023/033020. |
| International Search Report and Written Opinion dated Nov. 7, 2022 in PCT Application No. PCT/US2022/037393. |
| JP Office Action dated Dec. 26, 2023 in JP Application No. 20210576241, with English Translation. |
| JP Office Action dated Dec. 26, 2023 in JP Application No. 2021-526240, with English Translation. |
| JP Office Action dated Feb. 13, 2024 in JP Application No. 2023-63868, with English Translation. |
| JP Office Action dated Jan. 9, 2024 in JP Application No. 2023-179933, with English Translation. |
| JP Office Action dated Jan. 9, 2024 in JP Application No. 2023-184334 with English Translation. |
| KR Office Action dated Nov. 21, 2023 in KR Application No. 10-2022-7002869 with English Translation. |
| KR Office Action dated Nov. 21, 2023 in KR Application No. 10-2022-7029421 with English Translation. |
| KR Prior Art Search Report dated Apr. 3, 2023, in application No. KR 10-2022-7029421 with English translation. |
| KR Prior Art Search Report dated Aug. 25, 2023, in Application No. KR10-2021-7022858 with English translation. |
| KR Prior Art Search Report dated Nov. 14, 2023, in Application No. KR10-2023-7038357 with English translation. |
| KR Prior Art Search Report dated Oct. 30, 2023 in KR Application No. 10-2023-7036296 with English translation. |
| TW Office Action dated Dec. 20, 2023, in TW Application No. 109121579 with English Translation. |
| TW Office Action dated Feb. 21, 2024 in TW Application No. 109121664 with English translation. |
| TW Office Action dated Feb. 29, 2024 in TW Application No. 109134377 with English translation. |
| TW Office Action dated Jan. 2, 2024 in TW Application No. 109121639, with English Translation. |
| TW Office Action dated Jan. 11, 2024 in TW Application No. 108146890, with English Translation. |
| U.S. Corrected Notice of Allowance dated Jan. 31, 2024 in U.S. Appl. No. 17/309,247. |
| U.S. Final Office Action dated Feb. 27, 2024 in U.S. Appl. No. 18/298,003. |
| U.S. Non-Final Office Action dated Feb. 1, 2024 in U.S. Appl. No. 17/759,281. |
| U.S. Non-Final Office Action dated Nov. 20, 2023 in U.S. Appl. No. 18/377,245. |
| U.S. Appl. No. 18/580,334, inventors Peter D, et al., filed on Jan. 18, 2024. |
| U.S. Restriction Requirement dated Nov. 20, 2023 in U.S. Appl. No. 17/759,28. |
| Number | Date | Country | |
|---|---|---|---|
| 20220043334 A1 | Feb 2022 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62961647 | Jan 2020 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 17310635 | US | |
| Child | 17452365 | US |
